As filed with the Securities and Exchange Commission on October 31, 2018

Registration No. 333-                    

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

Linde plc

(Exact name of registrant as specified in its charter)

 

 

 

Ireland   2810   98-1448883

(State or other jurisdiction of

incorporation or organization)

 

(Primary Standard Industrial

Classification Code Number)

 

(I.R.S. Employer

Identification Number)

The Priestley Centre, 10 Priestley Road, The Surrey Research Park

Guildford, Surrey GU2 7XY

United Kingdom

+44 1483 242200

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Amended and Restated 2002 Praxair, Inc. Long Term Incentive Plan

2005 Equity Compensation Plan for Non-Employee Directors of Praxair, Inc.

Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan

Long Term Incentive Plan 2018 of Linde plc

(Full Title of Plans)

Guillermo Bichara

General Counsel

c/o Praxair, Inc.

10 Riverview Drive

Danbury, Connecticut 06810-5113

+1 (203) 837-2000

(Name, address, and telephone number, including area code, of agent for service)

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Securities Exchange Act of 1934, as amended:

 

Large accelerated filer      Accelerated filer  
Non-accelerated filer      Smaller reporting company  
     Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  ☐

 

 

CALCULATION OF REGISTRATION FEE

 

 

Title of each class of securities
to be registered
  Amount to be
registered(1)(2)
  Proposed maximum
offering price per
share(3)
  Proposed maximum
aggregate offering
price(3)
  Amount of
registration fee(4)
Ordinary shares, nominal value €0.001 per share issuable pursuant to Amended and Restated 2002 Praxair, Inc. Long Term Incentive Plan  

182,179

 

$60.92

 

$11,098,344.68

 

$1,345.12

Ordinary shares, nominal value €0.001 per share issuable pursuant to 2005 Equity Compensation Plan for Non-Employee Directors of Praxair, Inc.  

4,600

 

$60.92

 

$280,232.00

 

$33.96

Ordinary shares, nominal value €0.001 per share issuable pursuant to Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan  

19,700,908

 

$140.18

  $2,761,649,803.00  

$334,711.96

Ordinary shares, nominal value €0.001 per share issuable pursuant to Linde plc Long Term Incentive Plan 2018   473,128   $165.28   $78,198,595.84   $9,477.67

Total

 

20,360,815

 

$140.04

  $2,851,226,976.00   $345,568.71

 

 

(1)

This Registration Statement (the “Registration Statement”) registers an aggregate of 20,360,815 ordinary shares, nominal value €0.001 per share (the “Shares”), of Linde plc, a public limited company incorporated in Ireland (the “Registrant”), comprised of 182,179 Shares that may be issued pursuant to the exercise of outstanding stock options granted to participants under the 2002 Praxair, Inc. Long Term Incentive Plan (the “2002 Plan”), 4,600 Shares that may be issued pursuant to the exercise of outstanding stock options granted to participants under the 2005 Equity Compensation Plan for Non-Employee Directors of Praxair, Inc. (the “2005 Plan”), 19,700,908 Shares that may be issued pursuant to the exercise of outstanding stock options granted to participants under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan (the “2009 Plan”) or subject to outstanding equity-based awards other than stock options or that remain available for issuance under the 2009 Plan, and 473,128 Shares that may be issued pursuant to the Long Term Incentive Plan 2018 of Linde plc (the “2018 Plan”, and collectively, the “Plans”).

(2)

Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement also covers an indeterminate number of additional Shares as may be offered or issued under the Plans pursuant to this Registration Statement by reason of any stock split, stock dividends, or similar transactions or any other anti-dilutive or adjustment provisions of the Plans, as applicable.

(3)

Pursuant to Rule 457(h) of the Securities Act, the proposed maximum offering price per share and the proposed maximum aggregate offering are estimated solely for the purpose of calculating the amount of the registration fee and are based on (i) $60.92, which is the weighted average exercise price for Shares subject to the 182,179 outstanding stock options granted pursuant to the 2002 Plan, (ii) $60.92, which is the weighted average exercise price for Shares subject to the 4,600 outstanding stock options granted pursuant to the 2005 Plan, (iii) $118.48, which is the weighted average exercise price for Shares subject to the 10,566,587 outstanding stock options granted pursuant to the 2009 Plan, and (iv) with respect to all other shares of Registrant common stock covered by this Registration Statement, the average of the high and low prices of shares of common stock of Praxair, Inc., a Delaware corporation (the predecessor to the Registrant) as reported on the New York Stock Exchange on October 26, 2018.

(4)

Calculated by multiplying the proposed maximum aggregate offering price of securities to be registered by 0.0001212.

 

 

 


EXPLANATORY NOTE

On October 31, 2018, Praxair, Inc., a Delaware corporation (the “Predecessor”), and Linde Aktiengesellschaft, a stock corporation incorporated under the laws of Germany (“Linde AG”), combined under Linde plc, a public limited company incorporated in Ireland (the “Registrant”), as contemplated by the business combination agreement, dated June 1, 2017, as amended on August 10, 2017 (the “Business Combination Agreement”), by and among the Registrant, the Predecessor, Linde AG, Zamalight Holdco LLC and Zamalight Subco, Inc. (the “Business Combination”).

As contemplated by the Business Combination Agreement, the Board of Directors of the Registrant approved, effective as of the completion of the Business Combination, (i) the assumption by the Registrant of the Amended and Restated 2002 Praxair, Inc. Long Term Incentive Plan, the 2005 Equity Compensation Plan for Non-Employee Directors of Praxair, Inc., the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan, and all outstanding awards under such plans, and (ii) the adoption of the Long Term Incentive Plan 2018 of the Registrant (collectively, the “Plans”).

This Registration Statement on Form S-8 (the “Registration Statement”) is being filed by the Registrant, as successor registrant to the Predecessor, with the Securities and Exchange Commission (the “Commission”) for the purpose of registering 20,360,815 of the Registrant’s ordinary shares, nominal value €0.001 per share, for issuance to eligible employees of the Registrant or its subsidiaries pursuant to awards granted or that may in the future be granted under the Plans.

PART I

INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS

The document(s) containing the employee benefit plan information required by Item 1 of Form S-8 and the statement of availability of registrant information and any other information required by Item 2 of Form S-8 will be sent or given to participants as specified by Rule 428 under the Securities Act. In accordance with Rule 428 and the requirements of Part I of Form S-8, such documents are not being filed with the Commission either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act. The Registrant will maintain a file of such documents in accordance with the provisions of Rule 428. Upon request, the Registrant will furnish to the Commission or its staff a copy of any or all of the documents included in such file.

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3. Incorporation of Documents by Reference.

The following documents filed by the Registrant and Predecessor with the Commission pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”), are incorporated by reference into, and shall be deemed to be a part of, this Registration Statement:

 

  1.

Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed on March 23, 2018;

 

  2.

Registrant’s Current Report on Form 8-K filed on October 31, 2018 (to the extent filed and not furnished);

 

  3.

Predecessor’s Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed on February 28, 2018, as amended on April 30, 2018;

 

  4.

Predecessor’s Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, and June 30, 2018, filed on April 26 and July 26, 2018, respectively;

 

2


  5.

Predecessor’s Current Reports on Form 8-K, filed on April 10, July 10, September 7, October 22 (two filings), and October 31, 2018, respectively; and

 

  6.

The information set forth under the heading “Description of Linde plc Shares” included in Registrant’s Registration Statement on Form S-4 (Amendment No. 4), filed with the Commission on August 10, 2017.

All documents subsequently filed by the Registrant and/or the Predecessor with the Commission pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, after the date of this Registration Statement, but prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement. Each document incorporated or deemed incorporated by reference into this Registration Statement shall be deemed to be a part of this Registration Statement from the date of the filing of such document with the Commission until the information contained therein is superseded or updated by any subsequently filed document which is incorporated or deemed incorporated by reference into this Registration Statement or by any document which constitutes a part of the prospectus relating to the Plan meeting the requirements of Section 10(a) of the Securities Act. Any such information so modified or superseded shall not be deemed, except as so modified or superseded, to constitute part of this Registration Statement.

Item 4. Description of Securities.

The class of securities to be offered under this Registration Statement is registered under Section 12(b) of the Exchange Act.

Item 5. Interests of Named Experts and Counsel.

Not applicable.

Item 6. Indemnification of Directors and Officers.

Pursuant to Registrant’s constitution, subject to the provisions of and so far as may be permitted by the Irish Companies Act 2014 (the “Companies Act”), every director, officer or employee of the Registrant, and each person who is or was serving at the request of the Registrant as a director, officer or employee of another company, or of a partnership, joint venture, trust or other enterprise, shall be entitled to be indemnified by the Registrant against all costs, charges, losses, expenses and liabilities incurred by him or her in the execution and discharge of his duties or in relation thereto, including any liability incurred by him or her in defending any proceedings, civil or criminal, which relate to anything done or omitted or alleged to have been done or omitted by him or her as a director, officer or employee of the Registrant or such other company, partnership, joint venture, trust or other enterprise, and in which judgment is given in his favor (or the proceedings are otherwise disposed of without any finding or admission of any material breach of duty on his part) or in which he is acquitted or in connection with any application under any statute for relief from liability in respect of any such act or omission in which relief is granted to him or her by the court.

The Companies Act prescribes that such an indemnity only permits a company to pay the costs or discharge the liability of a director or the secretary where judgment is given in any civil or criminal action in respect of such costs or liability, or where an Irish court grants relief because the director or secretary acted honestly and reasonably and ought fairly to be excused. Registrant is a public limited liability company organized and existing under the laws of Ireland.

Effective as of October 22, 2018, Zamalight Subco, Inc., a wholly-owned indirect subsidiary of the Registrant, entered into indemnification agreements with each of the Registrant’s directors, indemnifying them in respect of any liability incurred by them while acting as a director of the Registrant in accordance with customary

 

3


standards. Upon completion of the Business Combination, Predecessor assumed all of Zamalight Subco, Inc.’s rights and obligations under these indemnification agreements.

The Registrant also maintains directors’ and officers’ liability insurance and fiduciary liability insurance covering certain liabilities that may be incurred by its directors and officers in the performance of their duties.

Item 7. Exemption From Registration Claimed.

Not applicable.

Item 8. Exhibits.

The following exhibits are filed herewith as part of this Registration Statement.

 

Exhibit No.

  

Description

  3.1    Amended and Restated Memorandum and Articles of Association of Linde plc (incorporated by reference to Exhibit 3.1 to Registrant’s Current Report on Form 8-K filed with the SEC on October 31, 2018, Commission file no. 333-218485).
  4.1    Amended and Restated 2002 Praxair, Inc. Long Term Incentive Plan.
  4.2    2005 Equity Compensation Plan for Non-Employee Directors of Praxair, Inc.
  4.3    Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan.
  4.4    Long Term Incentive Plan 2018 of Linde plc.
  5.1    Opinion of Arthur Cox.
23.1    Consent of PricewaterhouseCoopers LLP, independent registered public accounting firm.
23.2    Consent of PricewaterhouseCoopers LLP, independent registered public accounting firm.
23.3    Consent of KPMG AG Wirtschaftsprüfungsgesellschaft, independent auditors.
23.4    Consent of Arthur Cox (Included as part of its opinion filed as Exhibit 5.1).
24.1    Power of Attorney (Included on the signature pages to this Registration Statement).

Item 9. Undertakings.

(a) The undersigned Registrant hereby undertakes:

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

(i) To include any prospectus required by Section 10(a)(3) of the Securities Act;

(ii) To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in this effective Registration Statement; and

 

4


(iii) To include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement;

provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.

(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

(b) The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

*    *    *

(h) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

 

5


Exhibit Index

 

Exhibit No.

  

Description

  3.1    Amended and Restated Memorandum and Articles of Association of Linde plc (incorporated by reference to Exhibit 3.1 to Registrant’s Current Report on Form 8-K filed with the SEC on October 31, 2018, Commission file no. 333-218485).
  4.1    Amended and Restated 2002 Praxair, Inc. Long Term Incentive Plan.
  4.2    2005 Equity Compensation Plan for Non-Employee Directors of Praxair, Inc.
  4.3    Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan.
  4.4    Long Term Incentive Plan 2018 of Linde plc.
  5.1    Opinion of Arthur Cox.
23.1    Consent of PricewaterhouseCoopers LLP, independent registered public accounting firm.
23.2    Consent of PricewaterhouseCoopers LLP, independent registered public accounting firm.
23.3    Consent of KPMG AG Wirtschaftsprüfungsgesellschaft, independent auditors.
23.4    Consent of Arthur Cox (Included as part of its opinion filed as Exhibit 5.1).
24.1    Power of Attorney (Included on the signature pages to this Registration Statement).

 

6


SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of London, United Kingdom on this 31st day of October, 2018.

 

LINDE PLC
By:  

/s/ Guillermo Bichara

  Name:    Guillermo Bichara
  Title:   General Counsel

AUTHORIZED REPRESENTATIVE IN THE UNITED STATES

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant has duly caused this Registration Statement to be signed by the following duly authorized representative in the United States:

 

LINDE PLC
By:  

/s/ Guillermo Bichara

  Name:    Guillermo Bichara
  Title:   General Counsel

POWER OF ATTORNEY

Each of the undersigned officers and directors of the Registrant, a public limited liability company organized and existing under the laws of Ireland, hereby constitutes and appoints, Mr. Stephen F. Angel, Mr. Matthew J. White and Mr. Guillermo Bichara and each of them, as his or her true and lawful attorney-in-fact and agent, severally, with full power of substitution and resubstitution, in his or her name and on his or her behalf, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power of authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, thereby ratifying and confirming all that said attorneys-in-fact and agents, or their substitutes, may lawfully do or cause to be done.

 

7


Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities below on this 31st day of October, 2018.

 

Signature    Title

/s/ Stephen F. Angel

Stephen F. Angel

   Director and Chief Executive Officer
   (Principal Executive Officer)

/s/ Matthew J. White

Matthew J. White

   Chief Financial Officer
   (Principal Financial Officer)

/s/ Kelcey E. Hoyt

Kelcey E. Hoyt

   Controller
   (Principal Accounting Officer)

/s/ Prof. Dr. Wolfgang Reitzle

Prof. Dr. Wolfgang Reitzle

   Director and Chairman of the Board

/s/ Prof. Dr. Clemens Börsig

Prof. Dr. Clemens Börsig

   Director

/s/ Dr. Thomas Enders

Dr. Thomas Enders

   Director

/s/ Franz Fehrenbach

Franz Fehrenbach

   Director

/s/ Dr. Victoria Ossadnik

Dr. Victoria Ossadnik

   Director

/s/ Prof. Dr. Ann-Kristin Achleitner

Prof. Dr. Ann-Kristin Achleitner

   Director

/s/ Dr. Nance K. Dicciani

Dr. Nance K. Dicciani

   Director

/s/ Edward G. Galante

Edward G. Galante

   Director

/s/ Larry D. McVay

Larry D. McVay

   Director

/s/ Martin Richenhagen

Martin Richenhagen

   Director

/s/ Robert L. Wood

Robert L. Wood

   Director

 

8

Exhibit 4.1

2002 PRAXAIR, INC. LONG TERM INCENTIVE PLAN

Praxair, Inc. and Subsidiaries

 

 

Amended and Restated

As of February 24, 2004

Section  1. Purpose. The purpose of the 2002 Praxair, Inc. Long Term Incentive Plan (hereinafter referred to as the “Plan”) is to (a) advance the interests of Praxair, Inc. (the “Company”) and its stockholders by providing incentives and rewards to those employees who are in a position to contribute to the long term growth and profitability of the Company; (b) assist the Company and its subsidiaries and affiliates in attracting, retaining, and developing highly qualified employees for the successful conduct of their business; and (c) make the Company’s compensation program competitive with those of other major employers.

Section 2. Definitions.

2.1 A “Change in Control of the Company” shall be deemed to occur if any of the following circumstances shall occur:

 

  (i)

individuals who, on January 1, 2003, constitute the Board (the “Incumbent Directors”) cease for any reason to constitute at least a majority of the Board, provided that any person becoming a director subsequent to January 1, 2003, whose election or nomination for election was approved by a vote of at least two-thirds of the Incumbent Directors then on the Board (either by a specific vote or by approval of the proxy statement of the Company in which such person is named as a nominee for director, without objection to such nomination) shall be an Incumbent Director; provided, however, that no individual elected or nominated as a director of the Company initially as a result of an actual or threatened election contest with respect to directors or any other actual or threatened solicitation of proxies or consents by or on behalf of any person other than the Board shall be deemed an Incumbent Director;

 

  (ii)

any “person” (as such term is defined in Section 3(a)(9) of the Securities Exchange Act of 1934 (the “Exchange Act”) and as used in Sections 13(d)(3) and 14(d)(2) of the Exchange Act) is or becomes a “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing 20% or more of the combined voting power of the Company’s then outstanding securities eligible to vote for the election of the Board (the “Company Voting Securities”); provided, however, that the event described in this paragraph (ii) shall not be deemed to be a Change in Control by virtue of any of the following acquisitions, (A) by the Company or any Subsidiary; (B) by any employee benefit plan sponsored or maintained by the Company or Subsidiary; (C) by any underwriter temporarily holding securities pursuant to an offering of such securities; (D) pursuant to a Non-Qualifying Transaction (as defined in paragraph (iii)); or (E) pursuant to any acquisition by a Participant (as defined in Section 2.11) or any group of persons including a Participant (or any entity controlled by a Participant or any group of persons including a Participant);

 

  (iii)

the consummation of a merger, consolidation, share exchange or similar form of corporate transaction involving the Company or any of its Subsidiaries that requires the approval of the Company’s stockholders, whether for such transaction or the issuance of securities in the transaction (a “Business Combination”), unless immediately following such Business Combination (A) more than 50% of the total voting power of (x) the corporation resulting from such Business Combination (the “Surviving Corporation”); or (y) if applicable, the ultimate parent corporation that directly or indirectly has beneficial ownership of 100% of the voting securities eligible to elect directors of the Surviving Corporation (the “Parent Corporation”), is represented by Company Voting Securities that were outstanding immediately prior to such Business Combination (or, if applicable, shares into which such Company Voting Securities were converted pursuant to such Business Combination), and such voting power among the holders thereof is in substantially the

 

1


  same proportion as the voting power of such Company Voting Securities among the holders thereof immediately prior to the Business Combination; (B) no person (other than any employee benefit plan sponsored or maintained by the Surviving Corporation or the Parent Corporation), is or becomes the beneficial owner, directly or indirectly, of 20% or more of the total voting power of the outstanding voting securities eligible to elect directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation); and (C) at least a majority of the members of the board of directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) were Incumbent Directors at the time of the Board’s approval of the execution of the initial agreement providing for such Business Combination (any Business Combination which satisfies all of the criteria specified in (A), (B) and (C) above shall be deemed to be a “Non-Qualifying Transaction”); or

 

  (iv)

The stockholders of the Company approve a plan of complete liquidation or dissolution of the Company or a sale or disposition of all or substantially all of the Company’s assets.

Notwithstanding the foregoing, a Change in Control of the Company shall not be deemed to occur solely because any person acquires beneficial ownership of more than 20% of the Company Voting Securities as a result of the acquisition of Company Voting Securities by the Company which reduces the number of Company Voting Securities outstanding; provided, that if after such acquisition by the Company such person becomes the beneficial owner of additional Company Voting Securities that increases the percentage of outstanding Company Voting Securities beneficially owned by such person, a Change in Control of the Company shall then occur.

2.2 “Code” means the Internal Revenue Code of 1986, as now or hereafter amended.

2.3 “Committee” shall mean the Compensation and Management Development Committee of the Board of Directors of the Company or such other Committee appointed by the Board for the purpose of administering this Plan comprising two or more members of the Board who are “non-employee” directors within the meaning of Rule 16b-3 under the Exchange Act.

2.4 “Disability” means a Participant’s inability to engage in any substantial gainful activity because of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted, or can be expected to last, for a continuous period of six months or longer.

2.5 “Eligible Employee” means any employee of the Company or of a participating Subsidiary or Affiliate of the Company except those union-represented employees where no agreement has been reached with their collective bargaining representative for their participation in this Plan. No “Eligible Employee” shall be a member of the Committee.

2.6 “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended.

2.7 “Executive Officer” shall mean an Executive Officer of the Company, as such term is defined within the meaning of the Exchange Act or for purposes of Section 16 of the Exchange Act.

2.8 “Incentive Stock Option” means any stock option granted pursuant to this Plan which is designated as such by the Committee and which complies with Section 422 of the Code.

2.9 “Market Price” is the mean of the high and low prices of the Common Stock of the Company as reported in the New York Stock Exchange-Composite Transactions on the date for which a Market Price is to be determined under this Plan (or on the next preceding day such Stock was traded on a stock exchange included in the New York Stock Exchange-Composite Transactions if it was not traded on any such exchange on such date).

2.10 “Non-Qualified Stock Option” means any stock option granted pursuant to this Plan which is not an Incentive Stock Option.

2.11 “Participant” shall mean an individual selected to participate in the Plan pursuant to Section 3.

 

2


2.12 “Performance Award” shall mean a payment pursuant to Section 8 herein.

2.13 “Restricted Stock” means Stock of the Company subject to restrictions on the transfer of such Stock, conditions for forfeiture of such Stock, or any other limitations or restrictions as determined by the Committee.

2.14 “Retirement” shall mean termination of employment with the Company or a Subsidiary or Affiliate, other than for cause, with the right to receive immediately a non- actuarially reduced pension under the Company’s Retirement Program; provided, however, that if the Participant is employed by a foreign affiliate of the Company and/or is not eligible to participate in the Company’s Retirement Program, “Retirement” shall mean termination of employment with the Company or a Subsidiary or Affiliate, other than for cause, after the Participant has (i) attained age 65; (ii) attained age 62 and completed at least 10 years of employment with the Company; or (iii) accumulated 85 points, where each year of the Participant’s age and each year of employment with the Company count for one point.

2.15 “Stock” shall mean the Common Stock, $0.01 par value, of the Company.

2.16 “Subsidiary” and “Affiliate” of the Company each shall mean any entity in which the Company has a 50% or greater ownership interest, directly or indirectly.

Section  3. Participation. The Participants in the Plan (“Participants”) shall be those Eligible Employees who are selected to participate in the Plan by the Committee. Any Eligible Employee, or each member of any group of Eligible Employees, to whom the Committee by resolution has granted an award (or as to whom the Committee has delegated to the Chief Executive Officer the right to allocate awards pursuant to Section 4) shall be deemed a Participant with respect to such award.

Section  4. Administration. The Plan shall be administered and interpreted by the Committee, which shall have sole authority to make rules and regulations for the administration of the Plan. The interpretations and decisions of the Committee with regard to the Plan shall be final and conclusive and binding upon all Participants. The Committee may request advice or assistance or employ such persons (including without limitation, legal counsel and accountants) as it deems necessary for the proper administration of the Plan. The Committee shall (i) determine the number and types of awards to be made under the Plan; (ii) select the awards to be made to Participants; (iii) set the exercise price, the number of options to be awarded, and the number of shares to be awarded out of the total number of shares available for award; (iv) delegate to the Chief Executive Officer of the Company the right to allocate awards among Eligible Employees who are not Executive Officers of the Company, such delegation to be subject to such terms and conditions as the Committee in its discretion shall determine; (v) establish administrative regulations to further the purpose of the Plan; and (vi) take any other action desirable or necessary to interpret, construe or implement properly the provisions of the Plan.

Section 5. Awards.

5.1 Types of Awards . Awards under this Plan may be in any of the following forms (or a combination thereof) (i) stock option awards; (ii) grants of Stock or Restricted Stock; or (iii) Performance Awards. All awards shall be made pursuant to award agreements between the Participant and the Company. The agreements shall be in such form as the Committee approves from time to time.

5.2 Maximum Amount Available. The total number of shares of Stock (including Restricted Stock, if any) optioned or granted under this Plan during the term of the Plan shall not exceed 15,800,000 shares. Solely for the purpose of computing the total number of shares of stock optioned or granted under this Plan, there shall not be counted (i) any shares which have been forfeited; (ii) any shares covered by an option which, prior to such computation, has terminated in accordance with its terms or has been cancelled by the Participant or the Company; and (iii) any shares otherwise deliverable

 

3


to a Participant or his/her transferee upon exercise of an option, or upon the grant or vesting of a Stock Award (as defined in Section 7.1), which are withheld by the Company in order to satisfy tax withholding or exercise price obligations. In addition, there shall be credited to the number of authorized shares remaining for grant or option under this Plan, any share which is delivered to the Company by a Participant or his/her transferee in satisfaction of tax withholding or exercise payment obligations.

5.3 Adjustment in the Event of Recapitalization, etc. In the event of any change in the outstanding shares of the Company by reason of any stock split, stock dividend, recapitalization, merger, consolidation, combination or exchange of shares or other similar corporate change or in the event of any special distribution to the stockholders, the Committee shall make such equitable adjustments in the number of shares and prices per share applicable to options then outstanding and in the number of shares which are available thereafter for Stock Option Awards (as defined in Section 6.1) or other awards, both under the Plan as a whole and with respect to individuals and award type, as the Committee determines are necessary and appropriate. Any such adjustment shall be conclusive and binding for all purposes of the Plan.

Section 6. Stock Options.

6.1 Award Types. The Company may award options to purchase the Common Stock of the Company (hereinafter referred to as “Stock Option Awards”) to such Participants as the Committee (or the Chief Executive Officer of the Company, if the Committee in its discretion delegates the right to allocate awards pursuant to Section 4) authorizes and under such terms as the Committee establishes. The Committee shall determine with respect to each Stock Option Award, and designate in the grant, whether a Participant is to receive an Incentive Stock Option or a Non-Qualified Stock Option.

6.2 Per-Participant Limits. The maximum number of shares of Stock with respect to which Stock Option Awards may be granted under this Plan during any calendar year to any Participant is 1,000,000 except in the case of a multi-year grant, in which case the maximum number of shares for the Participant shall be 1,000,000 times the number of years during which the Participant is not to receive any additional grants of Stock Option Awards.

6.3 Exercise Price. The exercise price of each share of Stock subject to a Stock Option Award shall be specified in the grant, but in no event shall the exercise price be less than the closing price of the Common Stock of the Company on the date the award is granted as reported in the New York Stock Exchange-Composite Transactions. If the Participant to whom an Incentive Stock Option is granted owns, at the time of the grant, more than ten percent (10%) of the combined voting power of the Participant’s employer or a parent or subsidiary of the employer, the exercise price of each share of Stock subject to such grant shall be not less than one hundred ten percent (110%) of the closing price described in the preceding sentence.

6.4 Repricing. Without the prior approval of the Company’s shareholders, (a) the exercise price of any Stock Option Award granted pursuant to this Plan shall not be changed following the date of its grant, other than such equitable changes as may arise in connection with the adjustments permitted under Section 5.3 and no Stock Option Award may be cancelled and replaced with a new Stock Option Award with a lower exercise price where the economic effect would be the same as reducing the exercise price of the cancelled option.

6.5 Transferability .

(a) Stock Option Awards shall not be transferable by the Participant other than:

 

  (i)

In the case of the Participant’s death, pursuant to the beneficiary designation then on file with the Company, or, in the absence of such a beneficiary designation (or if the designated beneficiary has pre-deceased the Participant), by will or the laws of descent and distribution (in which case the Company without liability to any other person, may rely on the directions of the executor or administrator of the Participant’s estate with respect to the disposition or exercise of such options);

 

4


  (ii)

In the Committee’s discretion, the terms of a Non-Qualified Stock Option may permit the Participant to transfer the Stock Option Award to (w) his or her spouse, children (including by adoption), stepchildren or grandchildren (referred to herein as the Participant’s “Family Members”), (x) a trust or trusts for the exclusive benefit of such Family Members, (y) a partnership in which such Family Members are the only partners, or (z) such other persons or entities as the Committee may approve on a case-by-case basis; or

 

  (iii)

In the case of a transferee’s death, to his/her estate without rights to further distribution.

(b) Any transfer pursuant to this Section 6.5 shall be subject to the following:

 

  (i)

there may be no consideration for any such transfer;

 

  (ii)

the stock option agreement pursuant to which such Stock Option Award is granted must be approved by the Committee, and must expressly provide for transferability in a manner consistent with this Section 6.5; and

 

  (iii)

subsequent transfers of transferred Stock Option Awards shall be prohibited except those in accordance with this Section 6.5.

(c) Following transfer, any transferred Stock Option Award shall continue to be subject to the same terms and conditions as were applicable immediately prior to transfer. The events of death, Disability, Retirement and termination of employment with respect to an outstanding Stock Option Award shall be in relation to the original grantee Participant notwithstanding an earlier transfer of the Stock Option Award. Following such events, the Stock Option Award shall be exercisable by the transferee only to the extent and for the periods specified in Sections 6.7 and 6.8 hereof.

6.6 Duration of Stock Option Awards. A Stock Option Award by its terms shall be of no more than ten (10) years’ duration, except that an Incentive Stock Option granted to a Participant who, at the time of the grant, owns Stock representing more than ten percent (10%) of the combined voting power of the Participant’s employer or a parent or subsidiary of the employer shall by its terms be of no more than five (5) years’ duration.

6.7 Initial Vesting. A Stock Option Award by its terms shall be exercisable only after the earliest of:

(i) such period of time as the Committee shall determine and specify in the grant, but in no event less than three years following the date of grant of such award provided that options granted may partially vest after no less than one year so long as the entire grant does not vest fully until at least three years have elapsed from the date of grant;

(ii) the Participant’s death; or

(iii) a Change in Control of the Company.

In the event of the Participant’s Disability or Retirement or the termination by the Company of the Participant’s employment other than for cause, a Stock Option Award shall not be exercisable at the time of such event but shall become exercisable at the time specified in clauses (i), (ii) and (iii) above. Notwithstanding the foregoing, in the event of a Participant’s Retirement prior to the first anniversary date after the date of a Stock Option Award, such Stock Option Award shall not vest but shall be immediately forfeited.

 

5


6.8 Exercise Period. A Stock Option Award is only exercisable by a Participant (or, if the Stock Option Award has been duly transferred pursuant to Section 6.5, the transferee) while the Participant is in active employment with the Company, or its Subsidiary or Affiliate, except:

 

  (i)

in the case of a Participant’s death, the Stock Option Award shall remain exercisable by the transferee of the award during a three (3) year period following the date of death;

 

  (ii)

in the case of a Participant’s Retirement or Disability, the Stock Option Award, to the extent not forfeited in accordance with Section 6.7 above, shall remain exercisable during the original grant duration as specified in the grant agreement;

 

  (iii)

in the case of termination by the Company of the Participant’s employment other than for cause, the Stock Option Award shall remain exercisable during a three (3) year period commencing on the effective date of such termination;

 

  (iv)

in the case of termination by the Participant or the Company, of the Participant’s employment within two (2) years after a Change in Control of the Company, unless such termination of employment is for cause, the Stock Option Award shall remain exercisable during a three-year period commencing on the effective date of termination; or

 

  (v)

if the Committee decides that it is in the best interest of the Company to permit individual exceptions.

In no event may a Stock Option Award be exercised after its expiration date.

For purposes of this Plan, the employment of individuals employed by a Subsidiary or Affiliate of the Company shall be deemed to have been terminated by the Company at such time as the Company ceases to hold, either directly or indirectly, at least 50% of the total ownership interests of the entity.

6.9 Manner of Exercise. A Stock Option Award may be exercised by the Participant (or, if the Stock Option Award has been duly transferred pursuant to Section 6.5, the transferee) with respect to part or all of the shares subject to the option by giving written notice to the Company or its designee of the exercise of the option according to such procedures as the Vice President, Human Resources may establish.

6.10 Payment of Exercise Price. The exercise price for the shares for which an option is exercised shall be paid by the exerciser within ten (10) business days after the date of exercise and the terms of the Stock Option Award may provide that the exercise price may be paid:

 

  (a)

in cash;

 

  (b)

in whole shares of Common Stock of the Company owned by the exerciser prior to exercising the option;

 

  (c)

by having the Company withhold shares that otherwise would be delivered to the exerciser pursuant to the exercise of the option in an amount equaling in value the exercise price;

 

  (d)

in a combination of either cash and delivery of shares, or cash and withholding of shares; or

 

  (e)

by whatever other means the Committee may deem appropriate, other than by a loan by the Company to the exerciser.

The Company shall establish procedures in connection with payments pursuant to (b), (c), (d), and (e) above, to ensure that the Plan does not become subject to variable accounting by virtue of such payment methods. The value of any share of Common Stock delivered or withheld in payment of the exercise price shall be its Market Price on the date the option is exercised.

 

6


6.11 Limits on Incentive Stock Options. The aggregate fair market value of all shares of Stock with respect to which Incentive Stock Options are exercisable for the first time by a Participant in any one calendar year, under this Plan or any other stock option plan maintained by the Company (or by any subsidiary or parent of the Company), shall not exceed $100,000. The fair market value of such shares of Stock shall be the mean of the high and low prices of the common Stock of the Company as reported in the New York Stock Exchange- Composite Transactions on the date the related Stock Option Award is granted (or on the next preceding day such Stock was traded on a stock exchange included in the New York Stock Exchange-Composite Transactions if it was not traded on any such exchange on the date the related stock option is granted).

6.12 Payment of Taxes. To enable the Company to meet any applicable federal, state or local withholding tax requirements arising as a result of the exercise of a Stock Option Award, whether exercised by the Participant or his/her transferee, a Participant or the Participant’s estate shall pay to the Company the amount of tax to be withheld, or may elect to satisfy such obligation:

(a) by delivering to the Company other shares of Common Stock of the Company owned by the Participant prior to exercising the option;

(b) by making a payment to the Company consisting of a combination of cash and such shares of Common Stock; or

(c) if the exerciser is the grantee Participant, by having the Company withhold shares that otherwise would be delivered to the Participant pursuant to the exercise of the option for which the tax is being withheld, provided that withholding by such method shall be limited to the minimum required applicable tax withholding.

Such an election shall be made in such manner as may be prescribed by the Committee and the Committee shall have the right, in its discretion, to disapprove such election. Any such election must be made prior to the date to be used to determine the tax to be withheld and shall be irrevocable. The value of any share of Common Stock to be withheld by the Company or delivered to the Company pursuant to this Section 6.12 shall be the Market Price on the date used to determine the amount of tax to be withheld.

Section 7. Grants of Stock.

7.1 Award Types. The Committee may grant, either alone or in addition to other awards granted under the Plan, shares of Stock or Restricted Stock (hereinafter referred to as a “Stock Award”) to such Participants as the Committee (or the Chief Executive Officer of the Company, if the Committee in its discretion delegates the right to allocate awards pursuant to Section 4) authorizes and under such terms as the Committee establishes. The Committee, in its discretion, may also make a cash payment to a Participant granted shares of Stock or Restricted Stock under the Plan to allow such Participant to satisfy tax obligations arising out of receipt of the Stock or Restricted Stock. Alternatively, the terms of the Stock or Restricted Stock grant may allow for the Participant to satisfy tax withholding obligations by the means set forth in Section 7.7.

7.2 Aggregate and Individual Limits. Notwithstanding any provision in this Plan to the contrary, the combined number of shares granted under the Plan pursuant to Stock Awards or Performance Awards shall not exceed 20% of the maximum number of shares of Stock available for award under this Plan as provided in Sections 5.2 and 5.3. In addition, no more than 300,000 shares as a Stock Award shall be granted to one individual in a calendar year unless pursuant to a multi-year award. Grants of Stock other than Restricted Stock shall only be made in lieu of salary or cash bonus.

 

7


7.3 Vesting Periods. A grant of Restricted Stock pursuant to this Section 7 shall be subject to a minimum vesting period of at least three (3) years, or such longer period as the Committee, in its sole discretion, may determine. Notwithstanding the foregoing, the Committee may grant shares of Restricted Stock with a vesting period of at least two (2) years, or such longer period as the Committee, in its sole discretion, may determine, so long as vesting is based on performance criteria.

7.4 Rights as a Stockholder. The Participant shall have, with respect to Restricted Stock, all of the rights of a stockholder of the Company, including the right to vote the shares and the right to receive any dividends, unless the Committee shall otherwise determine.

7.5 Transferability. Restricted Stock may not be sold or transferred by the Participant until any restrictions that have been established by the Committee have lapsed.

7.6 Forfeiture. Upon a termination by the Participant or the Company, of the Participant’s employment for any reason during the period any restrictions are in effect, all Restricted Stock held by the Participant shall be forfeited without compensation to the Participant unless the Committee decides that it is in the best interest of the Company to permit individual exceptions.

7.7 Payment of Taxes. To enable the Company to meet any applicable federal, state or local withholding tax requirements arising as a result of the grant or vesting of a Stock Award, the Participant shall pay the Company the amount of tax to be withheld or may elect to satisfy such obligation:

 

  (a)

by having the Company withhold shares that otherwise would be delivered to the Participant pursuant to the granting or vesting of a Stock Award for which the tax is being withheld;

 

  (b)

by delivering to the Company other shares of Common Stock of the Company owned by the Participant prior to the grant or vesting of a Stock Award; or

 

  (c)

by making a payment to the Company consisting of a combination of cash and such shares of Common Stock. Such an election shall be made prior to the date to be used to determine the tax to be withheld. The value of any share of Common Stock to be withheld by the Company or delivered to the Company pursuant to this Section 7 shall be the Market Price on the date used to determine the amount of tax to be withheld. Section 8. Performance Awards.

8.1 Award Types. The Committee may grant, either alone or in addition to other awards granted under the Plan, awards of Stock and other awards that are valued in whole or in part by reference to, or are otherwise based on, the market value of the Common Stock, or other securities of the Company (“Performance Awards”) to such Participants as the Committee (or the Chief Executive Officer of the Company, if the Committee in its discretion delegates the right to allocate awards pursuant to Section 4) authorizes and under such terms as the Committee establishes. Performance Awards may be paid in Common Stock, Restricted Stock or other securities of the Company, cash or any other form of property as the Committee shall determine.

8.2 Terms and Conditions of Awards. Performance Awards shall entitle the Participant to receive an award if the measures of performance established by the Committee are met. The measures of performance shall be established by the Committee in its absolute discretion except that the performance measurement period shall be a period of at least twelve (12) months. The Committee shall determine the times at which Performance Awards are to be made and all conditions of such awards.

8.3 Aggregate and Individual Limits. Notwithstanding any provision in this Plan to the contrary, the combined number of shares granted under this Plan pursuant to Performance Awards or Stock Awards shall not exceed 20% of the maximum number of shares of Stock available for award under this Plan as provided in Sections 5.2 and 5.3. In addition, no more than 300,000 shares pursuant to any Performance Awards shall be granted to one individual in a calendar year unless pursuant to a multi-year award.

 

8


8.4 Transferability. The Participant shall not be permitted to sell, assign, tra nsfer, pledge or otherwise encumber shares received pursuant to this Section 8 prior to the date on which any applicable restriction or performance period established by the Committee lapses.

8.5 Payment of Taxes. To enable the Company to meet any applicable federal, state or local withholding tax requirements arising as a result of the vesting or payment of Performance Awards, a Participant shall pay the Company the amount of tax to be withheld or may elect to satisfy such obligation:

 

  (a)

by having the Company withhold shares that otherwise would be delivered to the Participant pursuant to the vesting or payment of Performance Awards for which the tax is being withheld;

 

  (b)

by delivering to the Company other shares of Common Stock of the Company owned by the Participant prior to the vesting or payment of Performance Awards; or

 

  (c)

by making a payment to the Company consisting of a combination of cash and such shares of Common Stock.

Such an election shall be made prior to the date used to determine the tax to be withheld. The value of any share of Common Stock to be withheld by the Company or delivered to the Company pursuant to this Section 8.5 shall be the Market Price on the date used to determine the amount of tax to be withheld.

Section 9. General Provisions.

9.1 Assignment. Subject to the provisions of Section 6.5, if applicable, any assignment or transfer of any awards without the written consent of the Company shall be null and void.

9.2 No Trust. Nothing contained herein shall require the Company to segregate any monies from its general funds, or to create any trusts, or to make any special deposits for any immediate or deferred amounts payable to any Participant for any year.

9.3 No Right to Employment. Participation in this Plan shall not affect the Company’s right to discharge a Participant.

9.4 Cancellation and Rescission of Awards.

 

  (a)

The Committee shall have the discretion with respect to any award granted under this Plan to establish upon its grant conditions under which (i) the award may be later forfeited, cancelled, rescinded, suspended, withheld or otherwise limited or restricted; or (ii) gains realized by the grantee in connection with an award or an award’s exercise may be recovered; provided that such conditions and their consequences are (A) clearly set forth in the grant agreement or other grant document; and (B) fully comply with applicable laws. These conditions may include, without limitation, actions by the Participant which constitute a conflict of interest with the Company, are prejudicial to the Company’s interests, or are in violation of any non-compete agreement or obligation, any confidentiality agreement or obligation, the Company’s applicable policies or the Participant’s terms and conditions of employment.

 

  (b)

The Committee may require, upon exercise, payment or delivery pursuant to an award, that the Participant certify in a manner acceptable to the Company that he or she is in compliance with the terms and conditions of the award grant.

 

9


Section 10. Amendment, Suspension, or Termination.

10.1 The Board of Directors may suspend, terminate, or amend the Plan, including, but not limited to, such amendments as may be necessary or desirable resulting from changes in the federal income tax laws and other applicable laws, but may not, without the affirmative vote of a majority of all votes duly cast on the matter at a meeting of the stockholders of the Company (provided that the total votes cast on the matter represent over 50% of the shares entitled to vote on the matter): (a) increase the total number of shares of Stock that may be optioned or granted under this Plan; (b) amend Section 6.4 with respect to re-pricing of Stock Option Awards; (c) change the eligibility requirements for participation in the Plan; or (d) adopt any other material revision to this Plan that would require the approval of the stockholders under the rules promulgated by the New York Stock Exchange.

10.2 It is the Company’s intent that the Plan comply in all respects with Rule 16b-3 under the Exchange Act and any related regulations. If any provision of this Plan is later found not to be in compliance with such Rule and regulations, the provisions shall be deemed null and void. All grants to, and exercises of options by Executive Officers under this Plan shall be executed in accordance with the requirements of Section 16 of the Exchange Act and regulations promulgated thereunder.

Section 11. Governing Law.

The validity, construction and effect of the Plan and any rules and regulations relating to the Plan shall be determined in accordance with the laws of the State of Connecticut and applicable federal law.

Section 12. Effective Date and Duration of the Plan.

This Plan shall be effective as of January 1, 2002. No award shall be granted under this Plan on or after January 1, 2012.

 

10


AMENDMENT TO THE

RESTATED 2002 PRAXAIR, INC. LONG TERM INCENTIVE PLAN

The Restated 2002 Praxair, Inc. Long Term Incentive Plan (the “Plan”) is hereby amended as follows, effective as of January 23, 2007:

1. Section 6.7 of the Plan is hereby amended in its entirety as follows:

“6.7 Initial Vesting. A Stock Option Award by its terms shall be exercisable only after the earliest of:

(i) such period of time as the Committee shall determine and specify in the grant, but in no event less than three years following the date of grant of such award provided that options granted may partially vest after no less than one year so long as the entire grant does not fully vest until at least three years have elapsed from the date of grant;

(ii) the Participant’s death; or

(iii) a Change in Control of the Company.

In the event of the Participant’s Disability or Retirement or termination by the Company of the Participant’s employment other than for cause, a Stock Option Award shall not be exercisable at the time of such event but shall become exercisable at the time specified in clauses (i), (ii) or (iii) above. Notwithstanding the foregoing: (a) in the event of a Participant’s Retirement prior to the first anniversary date after the date of a Stock Option Award, such Stock Option Award shall not vest but shall be immediately forfeited; and (b) except as otherwise determined by the Company’s Chief Executive Officer or his designee, in the event of the termination by the Company of the Participant’s employment other than for cause prior to the first anniversary date after the date of a Stock Option Award, such Stock Option Award shall not vest but shall be immediately forfeited.”

2. Section 6.8(iii) is of the Plan is hereby amended in its entirety as follows:

“(iii) in the case of termination by the Company of the Participant’s employment other than for cause, the Stock Option Award, to the extent not forfeited in accordance with Section 6.7 above, shall remain exercisable during a three (3) year period commencing on the effective date of such termination;”

January 23, 2007

PRAXAIR, INC.


AMENDMENT TO THE

RESTATED 2002 PRAXAIR, INC. LONG TERM INCENTIVE PLAN

Section 5.3 of the Restated 2002 Praxair, Inc. Long Term Incentive Plan, is hereby amended in its entirety as follows, effective as of October 24, 2006:

“5.3 Adjustment in the Event of Recapitalization, etc. In the event of any change in the outstanding shares of the Company by reason of any stock split, stock dividend, recapitalization, merger, consolidation, combination or exchange of shares or other similar corporate change or in the event of any special distribution to the stockholders, the Committee shall make equitable adjustments in the number of shares and prices per share applicable to Stock Option Awards then outstanding and in the number of shares which are available thereafter for Stock Option Awards or other awards, both under the Plan as a whole and with respect to individuals and award type. Such adjustments shall be made in a manner that the Committee determines is necessary and appropriate, and shall be conclusive and binding for all purposes of the Plan.”

October 24, 2006

PRAXAIR, INC.

Exhibit 4.2

2005 EQUITY COMPENSATION PLAN

FOR NON-EMPLOYEE DIRECTORS OF PRAXAIR, INC.

Adopted by the Board: February 22, 2005

Approved by Shareholders: April 26, 2005

Amended and Restated: January 26, 2010


2005 EQUITY COMPENSATION PLAN

FOR NON-EMPLOYEE DIRECTORS OF PRAXAIR, INC.

Section  1. Purpose. The 2005 Equity Compensation Plan For Non-Employee Directors of Praxair, Inc. (hereinafter referred to as the “Plan”) is established to attract, retain and compensate highly qualified individuals who are not employees of Praxair, Inc. for service as members of the Board and to provide them with an ownership interest in the Company’s common stock. The Plan will be beneficial to the Company and its stockholders by allowing these Non-Employee Directors to have a personal financial stake in the Company through an ownership interest in the Company, in addition to underscoring their common interest with stockholders in increasing the value of the Company’s stock over the long term.

Section 2. Definitions.

2.1 “Board” means the Board of Directors of the Company.

2.2 A “Change in Control of the Company” means the occurrence of any one of the following events with respect to the Company:

(i) individuals who, on January 1, 2003, constitute the Board (the “Incumbent Directors”) cease for any reason to constitute at least a majority of the Board, provided that any person becoming a director subsequent to January 1, 2003, whose election or nomination for election was approved by a vote of at least two-thirds of the Incumbent Directors then on the Board (either by a specific vote or by approval of the proxy statement of the Company in which such person is named as a nominee for director, without objection to such nomination) shall be an Incumbent Director; provided , however , that no individual elected or nominated as a director of the Company initially as a result of an actual or threatened election contest with respect to directors or any other actual or threatened solicitation of proxies [or consents] by or on behalf of any person other than the Board shall be deemed an Incumbent Director;

(ii) any “person” (as such term is defined in Section 3(a)(9) of the Securities Exchange Act of 1934 (the “Exchange Act”) and as used in Sections 13(d)(3) and 14(d)(2) of the Exchange Act) is or becomes a “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing 20% or more of the combined voting power of the Company’s then outstanding securities eligible to vote for the election of the Board (the “Company Voting Securities”); provided , however , that the event described in this paragraph (ii) shall not be deemed to be a Change in Control by virtue of any of the following acquisitions: (A) by the Company or any subsidiary, (B) by any employee benefit plan sponsored or maintained by the Company or subsidiary, (C) by any underwriter temporarily holding securities pursuant to an offering of such securities, (D) pursuant to a Non-Qualifying Transaction (as defined in paragraph (iii)) or (E) pursuant to any acquisition by a Director participating in this Plan or any group of persons including such a Director (or any entity controlled by such a Director or by any group of persons including such a Director);

(iii) the consummation of a merger, consolidation, statutory share exchange or similar form of corporate transaction involving the Company or any of its subsidiaries that requires the approval of the Company’s stockholders, whether for such transaction or the issuance of securities in the transaction (a “Business Combination”), unless immediately following such Business Combination: (A) more than 50% of the total voting power of (x) the corporation resulting from such Business Combination (the “Surviving Corporation”), or (y) if applicable, the ultimate parent corporation that directly or indirectly has beneficial ownership of 100% of the voting securities eligible to elect directors of the Surviving Corporation (the “Parent Corporation”), is represented by Company Voting Securities that were outstanding immediately prior to such Business Combination (or, if applicable, shares into which such Company Voting Securities were converted pursuant to such Business Combination), and such voting power among the holders thereof is in substantially the same proportion as the voting power of such Company Voting Securities among the holders thereof immediately prior to the Business Combination, (B) no person (other than any employee benefit plan sponsored or maintained by the Surviving Corporation or the Parent Corporation), is or becomes the beneficial owner, directly or indirectly, of 20% or more of the total voting power of the outstanding voting securities eligible to elect directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) and (C) at least a majority of the members of the board of directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) were Incumbent Directors at the time of the Board’s approval of the execution of the initial agreement providing for such Business Combination (any Business Combination which satisfies all of the criteria specified in (A), (B) and (C) above shall be deemed to be a “Non-Qualifying Transaction”); or

(iv) The stockholders of the Company approve a plan of complete liquidation or dissolution of the Company or a sale or disposition of all or substantially all of the Company’s assets.

Notwithstanding the foregoing, a Change in Control of the Company shall not be deemed to occur solely because any person acquires beneficial ownership of more than 20% of the Company Voting Securities as a result of the acquisition of Company Voting Securities by the Company which reduces the number of Company Voting Securities outstanding;


provided , that if after such acquisition by the Company such person becomes the beneficial owner of additional Company Voting Securities that increases the percentage of outstanding Company Voting Securities beneficially owned by such person, a Change in Control of the Company shall then occur.

2.3 “Closing Price” shall mean the closing price of the Stock as reported on the New York Stock Exchange-Composite Transactions on the closing date for which a Closing Price is to be determined under this Plan (or, if it was not traded on such date, the next preceding day such Stock was traded on an exchange included in the New York Stock Exchange-Composite Transactions).

2.4 “Code” means the Internal Revenue Code of 1986, as now or hereafter amended.

2.5 “Committee” shall mean the Governance and Nominating Committee of the Board or such other Committee appointed by the Board for the purpose of administering this Plan comprising two or more members of the Board all of whom are “non-employee” directors within the meaning of Rule 16b-3 under the Exchange Act.

2.6 “Company” means Praxair, Inc.

2.7 “Deferral Plan” means the Praxair, Inc. Director’s Fees Deferral Plan as amended and restated from time to time.

2.8 “Disability” means a Participant’s inability to engage in any substantial gainful activity because of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted, or can be expected to last, for a continuous period of twelve months or longer.

2.9 “Mandatory Deferrals” means the amounts described and granted pursuant to Section 9 of this Plan.

2.10 “Market Price” is the mean of the high and low prices of Stock as reported in the New York Stock Exchange-Composite Transactions on the date for which a Market Price is to be determined under this Plan (or, if it was not traded on such date, on the next preceding day such Stock was traded on a stock exchange included in the New York Stock Exchange-Composite Transactions).

2.11 “1995 Stock Option Plan” shall mean The Praxair, Inc. 1995 Stock Option Plan for Non-Employee Directors.

2.12 “Non-Employee Director” or “Director” means a member of the Board who is not an employee of the Company or a Subsidiary or Affiliate.

2.13 “Participant” shall mean an individual participating in the Plan pursuant to Section 3.

2.14 “Restricted Stock” means Stock of the Company subject to restrictions on the transfer of such Stock, conditions for forfeiture of such Stock, or any other limitations or restrictions as determined by the Committee and granted pursuant to Section 8 of this Plan.

2.15 “Retirement” shall mean a Non-Employee Director’s reaching the Board’s mandatory retirement age or ceasing to serve as a Director at a later age with the approval of the Board.

2.16 “Stock” shall mean the common stock, $0.01 par value, of the Company.

2.17 “Stock Option” shall mean an option to purchase Stock granted pursuant to Section 6 of this Plan.

2.18 “Subsidiary” and “Affiliate” of the Company each shall mean any entity in which the Company has a 50% or greater ownership interest, directly or indirectly.

Section  3. Participation. The Participants in the Plan shall be all Non-Employee Directors.

Section  4. Administration. The Plan shall be administered and interpreted by the Committee, which shall have sole authority to make rules and regulations for the administration of the Plan. The interpretations and decisions of the Committee with regard to the Plan shall be final and conclusive and binding upon all Participants. The Committee may request advice or assistance or employ such persons (including without limitation, legal counsel, consultants and accountants) as it deems necessary for the proper administration of the Plan. The Committee (i) shall determine the number and types of grants to be made under the Plan; (ii) shall select the types of grants to be made to Participants;(iii) shall set the exercise price, the number of options to be granted, and the number of shares to be granted out of the total number of shares available for grant; (iv) may establish administrative regulations to further the purpose of the Plan; and (v) may take any other action desirable or necessary to interpret, construe or implement properly the provisions of the Plan.

Section  5 . Grants.

5.1 Annual Grants. Each calendar year the Committee may make a grant to each Non-Employee Director in accordance with this Section 5. Except as provided in Section 5.6, if a grant is made, each Participant shall receive the identical grant without discrimination.


5.2 Aggregate Grant Value. The total value of each Participant’s annual grant as of the date of grant shall be such amount as the Board may from time to time determine.

5.3 Form and Terms of Grant. The Committee shall, in its discretion, (a) select the forms of grant to be made which can be Stock Options, Stock, Restricted Stock or Mandatory Deferrals, or a combination thereof, each as more particularly described in this Plan, and (b) set the terms and conditions of such grant subject to the applicable limitations set forth in this Plan.

5.4 Date of Grant. To the extent feasible, and except for a grant for 2005, such grants shall be made as of the same date that annual long term incentive grants are made to the Company’s officers and employees which is expected to be the date of the Board’s regularly scheduled meeting in February of each year. To the extent required by law, a grant of Mandatory Deferrals under Section 9 shall be made no later than the last meeting of the Committee occurring prior to the year for which the grant is being made.

5.5 2005 Grant. The first grants under this Plan shall be made at the first meeting of the Committee following the approval of this Plan by the shareholders of the Company, the date of which meeting shall be the date of grant. To reflect a grant of stock options made in 2005 under the 1995 Stock Option Plan, the total value of the initial grant under this Plan for 2005 for each Participant who received a grant of stock options in 2005 shall be (i) $70,000, less (ii) the value of the stock options granted in 2005 under the 1995 Stock Option Plan to such Participant. The value of such stock options shall be calculated using the same methodology as the Compensation and Management Development Committee of the Board used for determining the value of stock options granted to employees of the Company in 2005, but updated from the date of such employee grant to the date of the 2005 grant of options under the 1995 Stock Option Plan.

5.6 Grants Upon Initial Election or Appointment to the Board. With respect to a Non-Employee Director first elected at an annual meeting of shareholders of the Company or appointed by the Board during a year (including any Non-Employee Director first elected to the Board at the meeting of shareholders which approves this Plan), such Non-Employee Director shall receive a grant having a value equal to a pro-rata portion of that year’s grant dollar value based on the period of time from the effective date on which such Non-Employee Director begins serving on the Board to the end of such calendar year. To the extent feasible, the pro-rata grant shall be made in the same form(s) made to other Non-Employee Directors for such year, but shall reflect the effective date of the Non-Employee Director’s service on the Board as the applicable grant date.

5.7 Valuation of Grants. For purposes of determining the value of grants made hereunder (except for the 2005 grant), (1) the value of grants of Stock Options shall be determined using the same methodology as the Compensation and Management Development Committee (or such other Committee as determined by the Board) uses for determining the value of stock options granted to employees of the Company; and (2) the value of any grants of Stock and Restricted Stock shall be determined by the Closing Price on the date of grant.

5.8 Types of Grants. Grants under this Plan may be in any of the following forms of grants (or a combination thereof): (i) Stock Options; (ii) Stock, (iii) Restricted Stock, or (iv) Mandatory Deferrals.

5.9 Maximum Amount Available. The total number of shares of Stock (including Restricted Stock) optioned or granted under this Plan during the term of the Plan shall not exceed five hundred thousand (500,000) shares. Solely for the purpose of computing the total number of shares of Stock optioned or granted under this Plan, there shall not be counted (i) any shares which have been forfeited; and (ii) any shares covered by an option which, prior to such computation, has terminated in accordance with its terms or has been cancelled by the Participant or the Company.

5.10 Adjustment in the Event of Recapitalization, etc. In the event of any change in the outstanding shares of the Company by reason of any stock split, stock dividend, recapitalization, merger, consolidation, combination or exchange of shares or other similar corporate change or in the event of any special distribution to the stockholders, the Committee shall make equitable adjustments in the number of shares and prices per share applicable to Stock Option grants then outstanding and in the number of shares which are available thereafter for Stock Option grants or other awards, both under the Plan as a whole and with respect to individuals and award type. Such adjustments shall be made in a manner that the Committee determines is necessary and appropriate, and shall be conclusive and binding for all purposes of the Plan.

Section 6. Stock Options.

6.1 Grant Types. The Committee may grant, either alone or in combination with other forms of grant as provided in this Plan, options to purchase Stock (hereinafter referred to as “Stock Option grants”) under such terms as the Committee establishes, subject to the limitations set forth in this Section 6. All Stock Option grants shall be non-qualified stock options.

6.2 Exercise Price. The exercise price of each share of Stock subject to a Stock Option grant shall be specified in the grant, but in no event shall the exercise price be less than the Closing Price on the date of grant.

6.3 Repricing. Without the prior approval of the Company’s shareholders, the exercise price of any Stock Option grant made pursuant to this Plan shall not be changed following the date of its grant, other than such equitable changes as may arise in connection with the adjustments permitted under Section 5.10 and no Stock Option grant may be cancelled and replaced with a new Stock Option grant with a lower exercise price where the economic effect would be the same as reducing the exercise price of the cancelled option.


6.4 Transferability.

(a) Stock Option grants shall not be transferable by the Participant other than:

(i) In the case of the Participant’s death, pursuant to the beneficiary designation then on file with the Company, or, in the absence of such a beneficiary designation (or if the designated beneficiary has pre-deceased the Participant), by will or the laws of descent and distribution (in which case the Company without liability to any other person, may rely on the directions of the executor or administrator of the Participant’s estate with respect to the disposition or exercise of such options);

(ii) In the Committee’s discretion, the terms of a Stock Option may permit the Participant to transfer the Stock Option grant to (A) his or her spouse, children (including by adoption), stepchildren or grandchildren (referred to herein as the Participant’s “Family Members”), (B) a trust or trusts for the exclusive benefit of such Family Members, (C) a partnership in which such Family Members are the only partners, or (D) such other persons or entities as the Committee may approve on a case-by-case basis; or

(iii) In the case of a transferee’s death, to his/her estate without rights to further distribution.

(b) Any transfer pursuant to this Section 6.4 shall be subject to the following:

(i) there may be no consideration for any such transfer;

(ii) the stock option agreement pursuant to which such Stock Option grant is made must be approved by the Committee, and must expressly provide for transferability in a manner consistent with this Section 6.4; and

(iii) subsequent transfers of transferred Stock Option grants shall be prohibited except those in accordance with this Section 6.4.

(c) Following transfer, any transferred Stock Option grant shall continue to be subject to the same terms and conditions as were applicable immediately prior to transfer. The events of death, Disability, Retirement and termination of service as a Non-Employee Director with respect to an outstanding Stock Option grant shall be in relation to the original grantee Participant notwithstanding an earlier transfer of the Stock Option grant. Following such events, the Stock Option grant shall be exercisable by the transferee only to the extent and for the periods specified in Sections 6.6 and 6.7 hereof.

6.5 Duration of Stock Option Grants. A Stock Option grant by its terms shall be of no more than ten (10) years’ duration.

6.6 Initial Exercisability. A Stock Option grant by its terms shall be exercisable only after the earliest of:

(i) such period of time as the Committee shall determine and specify in the grant, but in no event less than three years following the date of grant, provided that Stock Options may be partially exercisable after no less than one (1) year so long as the entire grant does not become fully exercisable until at least three (3) years have elapsed from the date of grant;

(ii) the Participant’s death; or

(iii) a Change in Control of the Company.

In the event of the Participant’s Disability, Retirement, resignation or the termination of the Participant’s service as a Non-Employee Director other than for cause, a Stock Option grant shall not be exercisable at the time of such event but shall become exercisable at the time specified in clauses (i), (ii) and (iii) above. Notwithstanding the foregoing, in the event of a Participant’s Retirement, resignation or termination of service as a Non-Employee Director prior to the first anniversary date after the date of a Stock Option grant, such Stock Option grant shall not be exercisable but shall be immediately forfeited.

6.7 Exercise Period. A Stock Option grant is only exercisable by a Participant (or, if the Stock Option grant has been duly transferred pursuant to Section 6.4, the transferee) while the Participant is in active service as a Non-Employee Director, except:

(i) in the case of a Participant’s death, the Stock Option grant shall remain exercisable by the transferee of the grant during a three (3) year period following the date of death;

(ii) in the case of a Participant’s Retirement or Disability, the Stock Option grant, to the extent not forfeited in accordance with Section 6.6 above, shall remain exercisable during the original grant duration as specified in the grant agreement; or

(iii) in the case of a resignation or termination of the Participant’s service as a Non-Employee Director other than for cause, the Stock Option grant shall remain exercisable during a three (3) year period commencing on the effective date of such resignation or termination; or


(iv) in the case of a resignation or termination of the Participant’s services as a Non-Employee Director within two (2) years after a Change in Control of the Company, unless such termination of services is for cause, the Stock Option grant shall remain exercisable during a three-year period commencing on the effective date of termination; or

(v) if the Committee decides that it is in the best interest of the Company to permit individual exceptions.

In no event may a Stock Option grant be exercised after its expiration date.

6.8 Manner of Exercise. A Stock Option grant may be exercised by the Participant (or, if the Stock Option grant has been duly transferred pursuant to Section 6.4, the transferee) with respect to part or all of the shares subject to the option by giving written notice to the Company or its designee of the exercise of the option according to such procedures as the Committee may establish.

6.9 Payment of Exercise Price. The exercise price for the shares for which an option is exercised shall be paid by the exerciser within three (3) business days after the date of exercise and the terms of the Stock Option grant may provide that the exerciser price may be paid:

(a) in cash;

(b) in whole shares of Stock owned by the exerciser prior to exercising the option provided such shares have been held by the exerciser for at least six months;

(c) by having the Company withhold shares that otherwise would be delivered to the exerciser pursuant to the exercise of the option in an amount equaling in value the exercise price;

(d) in a combination of either cash and delivery of shares, or cash and withholding of shares; or

(e) by whatever other means the Committee may deem appropriate, other than by a loan by the Company to the exerciser.

The Company shall establish procedures in connection with payments pursuant to (b), (c), (d), and (e) above, to ensure that the Plan does not become subject to variable accounting by virtue of such payment methods. Shares of stock shall not be delivered to the exerciser until the full exercise price has been paid. The value of any share of Stock delivered or withheld in payment of the exercise price shall be its Market Price on the date the option is exercised.

Section 7. Grants of Stock.

The Committee may grant, either alone or in addition to other grants made under the Plan, shares of Stock.

Section 8. Grants of Restricted Stock.

8.1 Grant Types. The Committee may grant, either alone or in addition to other grants made under the Plan, shares of Restricted Stock under such terms as the Committee establishes, subject to the limitations set forth in this Section 8.

8.2 Vesting Periods. Restricted Stock shall be vested and transferable only after the earliest of;

(i) such period of time as the Committee shall determine and specify in the grant, but in no event less than three years following the date of grant;

(ii) the Participant’s death;

(iii) the Participant’s Disability; or

(iv) a Change in Control of the Company.

In the event of a Participant’s Retirement, resignation or termination of service as a Non-Employee Director other than for cause, the Restricted Stock shall be vested but not transferable at the time of such event but shall become transferable at the time specified in clauses (i) through (iv) above, except that if the Restricted Stock is taxable income to the Director at the time of such event, then the Director may sell or transfer up to thirty-five percent (35%) of the Restricted Stock at any time after such event.

8.3 Forfeitures of Restricted Stock. In the event a Director’s services as a Director are terminated for cause, any non-vested Restricted Stock shall be forfeited, unless the Committee shall otherwise determine that it is in the best interests of the Company to permit individual exceptions.

8.4 Rights as a Stockholder. The Participant shall have, with respect to Restricted Stock, all of the rights of a stockholder of the Company, including the right to vote the shares and the right to receive any dividends, unless the Committee shall otherwise determine.


8.5 Transferability. Restricted Stock may not be sold or transferred by the Participant until any restrictions that have been established by the Committee have lapsed.

Section 9. Mandatory Deferrals.

9.1 Grant Type. The Committee may award cash amounts, either alone or in addition to other grants made under the Plan, which shall be mandatorily deferred by way of the Deferral Plan. Such amounts shall be credited to the Director’s Stock Unit Account established under the Deferral Plan and shall be paid out under such terms and conditions as the Committee may determine at the time of award, provided that:

(i) such payout conditions are consistent with the terms of the Deferral Plan and do not conflict with any then current provisions of the Internal Revenue Code or Internal Revenue Service regulations or interpretations promulgated thereunder governing the deferral of taxes on compensation; and

(ii) except for any payout acceleration events as the Committee may permit or the Deferral Plan may require, payout of such amounts shall be deferred for a period of three (3) years from the date of grant or such longer period as the Committee may specify.

9.2 Forfeiture. Notwithstanding the foregoing, a Director shall forfeit any award amounts and earnings thereon that have been mandatorily deferred pursuant to Section 9.1 if (i) the Director’s service on the Board is terminated for cause, or (ii) the Director fails to meet any vesting conditions that the Committee may establish with respect to the award.

Section 10. General Provisions.

10.1 Assignment. Subject to the provisions of Section 6.4, if applicable, any assignment or transfer of any grants without the written consent of the Company shall be null and void.

10.2 No Trust. Nothing contained herein shall require the Company to segregate any monies from its general funds, or to create any trusts, or to make any special deposits for any immediate or deferred amounts payable to any Participant for any year.

10.3 Cancellation and Rescission of Grants.

(a) The Committee shall have the discretion with respect to any grant made under this Plan to establish upon its grant conditions under which (i) the grant may be later forfeited, cancelled, rescinded, suspended, withheld or otherwise limited or restricted; or (ii) gains realized by the grantee in connection with a grant or a grant’s exercise may be recovered; provided that such conditions and their consequences are

(A) clearly set forth in the grant agreement or other grant document; and (B) fully comply with applicable laws.

(b) The Committee may require, upon exercise, payment or delivery pursuant to a grant, that the Participant certify in a manner acceptable to the Company that he or she is in compliance with the terms and conditions of the grant.

10.4 Payment of Taxes. To enable the Company to meet any applicable federal, state, local or foreign withholding tax requirements arising as a result of the exercise of a Stock Option or the grant, vesting or payment of Stock or Restricted Stock, a Participant or the Participant’s estate shall pay to the Company the amount of tax to be withheld, or may elect to satisfy such obligation:

(a) By delivering to the Company other shares of Stock owned by the Participant for at least six months prior to the Option exercise or grant, vesting or payment of the Stock or Restricted Stock;

(b) by making a payment to the Company consisting of a combination of cash and such shares of Stock; or

(c) if the exerciser or grantee is the Participant, by having the Company withhold shares that otherwise would be delivered to the Participant pursuant to the Option exercise or grant, vesting or payment of the Stock or Restricted Stock for which the tax is being withheld, provided that withholding by such method shall be limited to the minimum required applicable tax withholding.;

Such an election shall be made in such manner as may be prescribed by the Committee and the Committee shall have the right, in its discretion, to disapprove such election. Any such election must be made prior to the date to be used to determine the tax to be withheld and shall be irrevocable. The value of any share of Stock to be withheld by the Company or delivered to the Company pursuant to this Section 10.4 shall be the Market Price on the date used to determine the amount of tax to be withheld.

The Company shall establish procedures in connection with payments pursuant to (a), (b), and (c) above, to ensure that the Plan does not become subject to variable accounting by virtue of such payment methods.

10.5 Termination of Prior Plan. Following the approval of this Plan by the shareholders of the Company, no further stock options will be granted to Non-Employee Directors under the 1995 Stock Option Plan.


10.6 Effect of Participation. Participation in this Plan shall not provide any Participant the right to continue service as a Director of the Company.

10.7 Termination for Cause. For purposes of Sections 6, 8 and 9 of this Plan, a Director who is not nominated for re-election to the Board or a Director who is not re-elected to the Board by the shareholders of the Company, shall not be considered a Director whose services as a Director were terminated for cause unless the Board duly adopts a resolution specifying otherwise and setting forth the reasons such event shall be deemed a termination for cause.

Section 11. Amendment, Suspension, or Termination.

11.1 The Board may suspend, terminate, or amend the Plan, including, but not limited to, such amendments as may be necessary or desirable resulting from changes in the federal income tax laws and other applicable laws, but may not, without the affirmative vote of a majority of all votes duly cast on the matter at a meeting of the stockholders of the Company (provided that the total votes cast on the matter represent over 50% of the shares entitled to vote on the matter): (a) increase the total number of shares of Stock that may be optioned or granted under this Plan; (b) amend Section 6.3 with respect to re-pricing of Stock Option grants; (c) change the eligibility requirements for participation in the Plan; or (d) adopt any other material revision to this Plan that would require the approval of the stockholders under the rules promulgated by the New York Stock Exchange.

11.2 It is the Company’s intent that the Plan comply in all respects with Rule 16b-3 under the Exchange Act and any related regulations and other authority. If any provision of this Plan is later found not to be in compliance with such rules and regulations, the provisions shall be deemed null and void. All grants to, and exercises of options under, this Plan shall be executed in accordance with the requirements of Section 16 of the Exchange Act and regulations promulgated thereunder.

Section 12. Governing Law.

The validity, construction and effect of the Plan and any rules and regulations relating to the Plan shall be determined in accordance with the laws of the State of Connecticut and applicable federal law.

Section 13. Effective Date and Duration of the Plan.

This Plan shall be effective upon approval of this Plan by the shareholders of the Company. No further grants shall be made under the Plan after April 30, 2010.

Exhibit 4.3

Praxair, Inc. and Subsidiaries

 

 

 

Amended and Restated

2009 Praxair, Inc.

Long Term Incentive Plan

Effective April 22, 2014


Table of Contents

 

Article 1.

  Establishment, Purpose, and Duration      2  

Article 2.

  Definitions      2  

Article 3.

  Administration      9  

Article 4.

  Shares Subject to this Plan and Maximum Awards      10  

Article 5.

  Eligibility and Participation      12  

Article 6.

  Stock Options      12  

Article 7.

  Stock Appreciation Rights      14  

Article 8.

  Restricted Stock Grants      15  

Article 9.

  Performance Units      17  

Article 10.

  Other Stock-Based Awards      18  

Article 11.

  Transferability of Awards      19  

Article 12.

  Performance Measures      20  

Article 13.

  Dividend Equivalents      22  

Article 14.

  Termination of Employment or Service as a Director      22  

Article 15.

  Rights of Participants      22  

Article 16.

  Change in Control      23  

Article 17.

  Amendment, Modification, Suspension, and Termination      24  

Article 18.

  Tax Withholding; No Liability with Respect to Tax   
  Qualification or Adverse Tax Treatment      24  

Article 19.

  Successors      25  

Article 20.

  General Provisions      25  


Amended and Restated

2009 Praxair, Inc.

Long Term Incentive Plan

Article 1. Establishment, Purpose, and Duration

1.1 Establishment . Praxair, Inc., a Delaware corporation (hereinafter referred to as the “Company”), hereby amends and restates its 2009 Praxair, Inc. Long Term Incentive Plan (the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan, hereinafter referred to as the “Plan”), as set forth in this document.

This Plan permits the grant of Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights (“SARs”), Restricted Stock, Restricted Stock Units, Performance Units, and Other Stock-Based Awards.

This Plan was originally adopted by the Board on February 24, 2009, became effective upon shareholder approval on April 28, 2009 and was subsequently amended, effective as of April 27, 2010, January 25, 2011 and October 23, 2012. This amendment and restatement of the Plan was adopted by the Board on January 28, 2014 and shall become effective upon shareholder approval on April 22, 2014 (the “Effective Date”) and shall remain in effect as provided in Section 1.3 hereof.

1.2 Purpose of this Plan . The purpose of this Plan is to provide a means whereby Employees develop personal involvement in the financial success of the Company, and to encourage them to devote their best efforts to the business of the Company, thereby advancing the interests of the Company and its shareholders. A further purpose of this Plan is to provide a means through which the Company may attract and retain able Employees and to provide a means whereby those individuals can acquire and maintain stock ownership, thereby strengthening their concern for the welfare of the Company. This Plan also provides a means of compensating Directors in the form of equity as a complement to other elements of the Directors’ overall compensation program and to align their interests with those of the Company’s shareholders.

1.3 Duration of this Plan . Unless sooner terminated as provided herein, this Plan shall terminate April 22, 2024. After this Plan is terminated, no Awards may be granted but Awards previously granted shall remain outstanding in accordance with their applicable terms and conditions and this Plan’s terms and conditions.

Article 2. Definitions

Whenever used in this Plan, the following terms shall have the meanings set forth below, and when the meaning is intended, the initial letter of the word shall be capitalized.

 

  2.1

“Acquisition Awards” has the meaning set forth in Section 4.2.

 

 

2


  2.2

“Administrator” has the meaning set forth in Section 3.4.

 

  2.3

“Award” means, individually or collectively, a grant under this Plan of Nonqualified Stock Options, Incentive Stock Options, SARs, Restricted Stock, Restricted Stock Units, Performance Units, or Other Stock-Based Awards, in each case subject to the terms of this Plan.

 

  2.4

“Award Agreement” means either (a) a written agreement entered into by the Company and a Participant setting forth the terms and provisions applicable to an Award granted under this Plan, or (b) a written or electronic statement issued by the Company to a Participant describing the terms and provisions of such Award, including any amendment or modification thereof. The Committee may provide for the use of electronic, Internet or other non-paper Award Agreements, and the use of electronic, Internet or other non-paper means for the acceptance thereof and actions thereunder by a Participant.

 

  2.5

“Beneficial Owner” or “Beneficial Ownership” shall have the meaning ascribed to such term in Rule 13d-3 of the General Rules and Regulations under the Exchange Act.

 

  2.6

“Board” means the Board of Directors of the Company.

 

  2.7

“Change in Control” means the occurrence of any one of the following events with respect to the Company:

 

  (a)

individuals who, on January 1, 2014, constitute the Board (the “Incumbent Directors”) cease, for any reason, to constitute at least a majority of the Board, provided that any person becoming a director subsequent to January 1, 2014, whose election or nomination for election was approved by a vote of at least two-thirds of the Incumbent Directors then on the Board (either by a specific vote or by approval of the Company proxy statement in which such person is named as a nominee for director, without objection to such nomination) shall be an Incumbent Director; provided, however, that no individual elected or nominated as a director of the Company initially as a result of an actual or threatened election contest with respect to directors or any other actual or threatened solicitation of proxies or consents by or on behalf of any person other than the Board shall be deemed an Incumbent Director;

 

  (b)

any “person” (as such term is defined in Section 3(a)(9) of the Exchange Act and as used in Sections 13(d)(3) and 14(d)(2) of the Exchange Act) is or becomes a Beneficial Owner, directly or indirectly, of securities of the Company representing 20% or more of the combined voting power of the Company’s then outstanding securities eligible to vote for the election of the Board (the “Praxair Voting Securities”); provided, however, that the event

 

3


  described in this Subsection 2.7(b) shall not be deemed to be a Change in Control by virtue of any of the following acquisitions: (A) by the Company or any of its subsidiaries; (B) by any employee benefit plan sponsored or maintained by the Company or any of its subsidiaries; (C) by any underwriter temporarily holding securities pursuant to an offering of such securities; or (D) pursuant to a Non-Qualifying Transaction (as defined in Subsection 2.7(c));

 

  (c)

the consummation of a merger, consolidation, statutory share exchange or similar form of corporate transaction involving the Company or any of its subsidiaries that requires the approval of the Company’s stockholders, whether for such transaction or the issuance of securities in the transaction (a “Business Combination”), unless immediately following such Business Combination: (A) more than 50% of the total voting power of (x) the corporation resulting from such Business Combination (the “Surviving Corporation”), or (y) if applicable, the ultimate parent corporation that directly or indirectly has Beneficial Ownership of 100% of the voting securities eligible to elect directors of the Surviving Corporation (the “Parent Corporation”), is represented by Praxair Voting Securities that were outstanding immediately prior to such Business Combination (or, if applicable, shares into which such Praxair Voting Securities were converted pursuant to such Business Combination), and such voting power among the holders thereof is in substantially the same proportion as the voting power of such Praxair Voting Securities among the holders thereof immediately prior to the Business Combination, (B) no person (other than any employee benefit plan sponsored or maintained by the Surviving Corporation or the Parent Corporation), is or becomes the Beneficial Owner, directly or indirectly, of 20% or more of the total voting power of the outstanding voting securities eligible to elect directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) and (C) at least a majority of the members of the board of directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) were Incumbent Directors at the time of the Board’s approval of the execution of the initial agreement providing for such Business Combination (any Business Combination which satisfies all of the criteria specified in (A), (B) and (C) above shall be deemed to be a “Non-Qualifying Transaction”); or

 

  (d)

the stockholders of the Company approve a plan of complete liquidation or dissolution of the Company or a sale or disposition of all or substantially all of the Company’s assets.

Notwithstanding the foregoing, to the extent an Award is subject to Code Section 409A, the Committee shall have the discretion to define Change in Control for such Award in a manner which complies with such Code Section.

 

 

4


  2.8

“Code” means the U.S. Internal Revenue Code of 1986, as amended from time to time. For purposes of this Plan, references to sections of the Code shall be deemed to include references to any applicable regulations thereunder and any successor or similar provision.

 

  2.9

“Committee” means, with respect to Awards granted to (a) Employees, the Compensation and Management Development Committee of the Board, and (b) Directors, the Governance and Nominating Committee of the Board, and in each case, any other committee designated by the Board to administer this Plan with respect to Employee or Director Awards. The Committee shall consist of not less than two directors. However, if a member of the Committee is not an “outside director” within the meaning of Code Section 162(m) or is not a “non-employee director” within the meaning of Rule 16b-3 under the Exchange Act, the Committee may, from time to time, delegate some or all of its functions under the Plan to a committee or subcommittee composed of members that meet the relevant requirements. The term “Committee” includes any such committee or subcommittee, to the extent of the Compensation and Management Development Committee’s delegation, or the Governance and Nominating Committee’s delegation, as the case may be. If the Committee does not exist or cannot function for any reason, the Board may take any action under the Plan that would otherwise be the responsibility of the Committee, other than any actions required to be carried out by a committee of at least two “outside directors” or “non-employee directors”.

 

  2.10

“Company” means Praxair, Inc., a Delaware corporation, and any successor thereto as provided in Article 18 herein.

 

  2.11

“Covered Employee” means any Employee who is or may become a “Covered Employee,” as defined in Code Section 162(m), and who is designated, either as an individual Employee or class of Employees, by the Committee within the shorter of (a) ninety (90) days after the beginning of the Performance Period, or (b) the period prior to the date twenty-five percent (25%) of the Performance Period has elapsed, as a “Covered Employee” under this Plan for such applicable Performance Period.

 

  2.12

“Director” means any director of the Company who is not an Employee.

 

  2.13

“Effective Date” has the meaning set forth in Section 1.1.

 

  2.14

“Employee” means any individual performing services for the Company or a Subsidiary and designated as an employee of the Company or its Subsidiaries on the payroll records thereof. An Employee shall not include any individual during any period he or she is classified or treated by the Company or its Subsidiary as an independent contractor, a consultant, or any employee of an employment, consulting, or temporary agency or any other entity other than the Company or its Subsidiary, without regard to whether such individual is subsequently determined to have been, or is subsequently retroactively reclassified as a common-law employee of the Company or its Subsidiary during such period.

 

5


  2.15

“Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time, or any successor act thereto.

 

  2.16

“Fair Market Value” or “FMV” means, in respect of any date on or as of which a determination thereof is being or to be made, the closing market price of a Share reported on the New York Stock Exchange Composite Transactions tape on such date, or, if no Shares were traded on such date, on the next preceding day on which sales of Shares were reported on the New York Stock Exchange Composite Transactions tape.

 

  2.17

“Grant Date” means the date an Award is granted to a Participant pursuant to the Plan.

 

  2.18

“Grant Price” means the price established at the time of grant of a SAR pursuant to Article 7, used to determine whether there is any payment due upon exercise of the SAR.

 

  2.19

“Incentive Stock Option” or “ISO” means an Option to purchase Shares granted under Article 6 to an Employee that is designated as an Incentive Stock Option and that is intended to meet the requirements of Code Section 422, or any successor provision.

 

  2.20

“Insider” shall mean an individual who is, on the relevant date, an executive officer of the Company or a more than ten percent (10%) Beneficial Owner of any class of the Company’s equity securities that is registered pursuant to Section 12 of the Exchange Act, as determined by the Board in accordance with Section 16 of the Exchange Act.

 

  2.21

“Market Price” means, in respect of any date on or as of which a determination thereof is being or to be made, the average of the high and low prices of a Share reported on the New York Stock Exchange Composite Transactions tape on such date, or, if no Shares were traded on such date, on the next preceding day on which sales of Shares were reported on the New York Stock Exchange Composite Transactions tape.

 

  2.22

“Nonqualified Stock Option” or “NQSO” means an Option that is not intended to meet the requirements of Code Section 422, or that otherwise does not meet such requirements.

 

  2.23

Officer ” means an Employee who is either (a) an “executive officer” (within the meaning of Rule 3b-7 of the Exchange Act), or (b) an “officer” elected by the Board and holding a position with a Company salary level of 18 or higher (or the future equivalent thereof).

 

6


  2.24

“Option” means an Incentive Stock Option or a Nonqualified Stock Option, as described in Article 6.

 

  2.25

“Option Price” means the price at which a Share may be purchased by a Participant pursuant to an Option.

 

  2.26

“Other Stock-Based Award” means an equity-based or equity-related Award not otherwise described by the terms of this Plan, granted pursuant to Article 10.

 

  2.27

“Participant” means any Employee or a Director to whom an Award is granted.

 

  2.28

“Performance-Based Compensation” means compensation under an Award that is intended to satisfy the requirements of Code Section 162(m) for certain performance-based compensation paid to Covered Employees. Any Award granted hereunder that is intended to be Performance-Based Compensation within the meaning of Code Section 162(m) shall be subject to the terms and provisions of this Plan and not the Praxair, Inc. Plan for Determining Performance-Based Awards Under Section 162(m).

 

  2.29

“Performance Goal” means, with respect to any applicable Award to an Employee, the one or more targets, goals or levels of attainment required to be achieved in terms of the specified Performance Measures during the specified Performance Period, as set forth in the related Award Agreement.

 

  2.30

“Performance Measures” means: (a) with respect to any Award to an Employee intended to qualify as Performance-Based Compensation, any one or more of the measures described in Article 12 on which the Performance Goals are based and which are approved by the Company’s shareholders pursuant to this Plan in order to qualify Awards as Performance-Based Compensation; and (b) with respect to any other Award, such performance measures as determined by the Committee in its sole discretion and set forth in the applicable Award Agreement for purposes of determining the applicable Performance Goal.

 

  2.31

“Performance Period” means the period of time during which the Performance Goals must be met in order to determine the degree of payout and/or vesting with respect to an Award granted to an Employee.

 

  2.32

“Performance Unit” means an Award to an Employee under Article 9 herein and subject to the terms of this Plan, denominated in Units, the value of which at the time it is payable is determined as a function of the extent to which corresponding Performance Goal(s) has been achieved during the applicable Performance Period.

 

7


  2.33

“Plan” means this Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan.

 

  2.34

“Restricted Stock ” means Shares issued pursuant to a Restricted Stock Grant under Article 8, so long as the Shares remain subject to the restrictions and conditions specified in the Award Agreement pursuant to which such Restricted Stock Grant is made.

 

  2.35

“Restricted Stock Grant” means an Award of Restricted Stock or Restricted Stock Units made pursuant to the provisions of Article 8.

 

  2.36

“Restricted Stock Unit” means a Unit issued pursuant to a Restricted Stock Grant under Article 8 so long as the Units remain subject to the restrictions and conditions specified in the Award Agreement.

 

  2.37

“Restriction Period” means the period when Restricted Stock or Restricted Stock Units are subject to a substantial risk of forfeiture (based on the passage of time, the achievement of Performance Goals, or upon the occurrence of other events as determined by the Committee, in its discretion), as provided in Article 8.

 

  2.38

“Share” means a share of common stock of the Company, $0.01 par value per share or any security issued by the Company in substitution or exchange therefor or in lieu thereof.

 

  2.39

“Share Equivalent” means a Unit (or fraction thereof, if authorized by the Committee) substantially equivalent to a hypothetical Share, credited to the Participant and having a value at any time equal to the FMV of a Share (or fraction thereof) at such time.

 

  2.40

“Stock Appreciation Right” or “ SAR ” means an Award, designated as a SAR, pursuant to the terms of Article 7 herein.

 

  2.41

“Subsidiary” means any corporation or other entity, whether domestic or foreign, in which the Company has or obtains, directly or indirectly, a proprietary interest of fifty percent (50%) or greater by reason of stock ownership or otherwise; provided, however, that (a) for purposes of determining whether any Employee can be a Participant with respect to any Award of Incentive Stock Option, the term “Subsidiary” has the meaning given to such term in Code Section 424, as interpreted by the regulations thereunder and applicable law; and (b) for purposes of determining whether any individual may be a Participant with respect to any Award of Options or SARs that are intended to be exempt from Code Section 409A, the term “Subsidiary” means any corporation or other entity to which the Company is an “eligible issuer of service recipient stock” within the meaning of Code Section 409A.

 

8


  2.42

“Unit” means a bookkeeping entry used by the Company to record and account for the grant or settlement of an Award until such time as the Award is paid, canceled, forfeited or terminated, as the case may be, which, except as otherwise specified by the Committee, shall be equal to one Share Equivalent.

Article 3. Administration

3.1 General . The Committee shall be responsible for administering this Plan, subject to this Article 3 and the other provisions of this Plan. The Committee may employ attorneys, consultants, accountants, agents, and other individuals, any of whom may be an Employee, and the Committee, the Company, and its officers and Directors shall be entitled to rely upon the advice, opinions, or valuations of any such individuals. All actions taken and all interpretations and determinations made by the Committee shall be final and binding upon the Participants, the Company, and all other interested individuals.

3.2 Authority of the Committee . The Committee shall have full and exclusive discretionary power to interpret the terms and the intent of this Plan and any Award Agreement or other agreement or document ancillary to, or in connection with, this Plan, to determine eligibility for Awards and to adopt such rules, regulations, forms, instruments, and guidelines for administering this Plan as the Committee may deem necessary or proper. Such authority shall include, but not be limited to, (a) selecting Participants, (b) establishing all Award terms and conditions, including the terms and conditions set forth in Award Agreements, (c) granting Awards as an alternative to or as the form of payment for grants or rights earned or due under compensation plans or arrangements of the Company, (d) construing any ambiguous provision of the Plan or any Award Agreement, (e) determining whether, to what extent and under what circumstances and method or methods (1) Awards may be (A) settled in cash, Shares, other securities, other Awards or other property, (B) exercised or (C) canceled, forfeited or suspended, (2) Shares, other securities, other Awards or other property, and other amounts payable with respect to an Award may be deferred either automatically or at the election of the Participant thereof or of the Committee, and (3) Awards may be settled by the Company or any of its designees, and (f) subject to Article 16 adopting modifications and amendments to this Plan or any Award Agreement, including, without limitation, any that are necessary to comply with the laws, rules or regulations of the countries and other jurisdictions in which the Company and/or its Subsidiaries operate or to accelerate the time or times at which the Award becomes vested, unrestricted or may be exercised.

3.3 Delegation. The Committee may delegate to one or more of its members or to one or more officers of the Company, and/or its Subsidiaries or to one or more agents or advisors, such administrative duties or powers as it may deem advisable, and the Committee or any individuals to whom it has delegated duties or powers as aforesaid may employ one or more individuals to render advice with respect to any responsibility the Committee or such individuals may have under this Plan. The Committee may, by resolution, authorize the Chief Executive Officer of the Company (the “CEO”) or any other officer of the Company, to do one or both of the following on the same basis as can the Committee: (a) designate Employees to be recipients of Awards

 

9


and (b) determine the size of any such Awards; provided, however, (i) the Committee shall not delegate such responsibilities for any Awards to be granted to an Employee who is considered an Insider; (ii) the resolution providing such authorization sets forth the total number of Awards the CEO or officer may grant; and (iii) the CEO or officer, as applicable, shall report periodically to the Committee regarding the nature and scope of the Awards granted pursuant to the authority delegated.

3.4 Indemnification. No member of the Committee or any person to whom administrative duties or powers have been delegated in accordance with Section 3.3 (each, an “Administrator”) will have any liability to any person (including any Participant) for any action taken or omitted or any determination made in good faith with respect to the Plan or any Award. Each Administrator will be indemnified and held harmless by the Company against and from any loss, cost, liability or expense (including attorneys’ fees) that may be imposed upon or incurred by such Administrator in connection with or resulting from any action, suit or proceeding to which such Administrator may be a party or in which such Administrator may be involved by reason of any action taken or omitted to be taken under the Plan or any Award Agreement and against and from any and all amounts paid by such Administrator, with the Company’s approval, in settlement thereof, or paid by such Administrator in satisfaction of any judgment in any such action, suit or proceeding against such Administrator, provided that the Company will have the right, at its own expense, to assume and defend any such action, suit or proceeding and, once the Company gives notice of its intent to assume the defense, the Company will have sole control over such defense with counsel of the Company’s choice. To the extent any taxable expense reimbursement under this paragraph is subject to Section 409A of the Code, (a) the amount thereof eligible in one taxable year shall not affect the amount eligible in any other taxable year; (b) in no event shall any expenses be reimbursed after the last day of the taxable year following the taxable year in which the Administrator incurred such expenses; and (c) in no event shall any right to reimbursement be subject to liquidation or exchange for another benefit. The foregoing right of indemnification will not be available to an Administrator to the extent that a court of competent jurisdiction in a final judgment or other final adjudication, in either case, not subject to further appeal, determines that the acts or omissions of such Administrator giving rise to the indemnification claim resulted from such Administrator’s bad faith, fraud or willful misconduct. The foregoing right of indemnification will not be exclusive of any other rights of indemnification to which an Administrator may be entitled under the Company’s certificate of incorporation or by-laws, as a matter of law, or otherwise, or any other power that the Company may have to indemnify such persons or hold them harmless.

Article 4. Shares Subject to this Plan and Maximum Awards

4.1 Number of Shares Available for Awards . Subject to adjustment as provided in Section 4.5, the maximum number of Shares which may be issued pursuant to Awards under this Plan on or after the Effective Date shall be 8,000,000 Shares (the “Share Authorization”). The Shares available for issuance under this Plan may be authorized and unissued Shares or treasury Shares. The maximum number of Shares of the Share Authorization that may be issued pursuant to ISOs under this Plan shall be 8,000,000 Shares. The maximum number of Shares of the Share Authorization that may be issued under this Plan pursuant to Awards other than Options or SARs shall be 2,600,000 Shares.

 

10


4.2 Share Usage. Shares subject to an Award that expires according to its terms or is forfeited, terminated, canceled or surrendered, in each case, without having been exercised or settled, or can be paid only in cash, will be available again for grant under the Plan, without reducing the number of Shares that are available for Awards under the Plan. In no event shall (a) any Shares subject to an Option that is cancelled upon the exercise of a tandem SAR, (b) any Shares subject to an Award that are surrendered in payment of the exercise price of an Option or in payment of the taxes associated with an Award, (c) any Shares subject to a SAR that are not issued in connection with the stock settlement of the SAR upon exercise thereof, or (d) any Shares repurchased by the Company using Option proceeds, become available for grant under the Plan pursuant to this Section. Shares subject to awards that are assumed, converted or substituted under the Plan as a result of the Company’s acquisition of another company (including by way of merger, combination or similar transaction) (“Acquisition Awards”) will not count against the Share Authorization. Available shares under a stockholder approved plan of an acquired company (as appropriately adjusted to reflect the transaction) may be used for Awards under the Plan and do not reduce the Share Authorization, subject to applicable stock exchange requirements.

4.3 Annual Award Limits. The following limits (each an “Annual Award Limit” and, collectively, “Annual Award Limits”), as adjusted pursuant to Section 4.5, shall apply to grants of Awards to Employees under this Plan, whether or not such Awards are intended to qualify as Performance-Based Compensation:

 

  (a)

Options and SARS : The maximum aggregate number of Shares subject to Options, SARs or any combination thereof granted in any one calendar year to any one Participant shall be 2,000,000 (with tandem Options and SARs being counted only once with respect to this limit).

 

  (b)

Other Awards Intended to be Performance-Based Compensation : The maximum aggregate number of Shares subject to Awards of Restricted Stock, Restricted Stock Units, Performance Units or Other Stock-Based Compensation that are intended to be Performance-Based Compensation granted in any one calendar year to any one Participant shall be 300,000 Shares or, in the event such Award is payable in cash, the equivalent cash value thereof on the first day of the performance period to which such Award relates, as determined by the Committee.

4.4 Director Awards. In order to retain and compensate Directors for their services, and to strengthen the alignment of their interests with those of the shareholders of the Company, the Plan permits the grant of stock-based awards to Directors. Aggregate Awards to any one Director in respect of any calendar year, solely with respect to his or her service as a Director, may not exceed $750,000 based on the Fair Market Value of stock-based Awards, determined as of the Grant Date.

 

11


4.5 Adjustments in Authorized Shares . In the event of any corporate event or transaction such as a merger, consolidation, reorganization, recapitalization, separation, partial or complete liquidation, stock dividend, other distribution of cash or property (other than normal cash dividends) to shareholders of the Company, stock split, reverse stock split, split up, spin-off, combination of Shares, exchange of Shares, dividend in kind, or other like change in capital structure affecting the number or type of outstanding Shares, the Committee, in order to prevent dilution or enlargement of Participants’ rights under this Plan, shall substitute or adjust, as applicable, the number and kind of Shares that may be issued under this Plan or under particular forms of Awards, the number and kind of Shares subject to outstanding Awards (including, without limitation, the substitution of other securities, cash or property in lieu thereof), the Option Price or Grant Price applicable to outstanding Awards, the Annual Award Limits, and other value determinations applicable to outstanding Awards.

To further reflect any of the foregoing events, transactions or adjustments, the Committee, in its sole discretion, may also make adjustments in the terms of any Awards under this Plan and may modify any other terms of outstanding Awards, including modifications of Performance Goals and changes in the length of Performance Periods, as it deems necessary or appropriate. The determination of the Committee as to the foregoing adjustments, if any, shall be conclusive and binding on Participants under this Plan.

Subject to the provisions of Article 16 and notwithstanding anything else herein to the contrary, without affecting the number of Shares reserved or available hereunder, the Committee may authorize the issuance or assumption of benefits under this Plan in connection with any merger, consolidation, acquisition of property or stock, or reorganization upon such terms and conditions as it may deem appropriate (including, but not limited to, a conversion of equity awards into Awards under this Plan in a manner consistent with FASB ASC Topic 718).

Article 5. Eligibility and Participation

Only Employees and Directors shall be eligible to participate in this Plan. Subject to the provisions of this Plan, the designated Committee may, from time to time, select those Employees or Directors to whom Awards shall be granted and shall determine, in its sole discretion, the nature of, any and all terms permissible by law, and the amount of each Award; provided, however, that no Award made to a Director shall be subject to or conditioned upon the attainment of any Performance Goal.

Article 6. Stock Options

6.1 Grant of Options . Subject to the terms and provisions of this Plan, Options may be granted to Participants in such number, and upon such terms, and at any time and from time to time as shall be determined by the Committee, in its sole discretion. Options may be granted in addition to, or in tandem with or independent of, SARs or any other Awards under the Plan.

 

12


6.2 Award Agreement . Each Option grant shall be evidenced by an Award Agreement that shall specify the Option Price, the term of the Option, the number of Shares to which the Option pertains, the conditions, including any Performance Goals, upon which an Option shall become vested and exercisable, and such other terms and conditions as the Committee shall determine which are not inconsistent with the terms of this Plan. The Award Agreement also shall specify whether the Option is intended to be an ISO or an NQSO. To the extent that an Award Agreement does not specify whether the Option is intended to be an ISO or an NQSO, such Option shall be an NQSO.

6.3 Option Price . The Option Price for each grant of an Option under this Plan shall be determined by the Committee in its sole discretion and shall be specified in the Award Agreement; provided, however, the Option Price (other than the Option Price of Acquisition Awards) must be at least equal to 100% of the FMV of the Shares as determined on the Grant Date.

6.4 Term of Options . Each Option granted to a Participant shall expire at such time as the Committee shall determine at the time of grant; provided, however, no Option shall be exercisable later than the day before the tenth (10 th ) anniversary of its Grant Date.

6.5 Exercise of Options . Options granted under this Article 6 shall be exercisable at such times and be subject to such restrictions and conditions as the Committee shall in each instance approve, which terms and restrictions need not be the same for each grant or for each Participant. Except upon a Change in Control and in certain limited situations (including, but not limited to, the death or disability of the Participant): (a) Awards of Options subject solely to the continued service of the Participant shall become exercisable no earlier than three (3) years after the Grant Date, provided that such Option may partially vest after no less than one (1) year following such Grant Date; and (b) any other Award of Options shall become exercisable no earlier than one (1) year after the Grant Date.

6.6 Payment . Options granted under this Article 6 shall be exercised by the delivery of a notice of exercise to the Company or an agent designated by the Company in a form specified or accepted by the Committee, or by complying with any alternative procedures which may be authorized by the Committee, setting forth the number of Shares with respect to which the Option is to be exercised, accompanied by full payment for the Shares.

A condition of the issuance of the Shares as to which an Option shall be exercised shall be the payment of the Option Price. The Option Price of any Option shall be payable to the Company in full either: (a) in cash or its equivalent; (b) by tendering (either by actual delivery or attestation) previously acquired Shares having an aggregate Market Price at the time of exercise equal to the Option Price (provided that the Shares that are tendered may be subject to a minimum holding period, as determined by the Committee in its discretion, prior to their tender to satisfy the Option Price if acquired under this Plan or any other compensation plan maintained by the Company or have been purchased on the open market); (c) by having the Company withhold Shares that otherwise would be delivered to the exerciser pursuant to the exercise of the Option having a value equaling the aggregate Option Price due; (d) by a cashless (broker-assisted) exercise; (e) by a combination of (a), (b), (c) and/or (d); or (f) any other method approved or accepted by the Committee in its sole discretion.

 

13


Subject to any governing rules or regulations, as soon as practicable after receipt of written notification of exercise and full payment (including satisfaction of any applicable tax withholding), the Company shall deliver to the Participant evidence of book entry Shares, or upon the Participant’s request, Share certificates in an appropriate amount based upon the number of Shares purchased under the Option(s).

Unless otherwise determined by the Committee, all payments under all of the methods indicated above shall be paid in United States dollars.

6.7 Notification of Disqualifying Disposition . If any Participant shall make any disposition of Shares issued pursuant to the exercise of an ISO under the circumstances described in Code Section 421(b) (relating to certain disqualifying dispositions), such Participant shall notify the Company of such disposition within ten (10) days thereof.

Article 7. Stock Appreciation Rights

7.1 Grant of SARs . Subject to the terms and conditions of this Plan, SARs may be granted to Participants at any time and from time to time as shall be determined by the Committee, in its sole discretion. Subject to the terms and conditions of this Plan, the Committee shall have complete discretion in determining the number of SARs granted to each Participant and, consistent with the provisions of this Plan, in determining the terms and conditions pertaining to such SARs. SARs may be granted under the Plan alone, in tandem with, in addition to or independent of, Options or any other Awards under the Plan.

7.2 SAR Agreement . Each SAR Award shall be evidenced by an Award Agreement that shall specify the Grant Price, the term of the SAR, the number of Shares to which the SAR pertains, the conditions, including any Performance Goals, upon which the SAR shall become vested and exercisable, and such other terms and conditions as the Committee shall determine, which are not inconsistent with the terms of this Plan.

7.3 Term of SAR . The term of a SAR granted under this Plan shall be determined by the Committee, in its sole discretion, and specified in the SAR Award Agreement; provided, however, no SAR shall be exercisable later than the tenth (10 th ) anniversary of its Grant Date.

7.4 Grant Price . The Grant Price for each Award of a SAR shall be determined by the Committee and shall be specified in the Award Agreement; provided, however, the Grant Price must be at least equal to 100% of the FMV of the Shares as determined on the Grant Date (other than the Grant Price of Acquisition Awards).

 

14


7.5 Exercise of SARs . SARs granted under this Article 7 shall be exercisable at such times and be subject to such restrictions and conditions as the Committee shall in each instance approve, which terms and restrictions need not be the same for each grant or for each Participant. Except upon a Change in Control and in certain limited situations (including, but not limited to, the death or disability of the Participant): (a) Awards of SARs subject solely to the continued service of the Participant shall become exercisable no earlier than three (3) years after the Grant Date provided that such SAR may partially vest after no less than one (1) year following such Grant Date; and (b) any other Award of SARs shall become exercisable no earlier than one (1) year after the Grant Date. The Committee may provide that a SAR shall be automatically exercised on one or more specified dates.

7.6 Payment of SARs . Upon the exercise of a SAR, a Participant shall be entitled to receive payment from the Company in an amount determined by multiplying:

 

  (a)

The excess of the FMV of a Share on the date of exercise over the Grant Price; by

 

  (b)

The number of Shares with respect to which the SAR is exercised.

At the discretion of the Committee, the payment upon exercise of a SAR may be in cash, Shares, or any combination thereof, or in any other manner approved by the Committee in its sole discretion. The Committee’s determination regarding the form of SAR payout shall be set forth in the Award Agreement pertaining to the grant of the SAR.

Article 8. Restricted Stock Grants

8.1 Grant of Restricted Stock or Restricted Stock Units . Subject to the terms and provisions of this Plan, the Committee, at any time and from time to time, may grant Restricted Stock Grants to Participants in such amounts as the Committee shall determine. A Restricted Stock Grant is the issue of Shares or Units in the name of a Participant subject to such terms and conditions as the Committee shall deem appropriate, including, without limitation, restrictions on the sale, assignment, transfer or other disposition of such Shares or Units and the requirement that the Participant forfeit such Shares or Units back to the Company (a) upon termination of employment of an Employee or termination of service as a Director for specified reasons within a specified period of time; (b) if any specified Performance Goals are not achieved during a specified Performance Period; or (c) if such other conditions as the Committee may specify are not satisfied.

8.2 Restricted Stock or Restricted Stock Unit Agreement . Each Restricted Stock Grant shall be evidenced by an Award Agreement that shall specify the Restriction Period(s), the number of Shares of Restricted Stock and/or Restricted Stock Units granted, the conditions and restrictions imposed upon the Restricted Stock Grant, and such other provisions as the Committee shall determine which are not inconsistent with the terms of this Plan.

 

15


8.3 Restriction Period . Each Restricted Stock Grant shall provide that in order for a Participant to receive unrestricted Shares or payment in settlement of a Restricted Stock Unit, the Participant must remain an Employee or a Director, as the case may be, for a period of time specified by the Committee in the Award Agreement. The Committee may also establish one or more Performance Goals that are required to be achieved during one or more Performance Periods within the Restriction Period as a condition to the lapse of restrictions of Awards to Employees. Except upon a Change in Control and in certain limited situations (including, but not limited to, the death or disability of the Participant): (a) Except as provided in clause (c) of this Section 8.3, Awards of Restricted Stock and/or Restricted Stock Units subject solely to the continued service of the Participant shall have a Restriction Period of not less than three (3) years from the Grant Date; (b) Awards to Employees of Restricted Stock and/or Restricted Stock Units subject to the achievement of one or more Performance Goals shall have a minimum Restriction Period of one (1) year; and (c) Awards of Restricted Stock and/or Restricted Stock Units subject solely to the continued service of a Director shall have such Restriction Period as the Committee shall determine; provided, however, that the aggregate number of Shares subject to Restricted Stock or Restricted Stock Unit Awards granted to Directors under clause (c) of this Section 8.3 with a vesting period of less than three (3) years shall not exceed five percent (5%) of the 2,600,000 Share Authorization under Section 4.1 of this Plan applicable to Awards other than Options or SARs, as may be adjusted from time to time pursuant to the provisions of this Plan. The Committee may provide for the lapse of restrictions in installments during the Restriction Period.

8.4 Restrictions . During the Restriction Period, the Participant may not sell, assign, transfer, pledge, hypothecate, encumber or otherwise dispose of or realize on the Shares or Units subject to the Restricted Stock Grant. Unless otherwise directed by the Committee, (i) all certificates representing Shares of Restricted Stock will be held in custody by the Company until all restrictions thereon have lapsed, together with a stock power or powers executed by the Participant in whose name such certificates are registered, endorsed in blank and covering such Shares, or (ii) all uncertificated Shares of Restricted Stock will be held at the Company’s transfer agent in book entry form with appropriate restrictions relating to the transfer of such Shares of Restricted Stock. The Committee may, in its sole discretion, include such other restrictions and conditions as it may deem appropriate.

8.5 Payment . Subject to Section 12.4 below, if applicable, upon expiration of the Restriction Period and if all conditions have been satisfied and any applicable Performance Goals attained, the Shares of Restricted Stock will be made available to the Participant or the Restricted Stock Units will be vested in the account of the Participant, free of all restrictions, provided that the Committee may, in its discretion, require (a) the further deferral of any Restricted Stock Grant beyond the initially specified Restriction Period; (b) that the Restricted Stock or Restricted Stock Units be retained by the Company; and (c) that the Participant receive a cash payment in lieu of unrestricted Shares or Units.

 

16


8.6 Rights as a Shareholder . Unless otherwise determined by the Committee and set forth in a Participant’s Award Agreement, the Participant shall have, with respect to shares of Restricted Stock, all of the rights of a shareholder of the Company, including the right to vote the shares and receive any dividends paid thereon. Any such dividends shall be reinvested on the dividend payment date in additional Shares of Restricted Stock under the Restricted Stock Grant and shall be subject to the restrictions and other terms and conditions set forth therein. A Participant shall not have, with respect to Restricted Stock Units, any voting or other rights of a shareholder of the Company; provided, however, that if determined by the Committee and set forth in the Participant’s Award Agreement, the Participant shall have the right to receive Dividend Equivalents in accordance with the provisions of Article 13.

8.7 Section  83(b) Election . The Committee may provide in an Award Agreement that the Award of Restricted Stock is conditioned upon the Participant making or refraining from making an election with respect to the Award under Code Section 83

(b). If a Participant makes an election pursuant to Code Section 83(b) concerning a Restricted Stock Award, the Participant shall be required to file promptly a copy of such election with the Company.

8.8 Restricted Stock Grants Intended to be Performance-Based Compensation . Restricted Stock Grant that is intended to be Performance-Based Compensation shall also be subject to the terms and conditions of Article 12 below and the termination provisions in the Award Agreement shall comply with the requirements of Code Section 162(m) (including any regulations, rulings, notices and procedures thereunder).

Article 9. Performance Units

9.1 Grant of Performance Units . Subject to the terms and provisions of this Plan, the Committee, at any time and from time to time, may grant Performance Units to Employees in such amounts and upon such terms as the Committee shall determine. Each Performance Unit shall represent the prospective contingent right to receive payment based upon Company and/or Subsidiary performance over a specified Performance Period. Each Performance Unit shall have an initial value that is established by the Committee at the time of grant and need not be equivalent to the value of a Share Equivalent. At the time of grant, the Committee, in its sole discretion, shall establish the Performance Period, Performance Measures, Performance Goals and such other terms and conditions applicable to such Award. The number of Shares and/or the amount of cash or other consideration earned in settlement of a Performance Unit shall be determined at the end of the Performance Period. Any Performance Unit that is intended to be Performance-Based Compensation shall also be subject to the terms and conditions of Article 12 below and the termination provisions in the Award Agreement shall comply with the requirements of Code Section 162(m) (including any regulations, rulings, notices and procedures thereunder).

9.2 Earning of Performance Units . Each Performance Unit Award Agreement shall provide that in order for an Employee to receive a payment in settlement of the Award, the Company must achieve certain Performance Goals over a designated Performance Period, with attainment of one or more Performance Goals determined using one or more specific Performance Measures. The Performance Goals and the Performance Period shall be established by the Committee in its sole discretion; provided, however, that except upon a Change in Control

 

17


and in certain limited situations (including, but not limited to, the death or disability of the Participant), the Performance Period must have a minimum duration of one (1) year. The Committee shall establish one or more Performance Measures for each Performance Period for determining the portion of the Performance Unit Award, which will be earned or forfeited, based on the extent to which the Performance Goals are achieved or exceeded. Such Performance Goals may include minimum, maximum and target levels of performance, with the size of the payment payable in settlement of the Performance Unit Award based on the level attained.

9.3 Form of Performance Unit Award. Performance Unit Awards shall be made on such terms and conditions not inconsistent with the Plan, and in such form or forms, as the Committee may, from time to time, approve. Performance Units may be awarded alone, in addition to, or independent of other Awards under the Plan. Subject to the terms of the Plan, the Committee shall, in its discretion, determine the number of Units subject to each Performance Unit Award made to an Employee and may impose different terms and conditions on any particular Performance Unit Award made to any Employee. The Performance Goals, Performance Period or Periods, Performance Measures and other terms and conditions applicable to any Performance Unit Award shall be set forth in the relevant Award Agreement.

9.4 Payment of Performance Units . Subject to the terms of this Plan and the applicable Award Agreement, after the later of the date the applicable Performance Period has ended or the date on which any other terms and conditions applicable to such Performance Unit Award have been satisfied, the holder of Performance Units shall be entitled to receive payout of the value and number of Performance Units earned by the Employee over the Performance Period, to be determined as a function of the extent to which the corresponding Performance Goals have been achieved. Subject to Section 12.4 below, if applicable, such payment shall be as determined by the Committee and as evidenced in the Award Agreement. Subject to the terms of this Plan, the Committee, in its sole discretion, may pay earned Performance Units in the form of Shares, cash, any combination thereof, or any other form as designated by the Committee in its sole discretion, equal to the value of the earned Performance Units at the close of the applicable Performance Period, or at such other time as specified in the Award Agreement. Any Shares paid in settlement of such Performance Units may be granted subject to any restrictions deemed appropriate by the Committee. The determination of the Committee with respect to the form of payout of such Awards shall be set forth in the applicable Award Agreement.

Article 10. Other Stock-Based Awards

10.1 Other Stock-Based Awards . The Committee may grant other types of equity-based or equity-related Awards not otherwise described by the terms of this Plan (including, subject to the limitations below, the grant or offer for sale of unrestricted Shares) in such amounts and subject to such terms and conditions, as the Committee shall determine. Such Awards may involve the transfer of actual Shares to Participants, or payment in cash or otherwise of amounts based on the value of Shares and may include, without limitation, Awards designed to comply with or take advantage of the applicable local laws of jurisdictions other than the United States. Notwithstanding any provision in this Plan to the contrary, Awards of unrestricted Shares shall only be made in lieu of salary and/or cash bonuses/variable compensation paid to Employees or cash fees paid to Directors.

 

18


10.2 Value of Other Stock-Based Awards . Each Other Stock-Based Award shall be expressed in terms of Shares or Units, as determined by the Committee. The Committee may, in its discretion, establish Performance Goals with respect to any Other Stock-Based Awards. If the Committee exercises its discretion to establish Performance Goals, the number and/or value of Other Stock-Based Awards that will be paid out to the Participant may depend on the extent to which the Performance Goals are met.

10.3 Payment of Other Stock-Based Awards . Payment, if any, with respect to an Other Stock-Based Award shall be made in accordance with the terms of the Award, in cash or Shares as the Committee determines.

10.4 Other Stock-Based Awards Intended to be Performance-Based Compensation . Any Other Stock-Based Award that is intended to be Performance-Based Compensation shall also be subject to the terms and conditions of Article 12 below and the termination provisions in the Award Agreement shall comply with the requirements of Code Section 162(m) (including any regulations, rulings, notices and procedures thereunder).

Article 11. Transferability of Awards

No Award under the Plan, and no right or interest therein, shall be (a) assignable, alienable, pledgable or transferable by a Participant, except by will or the laws of descent and distribution, or (b) subject to any obligation, or the lien or claims of any creditor, of any Participant, or (c) subject to any lien, encumbrance or claim of any party made in respect of or through any Participant, however arising. During the lifetime of a Participant, Options and SARs are exercisable only by, Shares issued upon the exercise of Options and SARs or in settlement of other Awards will be issued only to, and other payments in settlement of any Award will be payable only to, the Participant or his or her legal representative. Notwithstanding the foregoing, the Committee may, in its sole discretion and on and subject to such terms and conditions as it shall deem appropriate, which terms and conditions shall be set forth in the related Award Agreement: (i) authorize a Participant to transfer all or a portion of any Nonqualified Stock Option or SAR, as the case may be, granted to such Participant, provided that in no event shall any transfer be made to any person or persons other than such Participant’s spouse, children or grandchildren, or a trust or partnership for the exclusive benefit of one or more such persons, which transfer must be made as a gift and without any consideration; and (ii) provide for the transferability of a particular grant or Award pursuant to a domestic relations order. All other transfers and any retransfer by any permitted transferee are prohibited and any such purported transfer shall be null and void. Each Nonqualified Stock Option or SAR which becomes the subject of a permitted transfer (and the Participant to whom it was granted by the Company) shall continue to be subject to the same terms and conditions as were in effect immediately prior to such permitted transfer. The Participant shall remain responsible to the Company for the payment of all withholding taxes incurred as a result of any exercise of such Option or SAR. In

 

19


no event shall any permitted transfer of an Option, SAR or other grant or Award create any right in any party in respect of any Option, SAR or other grant or Award, other than the rights of the qualified transferee in respect of such Option, SAR or other Award specified in the related Award Agreement.

Article 12. Performance Measures

12.1 Performance Measures . The Performance Goals upon which the payment or vesting of an Award to a Covered Employee that is intended to qualify as Performance-Based Compensation shall be limited to the following Performance Measures:

 

  (a)

Net earnings or net income (before or after taxes);

 

  (b)

Earnings per share (basic or diluted);

 

  (c)

Net sales;

 

  (d)

Revenue growth;

 

  (e)

Operating profit;

 

  (f)

Return measures (including, but not limited to, return on assets, capital, invested capital, equity, sales, or revenue);

 

  (g)

Cash flow (including, but not limited to, operating cash flow, free cash flow, cash flow return on equity, and cash flow return on investment);

 

  (h)

Earnings before or after taxes, interest, depreciation, and/or amortization;

 

  (i)

Gross or operating margins;

 

  (j)

Productivity ratios;

 

  (k)

Share price (including, but not limited to, growth measures and total shareholder return);

 

  (l)

Expense targets;

 

  (m)

Margins;

 

  (n)

Operating efficiency;

 

  (o)

Market share;

 

  (p)

Working capital targets;

 

  (q)

Economic value added or EVA (net operating profit after tax minus the sum of capital multiplied by the cost of capital); and

 

  (r)

Objective safety measures.

Any Performance Measure(s) may be used to measure the performance of the Company and/or its Subsidiary as a whole or any business unit of the Company and/or its Subsidiary or any combination thereof, as the Committee may deem appropriate, or any of the above Performance Measures as compared to the performance of a group of comparator companies, or published or special index that the Committee, in its sole discretion, deems appropriate, or the Committee may select Share price as a Performance Measure as compared to various stock market indices. The Committee also has the authority to provide in an Award Agreement for accelerated vesting of any Award based on the achievement of Performance Goals pursuant to the Performance Measures specified in this Article 12, subject to compliance with Section 162(m) of the Code, to the extent an Award is intended to be Performance-Based Compensation.

 

20


Except as otherwise expressly provided in the Plan or an Award Agreement, all financial terms are used as defined under Generally Accepted Accounting Principles or such other objective accounting principles, as may be designated by the Committee.

12.2 Establishment of the Performance Period, Performance Goals and Formula. Except as otherwise required under applicable law, rule or regulation, a Participant’s Award that is intended to be Performance-Based Compensation shall be determined based on the attainment of written objective Performance Goals approved by the Committee for a Performance Period established by the Committee (i) while the outcome for that Performance Period is substantially uncertain and (ii) no more than 90 days after the commencement of the Performance Period to which the Performance Goal relates or, if less, the number of days which is equal to 25% of the relevant Performance Period. At the same time as the Performance Goals are established, the Committee will prescribe a formula to determine the amount of Performance-Based Compensation under the Award that may be payable based upon the level of attainment of the Performance Goals during the Performance Period.

12.3 Evaluation of Performance . The Committee may provide at the time of any such Award that any evaluation of performance may include or exclude any of the following events that occurs during a Performance Period: (a) asset write-downs and impairments; (b) gain/loss on sale of assets; (c) litigation or claim judgments or settlements (including insurance proceeds); (d) the effect of changes in tax laws, accounting principles, or other laws or provisions affecting reported results; (e) any reorganization and restructuring programs; (f) extraordinary nonrecurring items as described in FASB ASC Topic 105 (or such other applicable accounting principle, as may be designated by the Committee) and/or in management’s discussion and analysis of financial condition and results of operations appearing in the Company’s annual report to shareholders and/or other public filings for the applicable year; (g) acquisitions or divestitures; (h) foreign exchange gains and losses; and (i) the effect of any materially adverse and unforeseen market conditions beyond the control of the Company and its Subsidiaries, Employees, officers and directors. To the extent such inclusions or exclusions affect Awards to Covered Employees that are intended to be Performance-Based Compensation, they shall be prescribed in a form that meets the requirements of Code Section 162(m) for deductibility.

12.4 Adjustment of Performance-Based Compensation . Awards that are intended to qualify as Performance-Based Compensation may not be adjusted upward. The Committee shall retain the discretion to adjust such Awards downward, either on a formula or discretionary basis or any combination, as the Committee determines.

12.5 Committee Discretion . In the event that the Committee determines that it is advisable to grant Awards that shall not qualify as Performance-Based Compensation, the Committee may make such grants without satisfying the requirements of Code Section 162(m) and base vesting on Performance Measures other than those set forth in Section 12.1.

 

21


Article 13. Dividend Equivalents

Any Participant selected by the Committee may be granted dividend equivalents based on the dividends declared on Shares or Share Equivalents that are subject to any Award (other than Options and SARs), to be credited as of dividend payment dates, during the period between the date the Award is granted and the date the Award is exercised, vests, settled or expires, as determined by the Committee (“Dividend Equivalents”). Except as otherwise provided in the Plan or the applicable Award Agreement, such Dividend Equivalents shall be converted to cash or additional Shares or Share Equivalents by such formula, at such time and subject to such limitations as may be determined by the Committee; provided, however, that in no event shall any Dividend Equivalents become payable earlier than the date on which the underlying Award becomes vested and payable.

Article 14. Termination of Employment or Service as a Director

14.1 Stock Options and SARs . Each Award Agreement shall set forth the extent to which the Participant shall have the right to exercise an Option or SAR following termination of, as the case may be, (a) an Employee’s employment with the Company and/or its Subsidiaries or (b) a Director’s service as a director of the Company. Such provisions shall be determined in the sole discretion of the Committee, shall be included in the Award Agreement entered into with each Participant, need not be uniform among all Options and SARs issued under this Plan, and may reflect distinctions based on the reasons for termination.

14.2 Restricted Stock Grant, Performance Units and Other Stock-Based Awards . The Award Agreement for each Restricted Stock Grant, Performance Unit and Other Stock-Based Award shall set forth the extent to which such Award shall vest and/or may be forfeited upon termination of, as the case may be, (a) the Employee’s employment with the Company and/or its Subsidiaries or (b) Director’s service as a director of the Company. Such provisions shall be determined in the sole discretion of the Committee, shall be included in the Award Agreement entered into with each Participant, need not be uniform among all such Awards, and may reflect distinctions based on the reasons for termination. Notwithstanding the foregoing, to the extent a Restricted Stock grant, Performance Unit or Other Stock-Based Award is intended to be Performance-Based Compensation, the termination provisions in the Award Agreement shall comply with the requirements of Code Section 162(m) (including any regulations, rulings, notices and procedures thereunder).

Article 15. Rights of Participants

15.1 Employment . Nothing in this Plan or an Award Agreement shall interfere with or limit in any way the right of the Company and/or its Subsidiaries, to terminate any Employee’s employment at any time or for any reason not prohibited by law, nor confer upon any Employee any right to continue his employment, or upon any Director a right to continue to serve as a Director, for any specified period of time.

 

22


Neither an Award nor any benefits arising under this Plan shall constitute an employment contract with the Company and/or its Subsidiaries for an Employee or a contract for service as a director with the Company for a Director and, accordingly, subject to Article 16, this Plan and the benefits hereunder may be terminated at any time in the sole and exclusive discretion of the Committee without giving rise to any liability on the part of the Company and/or its Subsidiaries.

15.2 Participation . No individual shall have the right to be selected to receive an Award under this Plan, or, having been so selected, to be selected to receive a future Award.

15.3 Rights as a Shareholder . Except as otherwise provided herein, a Participant shall have none of the rights of a shareholder with respect to Shares covered by any Award until the Participant becomes the record holder of such Shares.

Article 16. Change in Control

The Committee, in its sole discretion, may specify in the applicable Award Agreement the effect, if any, of a Change in Control on any Award held by a Participant, including the adjustment or other treatment of Performance Goals; provided, however, that any such provision included in an Award Agreement granted to a Participant who is at the time an Officer shall specify that if (i) a Change in Control occurs and (ii) within two (2) years thereafter (or such other period of time following the Change in Control specified in the applicable Award Agreement), such Officer’s employment with the Company (or an applicable Subsidiary) or any successor thereto is terminated without “cause” (as defined in the applicable Award Agreement) or if the Officer terminates employment for “good reason” (as defined in the applicable Award Agreement), then such Award shall become partially or fully vested (including the lapsing of restrictions and conditions) and, as applicable, exercisable as of the date of such termination of employment.

Notwithstanding the foregoing, the Committee may, in its sole discretion, determine in connection with a Change in Control that any or all outstanding Awards granted under the Plan, whether or not exercisable, will be canceled and terminated and that in connection with such cancellation and termination, the holder of such Award may receive for each Share subject to such Awards a cash payment (or the delivery of shares of stock, other securities or a combination of cash, stock and securities equivalent to such cash payment) equal to the difference, if any, between the consideration received by shareholders of the Company in respect of a Share in connection with such transaction and the purchase price per share, if any, under the Award, multiplied by the number of Shares subject to such Award; provided that if such product is zero or less, the Award will be canceled and terminated without payment therefor.

 

23


Article 17. Amendment, Modification, Suspension, and Termination

17.1 Amendment, Modification, Suspension, and Termination . Subject to Section 17.2, the Board may, at any time and from time to time, alter, amend, modify, suspend, or terminate this Plan and any Award Agreement in whole or in part without approval of the Company’s shareholders, unless such approval is necessary to comply with applicable laws, including the Exchange Act and the Code, or the rules and regulations of any securities exchange on which the Shares are listed. In no event may the Board amend the Plan without the prior approval of the Company’s shareholders to (a) increase the maximum number of Shares which may be issued pursuant to the Plan; (b) increase any limitation set forth in the Plan on the number of Shares which may be issued, or the aggregate value of Awards which may be made, in respect of any type of Award to any single Participant during any specified period; (c) change the class of individuals eligible to participate in the Plan; (d) reduce the minimum Option Price or the minimum SAR Grant Price as set forth in Sections 6.3 and 7.4; or (e) reduce the minimum vesting period, Restriction Period or Performance Period requirements applicable to Awards under the Plan. Furthermore, except as provided in Sections 4.5 and 16.1, in no event may the terms of a previously granted Option or SAR be amended to reduce its Option Price or Grant Price, as applicable, or to cancel the Award in exchange for cash or an Option, SAR, or other Award with an Option Price, Grant Price or other exercise price that is less than the Option Price or Grant Price, as applicable, of the original Option or SAR, without obtaining approval of the Company’s shareholders.

17.2 Awards Previously Granted . Notwithstanding any other provision of this Plan to the contrary (other than Section  17.3), no termination, amendment, suspension, or modification of this Plan or an Award Agreement shall adversely affect in any material way any Award previously granted under this Plan, without the written consent of the Participant holding such Award.

17.3 Amendment to Conform to Law . Notwithstanding any other provision of this Plan to the contrary, the Board may amend the Plan or an Award Agreement, to take effect retroactively or otherwise, as deemed necessary or advisable for the purpose of conforming the Plan or an Award Agreement to any present or future law relating to plans of this or similar nature and to the administrative regulations and rulings promulgated thereunder. By accepting an Award under this Plan, a Participant agrees to any amendment made pursuant to this Section 17.3 to any Award granted under the Plan without further consideration or action.

Article 18. Tax Withholding; No Liability with Respect to Tax Qualification or Adverse Tax Treatment

All Awards under the Plan will be made subject to any applicable withholding for taxes of any kind. The Company shall have the right to deduct from any amount payable under the Plan, including delivery of Shares to be made under the Plan, all federal, state, city, local or foreign taxes of any kind required by law to be withheld with respect to such payment and to take such other actions as may be necessary in the opinion of the Company to satisfy all obligations for the payment of such taxes. The Company shall have the right to require a Participant to pay cash to satisfy withholding taxes as a condition to the payment of any amount (whether in cash or Shares) under the Plan.

 

24


Notwithstanding anything to the contrary contained herein, in no event shall the Company be liable to a Participant on account of an Award’s failure to (a) qualify for favorable United States or foreign tax treatment or (b) avoid adverse tax treatment under United States or foreign law, including, without limitation, Section 409A of the Code.

Article 19. Successors

All obligations of the Company under this Plan with respect to Awards granted hereunder shall be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.

Article 20. General Provisions

20.1 Forfeiture Events and Clawback . The Committee may specify in an Award Agreement that the Participant’s rights, payments, and benefits with respect to an Award shall be subject to reduction, cancellation, forfeiture, or recoupment upon the occurrence of certain specified events, in addition to any otherwise applicable vesting or performance conditions of an Award. Such events may include, but shall not be limited to, any Participant’s fraud resulting in the restatement of the Company’s published earnings, termination of an Employee’s employment or a Director’s service as a director for cause, termination of the Participant’s provision of services to the Company and/or its Subsidiary, violation of material Company and/or Subsidiary policies, breach of noncompetition, confidentiality, or other restrictive covenants that may apply to the Participant, or other conduct by the Participant that is detrimental to the business or reputation of the Company and/or its Subsidiaries. In addition, Awards shall be subject to the clawback or recapture policy, if any, that the Company may adopt from time to time to the extent provided in such policy and, in accordance with such policy, may be subject to the requirement that the Awards be repaid to the Company after they have been distributed or paid to the Participant.

20.2 Legend; Restrictions on Share Transferability; Stock Ownership Policy . The certificates for Shares may include any legend, which the Committee deems appropriate to reflect any restrictions on transfer of such Shares. The Committee may impose such restrictions on any Shares acquired pursuant to an Award as it may deem advisable, including, without limitation, minimum holding period requirements, restrictions under applicable federal securities laws, under the requirements of any stock exchange or market upon which such Shares are then listed and/or traded, or under any blue sky or state securities laws applicable to such Shares. In addition, as applicable, each Participant shall at all times be subject to compliance with the Company’s Executive Stock Ownership Policy, as in effect from time to time, with respect to each Award.

 

25


20.3 Gender and Number . Except where otherwise indicated by the context, any masculine term used herein also shall include the feminine, the plural shall include the singular, and the singular shall include the plural.

20.4 Severability . In the event any provision of this Plan shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of this Plan, and this Plan shall be construed and enforced as if the illegal or invalid provision had not been included.

20.5 Requirements of Law . The granting of Awards and the issuance of Shares under this Plan shall be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required.

20.6 Delivery of Title . The Company shall have no obligation to issue or deliver evidence of title for Shares issued under this Plan prior to:

 

  (a)

Obtaining any approvals from governmental agencies that the Company determines are necessary or advisable; and

 

  (b)

Completion of any registration or other qualification of the Shares under any applicable national or foreign law or ruling of any governmental body that the Company determines to be necessary or advisable.

20.7 Inability to Obtain Authority . The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority shall not have been obtained.

20.8 Investment Representations . The Committee may require any individual receiving Shares pursuant to an Award under this Plan to represent and warrant in writing that the individual is acquiring the Shares for investment and without any present intention to sell or distribute such Shares.

20.9 Employees or Directors Based Outside of the United States . Notwithstanding any provision of this Plan to the contrary, in order to comply with the laws in other countries in which the Company and/or its Subsidiaries operate or have Employees or in which Directors may reside, the Committee, in its sole discretion, shall have the power and authority to:

 

  (a)

Determine which Subsidiaries shall be covered by this Plan;

 

  (b)

Determine which Employees or Directors outside the United States are eligible to participate in this Plan;

 

  (c)

Modify the terms and conditions of any Award granted to Employees or Directors outside the United States to comply with applicable foreign laws;

 

26


  (d)

Establish subplans and modify exercise procedures and other terms and procedures, to the extent such actions may be necessary or advisable. Any subplans and modifications to Plan terms and procedures established under this Section 20.9 by the Committee shall be attached to this Plan document as appendices; and

 

  (e)

Take any action, before or after an Award is made, that it deems advisable to obtain approval or comply with any necessary local government regulatory exemptions or approvals.

Notwithstanding the above, the Committee may not take any actions hereunder, and no Awards shall be granted, that would violate applicable law.

20.10 Uncertificated Shares . To the extent that this Plan provides for issuance of certificates to reflect the transfer of Shares, the transfer of such Shares may be effected on a noncertificated basis, to the extent not prohibited by applicable law or the rules of any stock exchange.

20.11 Unfunded Plan . Participants shall have no right, title, or interest whatsoever in or to any investments that the Company, and/or its Subsidiaries may make to aid it in meeting its obligations under this Plan. Nothing contained in this Plan, and no action taken pursuant to its provisions, shall create or be construed to create a trust of any kind, or a fiduciary relationship between the Company and any Participant, beneficiary, legal representative, or any other individual. To the extent that any individual acquires a right to receive payments from the Company and/or its Subsidiaries under this Plan, such right shall be no greater than the right of an unsecured general creditor of the Company or a Subsidiary, as the case may be. All payments to be made hereunder shall be paid from the general funds of the Company or a Subsidiary, as the case may be, and no special or separate fund shall be established and no segregation of assets shall be made to assure payment of such amounts except as expressly set forth in this Plan.

20.12 No Fractional Shares . No fractional Shares shall be issued or delivered pursuant to this Plan or any Award. To the extent settlement or payout of an Award would result in a fractional Share being issuable, the number of Shares subject to settlement or payout under such Award shall be rounded down to the nearest whole Share and any rights to any fractional Shares (or payment therefor) shall be forfeited.

20.13 Section  409A of the Code; Deferrals. The Committee shall have full authority to give effect to any statement in an Award Agreement to the effect that an Award is intended to be “deferred compensation” subject to Section 409A, to be exempt from Section 409A or to have other intended treatment under Section 409A and/or other provision of the Code. To the extent necessary to give effect to this authority, in the case of any conflict or potential inconsistency between the Plan and a provision of any Award or Award Agreement with respect to the subject matter of this section, the Plan shall govern. With respect to any Award made under the Plan that is intended to be “deferred compensation” subject to Section 409A: (a) references to

 

27


termination of the Participant’s employment will mean the Participant’s “separation from service” with the Company or any applicable Subsidiary within the meaning of Section 409A; (b) any payment to be made with respect to such Award in connection with the Participant’s separation from service with the Company or any applicable Subsidiary that would be subject to the limitations in Section 409A(a)(2)(b) of the Code shall be delayed until six months after the Participant’s separation from service (or earlier death) in accordance with the requirements of Section 409A; (c) to the extent necessary to comply with Section 409A, any cash, other securities, other Awards or other property that the Company may deliver in lieu of Shares in respect of an Award shall not have the effect of deferring delivery or payment beyond the date on which such delivery or payment would occur with respect to the Shares that would otherwise have been deliverable (unless the Committee elects a later date for this purpose in accordance with the requirements of Section 409A); (d) if the Award includes a “series of installment payments” (within the meaning of Section 1.409A-2(b)(2)(iii) of the regulations promulgated under the Code), the Participant’s right to the series of installment payments shall be treated as a right to a series of separate payments and not as a right to a single payment; and (e) if the Award includes “dividend equivalents” (within the meaning of Section 1.409A-3(e) of the regulations promulgated under the Code), the Participant’s right to the dividend equivalents shall be treated separately from the right to other amounts under the Award.

To the extent permitted by Code Section 409A, the Committee may, whether at the time of grant or at any time thereafter prior to payment or settlement, require a Participant to defer, or permit (subject to such conditions as the Committee may from time to time establish) a Participant to elect to defer, receipt of all or any portion of any payment of cash or Shares that would otherwise be due to such Participant in payment or settlement of any Award under the Plan. If any such deferral is required by the Committee (or is elected by the Participant with the permission of the Committee), the Committee shall establish rules and procedures for payment of such deferrals. The Committee may provide for the payment or crediting of interest, at such rate or rates as it shall in its discretion deem appropriate, on such deferred amounts credited in cash and the payment or crediting of Dividend Equivalents in respect of deferred amounts credited in Share Equivalents or Restricted Stock Units. Deferred amounts may be paid in a lump sum or in installments in the manner and to the extent permitted, and in accordance with rules and procedures established by the Committee. This Section shall not apply to any grant of Options or SARs that are intended to be exempt from Code Section 409A.

20.14 Nonexclusivity of this Plan . The adoption of this Plan shall not be construed as creating any limitations on the power of the Board or Committee to adopt such other compensation arrangements as it may deem desirable for any Participant or Participants.

20.15 No Constraint on Corporate Action. Nothing in this Plan shall be construed to: (a) limit, impair, or otherwise affect the Company’s or a Subsidiary’s right or power to make adjustments, reclassifications, reorganizations, or changes of its capital or business structure, or to merge or consolidate, or dissolve, liquidate, sell, or transfer all or any part of its business or assets; or (b) limit the right or power of the Company or a Subsidiary to take any action which such entity deems to be necessary or appropriate.

 

28


20.16 Governing Law . The Plan and each Award Agreement shall be governed by the laws of the State of Connecticut, excluding any conflict of laws or choice of law rule or principle that might otherwise refer construction or interpretation of this Plan to the substantive law of another jurisdiction. Unless otherwise provided in the Award Agreement, recipients of an Award under this Plan are deemed to submit to the exclusive jurisdiction and venue of the federal or state courts of Connecticut, to resolve any and all issues that may arise out of or relate to this Plan or any related Award Agreement.

20.17 Right of Offset . Except with respect to Awards that are intended to be “deferred compensation” subject to Section 409A, the Company will have the right to offset against its obligation to deliver Shares (or cash, other securities or other property) under the Plan or any Award Agreement any outstanding amounts (including, without limitation, travel and entertainment or advance account balances, loans, repayment obligations under any Awards, or amounts repayable to the Company pursuant to tax equalization, housing, automobile or other employee programs) that the Participant then owes to the Company and any amounts the Committee otherwise deems appropriate pursuant to any tax equalization policy or agreement.

20.18 No Third Party Beneficiaries. Except as expressly provided therein, neither the Plan nor any Award Agreement will confer on any person other than the Company and the Participant of any Award any rights or remedies thereunder. The exculpation and indemnification provisions of Section 3.4 will inure to the benefit of an Administrator’s estate and beneficiaries and legatees.

20.19 Plan Headings. The headings in the Plan are for the purpose of convenience only and are not intended to define or limit the construction of the provisions hereof.

 

29

Exhibit 4.4

PLAN CONDITIONS

for the Option Rights and the Restricted Share Units

of the Long Term Incentive Plan 2018 of Linde plc (“ LTIP 2018 ”)

Content

 

Preamble

     2  

§ 1 Option Beneficiaries, Transfer

     3  

§ 2 Preconditions for Participation, Self- financed Investment Shares

     3  

§ 3 Option Rights

     5  

§ 4 Issue Conditions, Exercise Price

     6  

§ 5 Restricted Share Units

     6  

§ 6 Adjustment of Plan Conditions; Termination of Option Rights and Restricted Share Units

     7  

§ 7 Preconditions for Exercise: Waiting Period and Exercise Period

     9  

§ 8 Determination of the Number of Exercisable Option Rights and Vested Restricted Share Units in Case of Certain Events

     9  

§ 9 Exercising Option Rights, Settling Restricted Share Units

     10  

§ 10 Option Office

     12  

§ 11 Costs

     12  

§ 12 Announcements

     12  

§ 13 Taxes, Charges

     12  

§ 14 Liability and Risks

     13  

§ 15 Personal Data

     14  

§ 16 Concluding Provisions

     14  

ANNEX to the Linde plc Group Plan Conditions for the LTIP 2018

     16  

GLOSSARY

     21  


Preamble

 

(1)

On June 1, 2017, Linde Aktiengesellschaft, with its registered office in Munich, registered with the commercial register ( Handelsregister ) of the local court of Munich under registration number HRB 169850, and its legal successor, if any (“ Linde AG ”, and together with its subsidiaries and affiliated companies the “ Linde AG Group ”) and Praxair, Inc., a Delaware corporation (“ Praxair ”), inter alia , entered into a business combination agreement to come together under the newly formed holding company Linde Public Limited Company, registered under the laws of Ireland and with its registered office at Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland and principal executive offices at The Priestley Centre, 10 Priestley Road, The Surrey Research Park, Guildford, Surrey GU2 7XY, United Kingdom (“ Linde plc ”, and together with its subsidiaries and affiliated companies from time to time, the “ Linde plc Group ”) through an all-stock merger of equals transaction (the underlying business combination agreement of this transaction, as amended from time to time, the “ BCA ”).

 

(2)

On August 15, 2017, Linde plc issued a voluntary public takeover offer in the form of an exchange offer to acquire all ordinary bearer shares without par value ( auf den Inhaber lautende Stückaktien ohne Nennbetrag ) of Linde AG with the ISIN DE 0006483001 to the shareholders of Linde AG, which was accepted by more than 92 % of the outstanding shares (the “ Exchange Offer ”). Linde AG and Praxair closed the transaction on October 31, 2018 (“ Closing Time ”, provided that solely in the case of Option Beneficiaries (as defined in § 1 para. 1) who were members of Linde AG’s Executive Board as of October 31, 2018, Closing Time as used in the LTIP 2018 means the time of the effectiveness of the Post-Closing Reorganization, as defined in the BCA).

 

(3)

Under the Linde Long Term Incentive Plan (2012), authorized at the annual general meeting of Linde AG on May 4, 2012, as implemented from time to time (the “ Linde AG LTIP ”), Linde AG granted option rights (“ Linde AG Option Rights ”) and matching share rights (“ Linde AG Matching Share Rights ”) to the members of the Executive Board ( Vorstand ) of Linde AG as well as to members of management bodies of its affiliated companies in Germany and abroad and to selected executives of Linde AG and its affiliated companies in Germany and abroad (such Linde AG Option Rights and Linde AG Matching Share Rights, collectively, “ Linde AG LTIP Rights ”). Those Linde AG LTIP Rights provided for a four-year waiting period and, in the case of Linde AG Option Rights, became exercisable at the earliest four years after they had been issued. Thus, certain of the Linde AG LTIP Rights granted in 2015 (“ Tranche 2015 ”), 2016 (“ Tranche 2016 ”) and 2017 (“ Tranche 2017 ” and together with Tranche 2015 and Tranche 2016, the “ Linde AG LTIP Tranches ”) were each outstanding and their respective waiting periods had not expired as of immediately prior to the Closing Time (such Linde AG LTIP Rights “ Active Linde AG LTIP Rights ”).

 

(4)

Following the Closing Time, Linde AG terminated the Linde AG LTIP as set forth in Section 1.12(a) of the BCA, and as set forth in Sections 1.12(d) and 1.12(e) of the BCA, Linde plc now intends to grant to each person who is in service or employment with a member of the Linde AG Group and has not given or received notice of termination of such service or employment and who held immediately prior to the Closing Time Active Linde AG LTIP Rights which were terminated by Linde AG, a replacement award consisting of Option Rights (as defined in § 3 para. 1) to replace a portion of such person’s terminated Linde AG Option Rights and, if applicable, Restricted Share Units (as defined in § 5 para. 1) to replace a portion of such person’s terminated Linde AG Matching Share Rights. Participants in the Linde AG LTIP have no entitlement to receive replacement awards upon the termination of the Linde AG LTIP. The Linde AG LTIP does not require the rollover or replacement of Linde AG LTIP Rights in the event of a change in control of Linde AG. Thus, the replacement Option Rights and Restricted Share Units are granted by Linde plc on a purely voluntary basis.

 

(5)

On the basis of the aforesaid, the Option Beneficiaries shall be granted Option Rights and, if applicable, Restricted Share Units relating to ordinary shares of Linde plc, nominal value €0.001 per share (“ Linde plc Shares ”), on the basis of individual award letters issued by Linde plc (“ Award Letters ” and each, an “ Award Letter ”). The following Plan Conditions shall be an integral part of the individual agreements governing the replacement Option Rights and, if applicable, the replacement Restricted Share Units between Linde plc and the respective Option Beneficiary, which come into force upon proper and timely acceptance of the individual Award Letter by the Option Beneficiary.

 

(6)

The maximum aggregate number of Linde plc Shares that may be delivered pursuant to the Award Letters under the LTIP 2018 shall be 473,128.

 

2


(7)

The LTIP 2018 shall be administered by the compensation committee established by the Linde plc Board of Directors (the “ Board ”), which shall be composed of two or more directors, as determined by the Board; provided that, to the extent necessary to comply with the rules of any competent exchange on which Linde plc Shares are listed or quoted and Rule 16b-3 under the U.S. Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), and any other applicable laws or rules, the compensation committee shall be composed of two or more directors, all of whom shall be independent directors and all of whom shall meet the independence requirements of any competent exchange on which Linde plc Shares are listed or quoted (the “ Committee ”). The Committee may delegate, on such terms and conditions as it determines in its sole and plenary discretion, to one or more senior officers of Linde plc the authority to make grants pursuant to the LTIP 2018 to Option Beneficiaries (other than any officer subject to Section 16 of the Exchange Act), and all necessary and appropriate decisions and determinations with respect thereto. The Committee shall have sole and plenary authority to interpret, administer, reconcile any inconsistency in, correct any default in and/or supply any omission in, the LTIP 2018 and any instrument or agreement relating to, or grant made under, the LTIP 2018 and, subject to applicable law and the rules and regulations of any competent exchange on which Linde plc Shares are listed or quoted, may alter, amend, modify, suspend, or terminate these Plan Conditions and any Award Letter, provided that no such termination, amendment, suspension, or modification shall adversely and materially affect any Option Rights or Restricted Share Units previously granted under these Plan Conditions, without the written consent of the Option Beneficiary holding such Option Rights or Restricted Share Units.

§ 1 Option Beneficiaries, Transfer

 

(1)

For the purpose of these Plan Conditions, “ Option Beneficiaries ” are those persons who, immediately prior to the Closing Time, held any Active Linde AG LTIP Rights and who, as of the relevant Issue Date (as defined in § 3 para. 3), a) are in service or employment with a member of Linde AG Group, b) have not given or received notice of termination of such service or employment, and c) have received an Award Letter to reflect the replacement of the portion of such person’s Active Linde AG LTIP Rights with Option Rights and, if applicable, Restricted Share Units.

 

(2)

The Option Rights and the Restricted Share Units shall not be transferable nor shall they be used as collateral. Any purported transfer of Option Rights or Restricted Share Units or their use as collateral shall result in the immediate lapse of the Option Rights or Restricted Share Units without replacement or compensation.

 

(3)

Granting of Option Rights and, if applicable, Restricted Share Units and the delivery of Linde plc Shares in settlement of Option Rights and, if applicable, Restricted Share Units is made on a purely voluntary basis by Linde plc. Even the repeated granting of Option Rights, Restricted Share Units, Linde plc Shares or similar or comparable benefits under the LTIP 2018 or other incentive plans does not create any entitlement to further Option Rights, Restricted Share Units, Linde plc Shares or similar or comparable benefits in the future.

§ 2 Preconditions for Participation, Self-financed Investment Shares

 

(1)

Preconditions to the participation in the LTIP 2018 by an Option Beneficiary are a) the acceptance by the Option Beneficiary of the Option Rights and, if applicable, Restricted Share Units, as well as the consent of the Option Beneficiary to these Plan Conditions and b) the maintenance of a separate securities account by the Option Beneficiary (the “ LTIP 2018 Securities Account ”) during the term of the LTIP 2018 with an account bank or other entity nominated and engaged by Linde plc for the purpose of administration of the LTIP 2018 (the “ Account Bank ”) or as otherwise permitted by Linde plc from time to time. In addition to the LTIP 2018 Securities Account, the Account Bank shall open, and maintain during the term of the LTIP 2018, a clearing account relating to the LTIP 2018 Securities Account for the Option Beneficiaries (the “ LTIP 2018 Clearing Account ”). Those Option Beneficiaries who already have (i) a clearing account with the Account Bank may use their existing clearing account as their LTIP 2018 Clearing Account and/or (ii) a separate securities account with the Account Bank may use their existing separate securities account as their LTIP 2018 Securities Account.

 

(2)

For Option Beneficiaries who belonged to Linde Band 5 and higher of Linde AG Group on the issue date of the respective Linde AG LTIP Tranche, the participation in the LTIP 2018 with regard to the replacement of the portion of the respective Option Beneficiary’s Active Linde AG LTIP Rights under the respective Linde

 

3


  AG LTIP Tranche further requires a self-financed investment in a specified number of Linde plc Shares (the “ Self-financed Investment Shares ”). The number of Self-financed Investment Shares to be held, subject to an adjustment pursuant to § 6 para. 2, shall be notified to the respective Option Beneficiary by way of the Award Letter or in a separate communication. The Option Beneficiaries shall be obliged to transfer the Self-financed Investment Shares to their LTIP 2018 Securities Account. Except as set forth in § 2 para. 5 or determined pursuant to § 6 para. 6, the Self-financed Investment Shares shall be locked-up until the expiry of the respective Waiting Period (as defined in § 7 para. 1) and may not be sold or otherwise transferred by the Option Beneficiary during such period. The self-financed investment in Linde plc Shares shall be made within four months following the Issue Date (the “ Investment Period ”) and the Self-financed Investment Shares shall be transferred to the Option Beneficiary’s LTIP 2018 Securities Account during the Investment Period. Any and all shareholder rights of the Option Beneficiaries pertaining to the Self-financed Investment Shares held during the Waiting Period shall also exist during the Waiting Period, and the Self-financed Investment Shares shall in particular be entitled to dividends, if any, paid during the Waiting Period. Dividend payments on Self-financed Investment Shares shall be credited to the LTIP 2018 Clearing Account, and the Option Beneficiary shall be entitled to freely dispose of such credits at any time at his/her own discretion.

 

(3)

For Option Beneficiaries who belonged to Linde Band 4 of Linde AG Group on the issue date of the respective Linde AG LTIP Tranche, in order to continue to hold Restricted Share Units granted in replacement of the portion of the respective Option Beneficiary’s Linde AG Matching Share Rights granted under the respective Linde AG LTIP Tranche for the duration of the applicable Waiting Period, they must make a voluntary investment in Self-financed Investment Shares no later than the end of the Investment Period, provided that for these Option Beneficiaries, the self-financed investment shall not be a precondition for the participation in the LTIP 2018 nor a precondition for the granting of Option Rights. The number of voluntarily acquirable Self-financed Investment Shares for which Restricted Share Units shall be granted shall be notified to the respective Option Beneficiary by way of the Award Letter or in a separate communication. In the event the Option Beneficiary voluntarily acquires Self-financed Investment Shares, the self-financed investment in Linde plc Shares shall be made and the Self-financed Investment Shares shall be transferred to such Option Beneficiary’s LTIP 2018 Securities Account within the Investment Period. Except as otherwise stated in this para. 3, § 2 para. 2 shall apply accordingly.

 

(4)

To make the self-financed investment under the LTIP 2018, the Option Beneficiary may use a portfolio of Linde plc Shares already held by him/her, e.g., Linde plc Shares received in connection with the Exchange Offer, unless such Linde plc Shares are already locked-up for the purposes of another stock option plan of Linde plc Group or other forms of remuneration or are otherwise a precondition to the granting and/or the continuity of such forms of remuneration. In such case, the respective number of Linde plc Shares shall be transferred to the LTIP 2018 Securities Account within the Investment Period.

 

(5)

In the event of a termination of the Option Beneficiary’s employment or service contract under circumstances described in § 8 para. 2 a) and c), 3, 5 (in conjunction with para. 2 a) only) and 6, the Option Beneficiary will no longer be required to hold any Self-financed Investment Shares and may freely dispose of these Linde plc Shares as of such time.

 

(6)

An Option Beneficiary who has made a self-financed investment shall be obliged to comply with regular certification of holdings in accordance with the Linde plc policies and procedures as may be in effect from time to time and, at any time upon request of Linde plc, to provide evidence of the Option Beneficiary’s self-financed investment by submitting a bank statement showing the Self-financed Investment Shares relating to the self-financed investment. The certification documentation or bank statement shall confirm that the Self-financed Investment Shares were held by the Option Beneficiary from the day following the expiry of the Investment Period until the date of expiry of the Waiting Period, respectively, as of which date the certification documentation or bank statement shall be prepared. Notwithstanding the aforementioned, Linde plc may decide that the Account Bank shall grant Linde plc sight of the LTIP 2018 Securities Account and, if necessary, provide further information relating thereto. In particular, the Account Bank shall inform Linde plc if it becomes aware of a disposition by any Option Beneficiary of Self-financed Investment Shares before the expiry of the Waiting Period. To the extent it becomes aware thereof, the Account Bank shall further inform Linde plc about any third party enforcement measures with respect to the LTIP 2018 Securities Account. The Account Bank shall, in its account documentation, obtain the consent of the Option Beneficiary to the actions contemplated in this paragraph.

 

4


(7)

The Self-financed Investment Shares shall be transferred to the LTIP 2018 Securities Account free of any third party rights. The Option Beneficiary shall neither pledge the Self-financed Investment Shares nor shall he/she enter into any hedging arrangements or back-to-back-transactions by which the price risk pertaining to the Self-financed Investment Shares is fully or partially economically hedged. The Option Beneficiary shall further neither grant any sub-participations or interests in the Self-financed Investment Shares nor agree to any trust relationship relating to Self-financed Investment Shares in which the Option Beneficiary acts as a trustee. The Self-financed Investment Shares shall be subject to any Linde plc policy regarding share ownership, hedging and/or pledging as may be applicable to the Option Beneficiary from time to time.

 

(8)

If the Option Beneficiary does not comply with his/her obligations in relation to the Self-financed Investment Shares pursuant to § 2 para. 2 to 7, any and all Option Rights and Restricted Share Units of the Option Beneficiary shall lapse without replacement or compensation, provided that in the case of Option Beneficiaries who belonged to Linde Band 4 of Linde AG Group on the issue date of the respective Linde AG LTIP Tranche, this forfeiture provision shall apply solely to Restricted Share Units granted in replacement of the respective Option Beneficiary’s Linde AG Matching Share Rights granted under the respective Linde AG LTIP Tranche and not to Option Rights.

 

(9)

In acquiring Self-financed Investment Shares the respective Option Beneficiary shall ensure that he/she does not violate insider trading restrictions imposed by mandatory law or the rules of any stock exchange or by Linde plc, from time to time (“ Dealing Restrictions ”). If an Option Beneficiary for this reason is not allowed to make the self-financed investment within the Investment Period, the Investment Period shall be extended by that period during which the Dealing Restrictions prohibit such acquisition. In these cases, the end of the Investment Period shall be announced by Linde plc. If the acquisition and/or the holding of Self-financed Investment Shares by the Option Beneficiary is, or becomes, prohibited pursuant to the Dealing Restrictions or any other legal requirements or if the satisfaction of the Dealing Restrictions or any other legal requirements in connection with the Self-financed Investment Shares requires disproportionate efforts by Linde plc and/or the Option Beneficiary, e.g., the preparation of a prospectus or the involvement of an intermediate, Linde plc shall, with respect to the respective Option Beneficiary, be entitled to waive the self-financed investment as a precondition to such Option Beneficiary’s participation in the LTIP 2018. In such case, Linde plc may enter into an agreement with the respective Option Beneficiary on an individual basis.

§ 3 Option Rights

 

(1)

Linde plc grants replacement option rights to Option Beneficiaries, which confer the right to subscribe for Linde plc Shares as set forth in these Plan Conditions (“ Option Rights ”).

 

(2)

Linde plc grants to each Option Beneficiary an award of Option Rights with respect to a number of Linde plc Shares equal to the number set forth in the Option Beneficiary’s Award Letter or in a separate communication. The Award Letter or the separate communication also specifies the respective Elapsed Months and Waiting Periods (both as defined in § 7 para. 1) for the relevant Option Rights.

 

(3)

The Option Rights are deemed to be issued on the date specified in the Option Beneficiary’s Award Letter (“ Issue Date ”).

 

(4)

The maximum term of the Option Rights shall amount to the period of five years less the number of Elapsed Months, measured from the Issue Date, subject to the earlier lapse of the Option Rights pursuant to these Plan Conditions.

 

(5)

Option Rights which are not exercised or could not be exercised by the end of the term shall lapse without replacement or compensation.

 

5


§ 4 Issue Conditions, Exercise Price

 

(1)

Each Option Right shall entitle the Option Beneficiary to subscribe for one share of Linde plc (“ Option Ratio ”) at the Exercise Price pursuant to these Plan Conditions. The “ Exercise Price ” shall be EUR 1.67.

 

(2)

Linde plc may, at its sole discretion at any time prior to the Exercise Period (as defined in § 7 para. 2), choose to either

 

  a)

deliver either newly issued Linde plc Shares or treasury Linde plc Shares, or

 

  b)

fulfill the obligation to deliver Linde plc Shares by making a cash payment to the Option Beneficiary, in which case no Exercise Price according to § 4 para. 1 shall be due, in an amount per Linde plc Share equal to the excess of (i) the closing price of a Linde plc Share in the Xetra trading (or a comparable successor system) on the Frankfurt Stock Exchange on the Exercise Date (as defined in § 9 para. 4) over (ii) the Exercise Price (“ Cash Compensation ”). Linde plc may, at its sole discretion, choose whether to make the payment of the Cash Compensation to the LTIP 2018 Clearing Account or to any other account of the respective Option Beneficiary.

The decision to fulfill the obligation to deliver Linde plc Shares by making a cash payment to the Option Beneficiary according to § 4 para. 2 b) shall be announced to the Option Beneficiaries in the form as set forth in § 12 prior to the start of the Option Rights’ respective Exercise Period.

 

(3)

Linde plc Shares issued or transferred from treasury following the exercise of Option Rights shall rank equally in all respects with all other Linde plc Shares then in issue, save that they will not rank for any voting, dividend or other rights attaching to Linde plc Shares by reference to a record date preceding the date of their issue or transfer from treasury.

§ 5 Restricted Share Units

 

(1)

Linde plc grants, if applicable, replacement restricted share units to certain Option Beneficiaries, that represent an unfunded and unsecured promise to deliver Linde plc Shares to such Option Beneficiaries as set forth in these Plan Conditions (“ Restricted Share Units ”).

 

(2)

Linde plc grants to each Option Beneficiary who, immediately prior to the Closing Time, held Linde AG Matching Share Rights an award of Restricted Share Units with respect to a number of Linde plc Shares equal to the number set forth in the Option Beneficiary’s Award Letter or in a separate communication. The Award Letter or the separate communication also specifies the respective Elapsed Months and Waiting Periods for the relevant Restricted Share Units.

 

(3)

The Restricted Share Units are deemed to be issued on the Issue Date.

 

(4)

If the following conditions are satisfied, the Restricted Share Units shall vest at the end of the Waiting Period and Linde plc shall, in accordance with the following conditions and, subject to an adjustment pursuant to § 6 para. 5, deliver to the Option Beneficiary one Linde plc Share in respect of each Restricted Share Unit that so vests:

 

  a)

the Self-financed Investment Shares have been transferred into the LTIP 2018 Securities Account in accordance with the provisions set forth in § 2 para. 2 or 3, as applicable, above within the Investment Period,

 

  b)

the Option Beneficiary has not violated the provisions under § 2 para. 4 to 7,

 

  c)

the Self-financed Investment Shares have been held in the LTIP 2018 Securities Account by the Option Beneficiary permanently from the end of the Investment Period until the end of the Waiting Period except as provided for in § 2 para. 5,

 

6


  d)

at the end of the Waiting Period, the respective Option Beneficiary has an employment or service contract with Linde plc or any member of the Linde plc Group which has not been terminated. If the employment or service contract is terminated prior to the expiry of the Waiting Period, § 8 shall apply to the Restricted Share Units mutatis mutandis, and

 

  e)

if the Linde plc Shares to be delivered to the Option Beneficiary are newly issued Linde plc Shares, the Option Beneficiary will have paid to Linde plc, or made arrangements satisfactory to Linde plc to procure the payment of, the nominal value of the Linde plc Shares to be issued, in cash.

 

(5)

For the fulfillment of its obligations under the Restricted Share Units, Linde plc intends to use either newly issued Linde plc Shares or treasury Linde plc Shares. However, Linde plc shall, instead of delivering Linde plc Shares, be entitled to make a cash payment to the respective Option Beneficiary the amount of which shall be equal to the product of the number of Linde plc Shares to be delivered to the Option Beneficiary and the average of the closing prices of a Linde plc Share in the Xetra trading (or a comparable successor system) on the Frankfurt Stock Exchange within the last 60 trading days of the Waiting Period.

 

(6)

Linde plc Shares issued or transferred from treasury to settle Restricted Share Units shall rank equally in all respects with all other Linde plc Shares then in issue, save that they shall not rank for any voting, dividend or other rights attaching to Linde plc Shares by reference to a record date preceding the date of their issue or transfer from treasury.

§ 6 Adjustment of Plan Conditions; Termination of Option Rights and Restricted Share Units

 

(1)

In the event of (a) a variation or reduction in the share capital of Linde plc or (b) a demerger, delisting, special dividend or other similar event, Linde plc may adjust the Option Ratio and/or the Exercise Price to avoid or minimize any alteration of the economic value of the Option Rights, provided always that the adjusted Exercise Price shall in all cases be no lower than the nominal value per Linde plc Share. 1

 

(2)

The number of Linde plc Shares to be held as Self-financed Investment Shares pursuant to § 2 para. 2 or 3, as applicable, and the maximum aggregate number of Linde plc Shares specified in paragraph 6 of the Preamble, shall be adjusted in the same manner as any adjustment made to the Option Ratio pursuant to § 6 para. 1.

 

(3)

The adjustment pursuant to § 6 para. 1 and 2 shall be calculated by Linde plc. Linde plc shall announce the adjusted Option Ratio and/or adjusted Exercise Price, the adjusted number of Self-financed Investment Shares, the adjusted maximum aggregate number of Linde plc Shares and the reference date from which the adjusted Option Ratio and/or adjusted Exercise Price shall apply, in accordance with the form set forth in § 12.

 

(4)

Fractions of Linde plc Shares shall not be delivered. In the event that the aforementioned adjustment results in fractions of Linde plc Shares, the number of Linde plc Shares subject to Option Rights shall be determined by rounding based on commercial principles. Fractions of Linde plc Shares not taken into account shall neither be compensated in cash nor otherwise.

 

(5)

The provisions of this § 6 para. 1 through 4 shall apply to Restricted Share Units mutatis mutandis provided that the number of Self-financed Investment Shares that must be held in respect of Restricted Share Units shall be adjusted in the same ratio as the Option Ratio pursuant to § 6 para. 1, regardless of the number of Linde plc Shares the Option Beneficiary holds as self-financed investment.

 

1  

Note to Linde Accounting : Under U.S. GAAP, in order to avoid incremental charges, certain adjustments are typically mandatory (with the manner of adjustment determined by the committee that administers the LTIP).

 

7


(6)

In the event that a Change in Control (as defined in the Annex) occurs or is about to occur, Linde plc shall determine that one or more of the following actions shall apply to outstanding Option Rights and Restricted Share Units, without the consent of the Option Beneficiary (save as required by applicable law), contingent upon the Change in Control becoming effective in accordance with its terms:

 

  a)

If Linde plc is the surviving entity, Option Rights and/or Restricted Share Units shall continue in effect, subject to such adjustments to

 

   

the Option Ratio and/or the Exercise Price,

 

   

the number of Linde plc Shares to be held as Self-financed Investment Shares pursuant to § 2 para. 2 or 3, as applicable,

 

   

the maximum aggregate number of Linde plc Shares specified in paragraph (6) of the Preamble, and

 

   

the number of Linde plc Shares subject to a Restricted Share Unit

as Linde plc shall determine are appropriate to account for the Change in Control, and otherwise in accordance with the terms of such Option Rights and/or Restricted Share Units;

 

  b)

Options Rights, to the extent not fully exercisable, shall become exercisable in full or in part;

 

  c)

Restricted Share Units, to the extent not vested and/or settled in full, shall vest in full or in part and be settled;

 

  d)

Option Rights having an Exercise Price equal to or greater than the value of the consideration payable for a Linde plc Share in the Change in Control shall be cancelled, without payment to the Option Beneficiary of consideration;

 

  e)

Option Rights and/or Restricted Share Units shall be cancelled in consideration of one or more payments to the Option Beneficiary per Linde plc Share subject to such Option Rights or Restricted Share Units, from Linde plc or the acquiring entity or its parent company, in cash and/or securities and/or other consideration, equivalent in value, in respect of Option Rights, to the amount by which the price payable for a Linde plc Share in the Change in Control exceeds the Exercise Price and in respect of Restricted Share Units, to the price payable for a Linde plc Share in the Change in Control;

 

  f)

Option Beneficiaries shall be given an opportunity to exercise Option Rights within a specified period, failing which such Option Rights shall lapse without replacement or compensation;

 

  g)

Option Rights and/or Restricted Share Units shall be assumed by the acquiring entity (or a parent or subsidiary of such entity) and converted into, or cancelled and replaced with, an equivalent award in respect of such entity’s shares;

 

  h)

Option Rights and/or Restricted Share Units shall continue in effect in accordance with their terms;

 

  i)

Self-financed Investment Shares held by an Option Beneficiary shall be released from lock-up in whole or in part, and such released Self-financed Investment Shares may be sold or transferred by the Option Beneficiary; or

 

  j)

any other action that Linde plc determines is equitable and substantially delivers or preserves the economic value of the Option Right or Restricted Share Unit, having regard to the terms of the Option Right or Restricted Share Unit and the terms of the Change in Control.

Any such action shall take effect as of the time the Change in Control becomes effective in accordance with its terms or such other date as Linde plc determines.

Linde plc is not obliged to take the same action or actions with respect to all Option Rights and Restricted Share Units or with respect to all Option Beneficiaries.

Linde plc shall have full and final authority to determine conclusively whether a Change in Control has occurred pursuant to these Plan Conditions, the date the Change in Control becomes effective and any incidental matters relating thereto.

 

8


§ 7 Preconditions for Exercise: Waiting Period and Exercise Period

 

(1)

Subject to § 6 para. 6, the Option Rights may be exercised at the earliest on the fourth anniversary of the Issue Date less the respective Elapsed Months (“ Waiting Period ”). The “ Elapsed Months ” is the number of months commencing with the first full calendar month after the date on which Tranches 2015, 2016 and 2017 were granted, respectively, up to and including the full calendar month of the Issue Date.

 

(2)

The Option Rights may be exercised within the period of twelve months after the end of the Waiting Period (“ Exercise Period ”). Unless otherwise determined by the Committee, the Option Beneficiaries may not exercise the Option Rights during the following “ Lock-up Periods ”: three weeks before and until one day after the publication of quarterly results or results for the first six months, the last two weeks before the end of a financial year until one day after the publication of the results of the respective financial year, the period starting 14 weeks before until the third Banking Day after the annual general meeting of Linde plc and such other lock-up period(s) determined by Linde plc from time to time. The periods between these Lock-up Periods during which the Option Beneficiary may exercise the Option Rights are the “ Exercise Times ”. “ Banking Day ” is any day, other than Saturday and Sunday, on which banks are open for general business in Frankfurt am Main, Germany.

 

(3)

Regardless of the aforementioned Lock-up Periods, the Option Beneficiaries shall obey any potential statutory or mandatory law or the rules of any stock exchange or Linde plc internal prohibitions or guidelines (in particular with respect to the Dealing Restrictions) when exercising the Option Rights.

§ 8 Determination of the Number of Exercisable Option Rights and Vested Restricted Share Units in Case of Certain Events

 

(1)

Except as set forth in § 8 para. 2 and determined on the basis of § 6 para. 6, Option Rights may only be exercised if the Option Beneficiary is in service or employment with Linde plc or any member of the Linde plc Group at the time of exercise and notice of termination has not been given by either party with regard to the service or employment agreement. Apart from any specific exemption set forth in these Plan Conditions, Option Rights which may not be exercised pursuant to sentence 1 shall lapse without replacement or compensation regardless of the reason for such termination (including death).

 

(2)

The Option Rights shall not lapse, if

 

  a)

the termination of the employment or service contract is brought about by Linde plc or by a member of the Linde plc Group without cause (in particular in the event of termination for economic reasons, transfer of operations to another legal entity, take-over of Linde plc or sale of shareholdings). This also applies if the Option Beneficiary personally terminates his/her employment relationship or service contract pursuant to its terms following a transfer of operations to another legal entity or a sale of shareholdings,

 

  b)

the Option Beneficiary changes his/her employment relationship or service contract from a member of the Linde plc Group to Linde plc or another member of the Linde plc Group, or

 

  c)

the Option Beneficiary

 

   

retires, i.e. , termination of his/her occupation for reasons of old-age (retirement age under the statutory pension scheme, Regelaltersgrenze in der gesetzlichen Rentenversicherung, or equivalent provision under applicable local law), or

 

   

suffers a permanent partial or complete reduction in earning capacity ( teilweise oder volle Erwerbsminderung ) (§ 43 German Social Security Statute VI, SGB  VI, or equivalent provision under applicable local law), it being understood that a reduction in earning capacity shall be regarded as permanent if such reduction in earning capacity lasts at least six months.

 

9


(3)

In the event of the Option Beneficiary’s death, Linde plc shall pay the person(s) entitled to exercise the deceased Option Beneficiary’s property rights a cash compensation for the Option Rights which have lapsed in accordance with the following provisions (“ Heirs’ Compensation ”):

 

  a)

In the event of the Option Beneficiary’s death prior to the expiry of the Waiting Period, the amount of the Heirs’ Compensation shall be equal to (i) the product of the number of Option Rights held by the Option Beneficiary immediately prior to death and the average of the closing prices of a Linde plc Share in the Xetra trading (or a comparable successor system) on the Frankfurt Stock Exchange within the first ten stock exchange trading days of the Exercise Period, less (ii) the product of the Exercise Price and the number of Option Rights held by the Option Beneficiary immediately prior to death.

 

  b)

In the event of the Option Beneficiary’s death after the expiry of the Waiting Period but within the Exercise Period and prior to exercise of Option Rights, the amount of the Heirs’ Compensation shall be equal to (i) the product of the number of Option Rights held by the Option Beneficiary immediately prior to death and the average closing prices of a Linde plc Share in the Xetra trading (or a comparable successor system) on the Frankfurt Stock Exchange within such Exercise Time in which the Option Beneficiary dies or, in case the Option Beneficiary dies within a Lock-up Period, within such Exercise Time which follows the respective Lock-up Period, less (ii) the product of the Exercise Price and the number of Option Rights held by the Option Beneficiary immediately prior to death.

 

(4)

If the employment or service contract of the Option Beneficiary terminates prior to the expiry of a Waiting Period due to any of the events mentioned in § 8 para. 2, the Waiting Period shall not expire on the date of termination of the employment or service contract of the Option Beneficiary and, instead, the Option Rights shall become fully exercisable at the end of the Waiting Period as if the Option Beneficiary’s employment or service contract had not terminated.

 

(5)

In the event the employment or service contract is terminated by way of a severance agreement, the Option Rights shall lapse without replacement or compensation unless the severance agreement shall replace a termination of the employment or service contract due to one of the reasons mentioned in § 8 para. 2 a) and b). If the Option Rights do not lapse pursuant to § 8 para. 2 a) and b), the terms of § 8 para. 4 shall apply mutatis mutandis.

 

(6)

The provisions of § 8 para. 1 through 5 shall apply mutatis mutandis to Restricted Share Units that are outstanding as of the date of termination of employment or service. Upon expiry of the Waiting Period in respect of Restricted Share Units, as set forth in § 8 para. 2, 3 and 4, such Restricted Share Units shall be settled, pursuant to § 9 para. 6.

§ 9 Exercising Option Rights, Settling Restricted Share Units

 

(1)

The Exercise Notice (as defined in § 9 para. 2) may be submitted from the beginning of the Exercise Period with effect as of the respective Exercise Date (as defined in § 9 para. 4).

 

(2)

In order to exercise Option Rights, the Option Beneficiaries must submit to Linde plc an electronic exercise notice using the pre-printed forms available on the website for the LTIP 2018 or otherwise made available to the Option Beneficiaries (“ Exercise Notice ”). All Option Rights which may be exercised in a specific Exercise Period may only be exercised once in accordance with the provisions above. With the Exercise Notice the Option Office (as defined in § 10), to the extent provided in the forms available from Linde plc, is authorized by the Option Beneficiary – by means of exemption from the legal restrictions of self-dealing (§ 181 German Civil Code) – to make the necessary statements and actions to subscribe for the newly issued Linde plc Shares respectively and/or acquire treasury shares of Linde plc (should Linde plc choose to deliver treasury Linde plc Shares pursuant to § 4 para. 2 a) in its own name, but for the account of the Option Beneficiary. The Exercise Notice may also be submitted in writing or by fax to the address or fax number designated by Linde plc, or in such other manner as provided by Linde plc from time to time. In the event of an exercise in writing or by fax, the receipt of the fax or the respective letter by the Option Office shall be decisive for the timely exercise within the meaning of § 9 para. 4 a).

 

10


(3)

In submitting the Exercise Notice the Option Beneficiary may choose one of the following alternatives:

 

  a)

Exercise and Hold ”: exercising the Option Rights in order to acquire and transfer the Linde plc Shares into the LTIP 2018 Securities Account;

 

  b)

Exercise and Sell ”: exercising the Option Rights with the instruction to the Option Office to sell all Linde plc Shares on behalf of the Option Beneficiary on the stock exchange without limit at the best possible price; or

 

  c)

Exercise and Sell to Cover ”: exercising the Option Rights with the instruction to the Option Office to sell as many Linde plc Shares on behalf of the Option Beneficiary on the stock exchange without limit at the best possible price as necessary to cover (i) the Exercise Price for all Linde plc Shares, (ii) all charges and costs arising from, or becoming payable due to, the exercising of the Option Rights or this instruction, and (iii) the advance payment on taxes and other charges (as described in § 9 para. 4) and to transfer the remaining Linde plc Shares into the LTIP 2018 Securities Account.

With regard to the exercise alternatives of “Exercise and Sell” and “Exercise and Sell to Cover”, it should be noted that the Option Office shall firstly sell the Linde plc Shares which were initially placed into the account and shall lastly sell the Linde plc Shares which were lastly placed into the account.

 

(4)

An exercise of Option Rights shall take effect on the Banking Day on which the following conditions have been fulfilled by 11:00 am (Frankfurt am Main, Germany, local time):

 

  a)

the Exercise Notice has been received by the Option Office; and

 

  b)

only with respect to the alternative “Exercise and Hold”, an amount designated on the website for the LTIP 2018 comprising;

 

  (i)

the Exercise Price for all Linde plc Shares to be acquired by the Option Beneficiary, unless Linde plc decided to choose the exercise alternative pursuant to § 4 para. 2 b),

 

  (ii)

all costs and charges which become payable upon exercise of the Option Rights, and

 

  (iii)

the advance payment on taxes and other charges (as described in § 13 para. 5), if applicable in the respective country,

has been paid to Linde plc (“ Exercise Date ”). Linde plc may, in its sole discretion, require that the Option Beneficiary satisfy such payment by crediting the amount described in b) above to the account of the Option Beneficiary with the Account Bank, in which case the Option Beneficiary explicitly agrees that the amount described in b) above may be debited from his account with the Account Bank by the Option Office.

 

(5)

If the Option Beneficiary does not choose the exercise alternative “Exercise and Sell”, the Linde plc Shares to be delivered with respect to the exercise of the Option Rights shall be credited to the LTIP 2018 Securities Account of the Option Beneficiary as soon as possible after the Exercise Notice becomes effective, generally within five Banking Days. Linde plc may make arrangements with the Option Office to have the Option Office, with respect to the exercise alternatives “Exercise and Sell” and “Exercise and Sell to Cover”, pre-fund the Exercise Price for the account of the Option Beneficiary and deduct a) the prefunded Exercise Price, b) any costs and charges and c) the advance payment on taxes and other charges (as described in § 9 para. 4 b) (ii) and (iii)) from the proceeds upon sale of the Linde plc Shares for the account of the Option Beneficiary and pass on the advance payment on taxes and other charges (as described in § 9 para. 4 b) (iii)) to Linde plc or the employer of the Option Beneficiary. The Option Beneficiary hereby agrees to such procedure and to such other reasonable procedures for the payment of the Exercise Price and the amounts described in b) and c) above as Linde plc may implement from time to time.

 

11


(6)

In respect of Restricted Share Units, Linde plc Shares shall be credited to the Option Beneficiary’s LTIP 2018 Securities Account automatically within ten (10) Banking Days after expiry of the Waiting Period if the requirements of § 5 para. 4 are met; an exercise of the Restricted Share Units is not required. If Linde plc decides to pay a cash compensation pursuant to § 5 para. 5 instead of delivering Linde plc Shares, this amount shall be automatically transferred to the Option Beneficiary with the next practicable payroll which the Option Beneficiary receives from Linde plc Group.

§ 10 Option Office

Linde plc is entitled to appoint at any time at its own choice employees of Linde plc or a member of the Linde plc Group, a credit institute, a specialist share/option plan administrator or an accounting firm as Linde plc’s option office (“ Option Office ”). Notwithstanding any other functions the Option Office may otherwise have or exercise in relation to Linde plc or a member of Linde plc Group, for the purposes of these Plan Conditions the Option Office acts exclusively for the Option Beneficiary in exercising such Option Beneficiary’s Option Rights. The liability of the Option Office is limited, however, to gross negligence and willful misconduct, provided that this does not relate to those main obligations which are essential for the fulfillment of these Plan Conditions ( Kardinalpflichten ).

§ 11 Costs

The Option Beneficiary bears the transaction costs arising out of the exercising of Option Rights and settlement of Restricted Share Units, including any exercise commission, any costs of selling the Linde plc Shares as well as any costs for his/her LTIP 2018 Securities Account. Linde plc bears its internal costs.

§ 12 Announcements

 

(1)

Announcements and statements by Linde plc concerning these Plan Conditions will be sent to the Option Beneficiaries by means of electronic data transmission. In exceptional cases the statements may be sent in writing or by fax as well.

 

(2)

All statements by the Option Beneficiary concerning the Option Rights or the Restricted Share Units must be made in the German or English language by means of electronic data transmission (email) vis-à-vis Linde plc to the (email) address of Linde plc mentioned in the Award Letter, even if addressed to the Option Office. The statements may be made in writing or by fax as well.

 

(3)

The Option Beneficiary is well aware of the risks related to the transmission via fax or electronic data transmission, in particular the possible technical failure of the transmission and the risk of misuse as a result of lack of an original signature. The decision to use fax or electronic data transmission is solely with the Option Beneficiary. All risks related thereto are therefore borne by the Option Beneficiary.

§ 13 Taxes, Charges

 

(1)

Any taxes, social security contributions or other expenses and public charges which accrue to the Option Beneficiary in conjunction with the grant, exercise, vesting or settlement of Option Rights, the grant, vesting or settlement of Restricted Share Units and the delivery of cash or Linde plc Shares in connection therewith are to be borne by the Option Beneficiary. The same applies if Linde plc chooses to satisfy and/or settle Option Rights or Restricted Share Units by way of Cash Compensation or a cash payment made in connection with a Change in Control.

 

(2)

In case the Option Beneficiary is obliged to pay taxes in Germany, the income tax and any other taxes and compulsory social security contributions on the non-cash benefit obtained by the Option Beneficiary from granting or exercising of Option Rights and granting or settlement of Restricted Share Units will be retained from the payments to the Option Beneficiary in accordance with legal provisions applicable from time to time (“ Withholding of Income Tax ”) except to the extent due to the exercising alternative chosen by the Option Beneficiary (§ 9 para. 3), an advance payment on taxes and other charges has already been made. This may lead to a complete reduction of the payments to the Option Beneficiary in a certain month. If the Withholding

 

12


  of Income Tax exceeds the payments to the Option Beneficiary from which taxes and other charges may be withheld, the Option Beneficiary shall pay the excess to Linde plc or, in the sole discretion of Linde plc, Linde plc or the employing company may debit the difference by means of a direct debit from the Option Beneficiary’s payment account subject to sufficient prior written notification. In this case, the Option Beneficiary must ensure that the account has sufficient funds, otherwise a notification on the insufficient payment will be sent to the competent revenue authorities of taxes and charges.

 

(3)

In case of Option Beneficiaries who are subject to tax outside of Germany, Linde plc or any employing company may deduct or withhold such amount and make such arrangements as it considers necessary to meet any liability to taxation, social security or other charges in respect of the Option Rights, the Restricted Share Units, and the Linde plc Shares delivered upon exercising the Option Rights and settling the Restricted Share Units unless, due to the exercising alternative chosen by the Option Beneficiary (§ 9 para. 3), an advance payment on taxes and other charges has already been made. These arrangements may include the withholding of the payments to the Option Beneficiary, the sale of any Linde plc Shares, or in the case of Cash Compensation, a deduction from that payment, unless the Option Beneficiary discharges his/her respective liability to pay taxes, social security contributions or other charges himself or herself, and provides evidence thereof, to the satisfaction of Linde plc or the employing company.

 

(4)

To the extent an advance payment on taxes and other charges due to the exercising alternative chosen by the Option Beneficiary (§ 9 para. 3) exceeds the amount to be withheld pursuant to § 13 para. 2 or 3, the Option Beneficiary shall be reimbursed for the excess amount by Linde plc or the employing company via his/her payments account.

 

(5)

The advance payment on taxes and other charges shall be calculated by multiplying the number of Linde plc Shares subscribed for by a) the excess of the closing price of a Linde plc Share in the Xetra trading (or a comparable successor system) on the Frankfurt Stock Exchange on the last stock exchange trading day prior to the exercise over the Exercise Price and b) the applicable tax rate as determined by Linde plc.

§ 14 Liability and Risks

 

(1)

Linde plc does not bear or take any responsibility whatsoever for general market developments or the market price of Linde plc Shares. For this reason, there is in particular no guarantee that an Option Beneficiary will obtain any economic benefit from the grant or exercise of Option Rights, or the grant, vesting or settlement of Restricted Share Units, or the delivery of Linde plc Shares or be in a position to make a profit on the sale of Linde plc Shares. The acceptance and exercise of Option Rights, the acceptance of Restricted Share Units, as well as the acquisition of Self-financed Investment Shares as a precondition to participation in the LTIP 2018 (from Band 5 and higher of Linde AG Group on the issue date of the respective Linde AG LTIP Tranche) or, on a voluntary basis, as a precondition to the vesting of Restricted Share Units (Band 4 of Linde AG Group on the issue date of the respective Linde AG LTIP Tranche) are therefore carried out solely at the individual Option Beneficiary’s risk. The Option Beneficiary in particular bears the price risk and the risk of losing his/her self-financed investment relating to Self-financed Investment Shares.

 

(2)

Linde plc also does not bear or take any responsibility whatsoever for the legal treatment of taxes and charges, especially that taxes and charges to be retained or taxes and charges to be paid by the Option Beneficiary only accrue based on the difference between the Exercise Price and the current stock exchange price when Option Rights are exercised or to the market price of Linde plc Shares when Restricted Share Units are settled or to an actually generated profit from a sale or another specific amount when Linde plc Shares are delivered. It is recommended that Option Beneficiaries consult a tax expert. The respective Option Beneficiary shall bear the cost of such tax consultation.

 

(3)

In case of a submission by fax, Linde plc may determine the authenticity of orders only via the incoming fax order since the original is not available for review. In principle, Linde plc cannot verify just by receiving the fax whether an order was falsified or not (e.g., by affixing a signature from another document). The Option Beneficiary authorizes Linde plc hereby to carry out fax orders received by it provided that these, on their face, carry the signature of the Option Beneficiary. Linde plc does not bear or take any responsibility or liability whatsoever for the availability, functioning, stability or reliability of the telecommunication network or for timely and complete transmission.

 

13


(4)

The technical and organizational measures carried out by Linde plc in order to ensure the functioning of the website and the security of data are in line with up to date customary standards. The availability, functioning, stability and reliability of the website may, from time to time, be subject to disturbance and dysfunction. Linde plc does not bear or take any responsibility or liability whatsoever for the availability, functioning, stability and reliability of the telecommunication network, any internet provider or third party network elements, or for access to Linde plc’s website or timely and complete transmission. Linde plc further bears and takes no responsibility whatsoever for defects or flaws in the hard- and software used for the website, including those of service providers, provided that this does not apply in case of intent or gross negligence. Linde plc reserves the right to interrupt or close down the website without any announcement, e.g., due to safety reasons following unauthorized third party impact.

 

(5)

Linde plc’s liability shall be limited to willful misconduct and gross negligence provided that this does not relate to those main obligations which are essential for the fulfillment of these Plan Conditions ( Kardinalpflichten ).

§ 15 Personal Data

 

(1)

Due to the Option Beneficiary’s participation in the LTIP 2018 and to the extent necessary for the performance of the Plan Conditions, Linde plc, his/her employer, any member of the Linde plc Group, the Option Office and other third parties, in particular service providers commissioned by Linde plc or a member of the Linde plc Group, process personal data (such as name, address, contact details, account details, number and status of Option Rights and Restricted Share Units) of the Option Beneficiary in relation to the grant of Option Rights and Restricted Share Units and the administration and implementation of the LTIP 2018 on the legal basis of Art. 6 (1) sentence 1 subsec. b of the Regulation (EU) 2016/679 (General Data Protection Regulation).

 

(2)

The Option Beneficiary is responsible for keeping his/her personal data that is available to Linde plc, and/or the member of the Linde plc Group he/she is (or was last) employed with, up to date at any time.

 

(3)

In case of doubt, Linde plc or the member of the Linde plc Group the Option Beneficiary is (or was last) employed with is entitled to verify the Option Beneficiary’s identity (including with the help of external service providers commissioned by Linde plc or the member of the Linde plc Group) and/or request adequate evidence to the extent necessary for the performance of the Plan Conditions.

§ 16 Concluding Provisions

 

(1)

The Option Beneficiary is obliged to comply with all legal obligations, in particular the prohibition on insider trading and any insider trading guidelines adopted by Linde plc as well as any applicable obligations to report directors’ dealings at all times, in particular, if and when applicable, upon the grant of Option Rights and Restricted Share Units, the exercise or settlement of any Option Rights or Restricted Share Units and/or in the case of a transaction in Linde plc Shares, which are acquired due to Option Rights or Restricted Share Units or which are (to be) held as Self-financed Investment Shares.

 

(2)

The delivery of Linde plc Shares and any payments, including, but not limited to Cash Compensation under these Plan Conditions is not part of an Option Beneficiary’s contract of employment or of his remuneration under the employment agreement and will not form part of an Option Beneficiary’s remuneration for the purpose of determining entitlement to any benefit of employment including any pension or retirement benefit, life assurance, health insurance or other similar benefit, whether existing or subsequently introduced.

 

(3)

In addition to or in deviation from the Plan Conditions, certain specific provisions may apply to Option Beneficiaries resident or otherwise subject to taxation in certain jurisdictions at the Issue Date or upon exercise of the Option Rights. The provisions contained in the Annex to these Plan Conditions are an integral part of these Plan Conditions.

 

14


(4)

The Option Rights, the Restricted Share Units and these Plan Conditions are subject to the laws of Germany, excluding the conflict of law rules.

 

(5)

In case the Option Beneficiary does not have a place of general jurisdiction in Germany, the jurisdiction for all legal conflicts arising out of matters provided for in these Plan Conditions is Munich, Germany.

 

(6)

Should one of the provisions of these Plan Conditions be or become ineffective or unenforceable either in whole or in part, the remaining provisions shall remain unaffected. As far as legally possible, a provision shall replace an ineffective or unenforceable provision if it respects the sense and purpose of these Plan Conditions at the time the Option Rights or Restricted Share Units are granted. Should a legal gap arise as a result of ineffectiveness or unenforceability or should these Plan Conditions prove to be incomplete for any other reason, the legal gap is to be rectified by means of a supplementary contractual interpretation corresponding to the sense and purpose of these Plan Conditions, by taking into account the legitimate interests of the parties concerned.

 

15


ANNEX to the Linde plc Group Plan Conditions for the LTIP 2018

NOTE: In addition to or in deviation from the Plan Conditions, certain specific provisions may apply to Option Beneficiaries resident in certain jurisdictions at the Issue Date. This Annex describes such provisions.

Please note that the below descriptions may not be comprehensive and they may not apply and/or other provisions may apply at the time Option Rights become exercisable and Restricted Share Units are settled.

For All Jurisdictions , the following applies:

Offer Strictly Private

The offer to acquire Option Rights and the granting of Restricted Share Units is addressed only to directors, officers and employees of companies belonging to the Linde plc Group.

Accordingly, the Option Rights are issued, and the Restricted Share Units are granted, to the Option Beneficiaries on a strictly private and personal basis. This means that the Option Rights and the Restricted Share Units are offered to those individual Option Beneficiaries only who are the addressees of an Award Letter. No other person is the addressee of an Award Letter and thus of the offer made thereby and the offer may not be taken up by any other person. The addressee is not allowed to transfer the right to accept the offer to any other person.

No Copying or Distribution

Also, you must not copy or distribute an Award Letter or the Plan Conditions nor any other document or information given in relation to the LTIP 2018.

No Review of Documents by Securities or Regulatory Authority

Neither the contents of the Award Letter nor the contents of the Plan Conditions or the additional information (in particular any brochure) have been reviewed by any Securities or Regulatory Authority in any jurisdiction. If you are in doubt about any of the contents of this document, you should obtain independent professional advice.

 

16


For specific Jurisdictions, the following applies in addition to the above:

 

Australia

  

Risks of receiving and holding Option Rights, Restricted Share Units and Linde plc Shares

 

Every investment involves an element of risk and employees should be aware that there are risks associated with participation in the LTIP 2018 and acquiring and holding Option Rights, Restricted Share Units and Linde plc Shares.

 

Your Option Rights and Restricted Share Units (if applicable) are subject to Waiting Periods, Lock-up Periods and Dealing Restrictions under the LTIP 2018. You also cannot deal with any Linde plc Shares you receive upon vesting and exercise of your Option Rights and/or Restricted Share Units and you are obliged to comply with all legal obligations, in particular the prohibition on insider trading and any insider trading guidelines adopted by Linde plc.

 

Your Option Rights and Restricted Share Units (if applicable) and therefore your rights to the associated Linde plc Shares, generally depend on your continued employment with the Linde plc group. If your employment with the Linde plc group ceases before the expiry of the Waiting Period, your Option Rights and Restricted Share Units (if applicable) will lapse in certain circumstances. Further, if your employment with the Linde plc group ceases during the Exercise Period, any vested Option Rights and Restricted Share Units (if applicable) that have not yet been exercised may also lapse in certain circumstances.

 

The Option Ratio, the Exercise Price of Option Rights and/or the number of Linde plc Shares to be held as Self-financed Investment Shares may be adjusted if there is any reorganisation of Linde plc’s capital (such as a variation or reduction in the share capital of Linde plc or a demerger, delisting, special dividend or other similar event).

 

Your Option Rights and Restricted Share Units (if applicable) will be granted for no consideration but the Option Rights will be exercisable into Linde plc Shares at the Exercise Price. The Exercise Price may exceed the market price of Linde plc Shares for part or all of the Exercise Period.

 

The grant or allocation of Option Rights and Restricted Share Units may have individual tax consequences.

 

The value of your Option Rights and Restricted Share Units (if applicable) and Linde plc Shares is related to the market price of Linde plc Shares at the relevant time. Linde plc is subject to business risks and uncertainties that could impact on its performance, and consequently affect the market price of its shares, and therefore your Option Rights and Restricted Share Units (if applicable) and/or Linde plc Shares. The market price of Linde plc Shares may also be affected by other factors such as the performance of the economy generally and overall financial market conditions. If the earnings of Linde plc fall, dividends on Linde plc received by you following vesting or exercise of Option Rights and Restricted Share Units (if applicable) may not occur as expected, affecting the value of those Linde plc Shares.

 

Exchange rates can also vary which may impact on the value of Linde plc Shares you acquire under the LTIP 2018 when converted to Australian dollars.

    

 

Exchange rates

 

The price at which Linde plc Shares may be acquired following the exercise of the Option Rights is EUR
1.67 per share, which corresponds to 2.69 Australian dollars as per 23 October 2018.

  

Linde plc will provide you upon your request at any time in the period starting one week before and extending through the entire Exercise Period as soon as reasonably possible with:

 

a) the current market price of the Linde plc Shares as well as the Australian dollar equivalent thereof at such time; and

 

b) the price at which Linde plc Shares are acquired following the exercise of the Option Rights as well as the Australian dollar equivalent thereof at such time.

 

Neither the content of the Award Letter nor of the Plan Conditions or any other document related thereto constitutes financial product advice provided by Linde plc. Any advice given in relation to the Option Rights or Restricted Share Units offered under the LTIP 2018 does not take into account an Option Beneficiary’s objectives, financial situation and needs and Option Beneficiary should consider obtaining their own financial product advice from a person who is licensed by the Australian Securities and Investments Commission to give such advice.

 

17


Brazil   

Option Beneficiaries resident in Brazil who are officers or directors of a Linde plc Group entity in Brazil are requested to check with their local bank any formal requirements for the remittance of funds to Linde plc at the time of exercise of the Option Rights.

 

Option Beneficiaries resident in Brazil may not be allowed at the time of the exercise of the Option Rights to remit any funds to Linde plc to the extent such funds shall cover any deposit fees, securities account fees, wire transfer fees or the like. Accordingly, Option Beneficiaries may well be advised to instruct the Option Office at the time of the exercise of the Option Rights to sell shares and have the Option Office deduct from the proceeds any fees which the Option Beneficiary may have to bear.

 

A report to the Central Bank of Brazil is necessary if the self-financed investment, the Linde plc Shares received in connection with settlement of Restricted Share Units or the Linde plc Shares received after exercising the Option Rights amounts on its own or in total to at least USD 100,000 in one calendar year.

Quebec/Canada   

The Option Beneficiaries acknowledge having specifically requested that this LTIP 2018 as well as all other documents relating thereto be drawn up in the English language only.

 

Les détenteurs d’options reconnaissent avoir spécifiquement exigé que ce LTIP 2018 de même que tous les documents s’y rattachant soient rédigés en langue anglaise uniquement.

China    The State Administration of Foreign Exchange (SAFE) requires that after termination of the employment contract (termination by the employee or a member of the Linde plc Group, retirement, occupational disability or death) the employees have to liquidate their portfolio within 6 months after termination. This concerns the Self-financed Investment Shares as well as Linde plc Shares received in connection with settlement of Restricted Share Units. All Option Rights that have not yet been exercised or could not be exercised, will lapse 6 months after the termination of the employment contract without replacement or compensation, unless otherwise agreed to by Linde plc and the relevant Option Beneficiary.
India   

Option Beneficiaries may have to make remittance of (i) the price of EUR 1.67 per Linde plc Share upon exercise of Option Rights; and/or (ii) the acquisition price for acquiring the Self-financed Investment Shares. For subscription/purchase of Linde plc Shares as stated in point (i) and (ii) above, Option Beneficiaries in India are required to make remittance through an authorized dealer bank (“ADB”). This requires that the Option Beneficiaries must open a bank account with a designated branch of an ADB.

 

For the purpose of such remittance, the Option Beneficiaries must furnish form A2 with the ADB. The form A2 is available from the Option Beneficiary’s ADB. The Option Beneficiaries are responsible for opening the account with the ADB and for making the remittance for share purchase and payment of the purchase price within the applicable deadline.

 

18


    

Exchange control regulations may also require that Option Beneficiaries repatriate to the bank account in
India any proceeds on the sale of the Linde plc Shares immediately upon receipt and in any event no later
than 90 days from the date of sale. It is the Option Beneficiary’s duty to comply with all legal and regulatory
requirements that may be applicable at the time of sale of the shares.

 

Each Option Beneficiary can only remit up to USD 250,000 per financial year in total.

 

Option Beneficiaries resident in India at the time of exercise of Option Rights are advised to consult their
local employer.

New Zealand    Option Beneficiaries have to pay for every Linde plc Share received in respect of a Restricted Share Unit upon settlement a consideration of 1 cent.
UK    By accepting the Option Rights and Restricted Share Units, each Option Beneficiary who is required to acquire Self-financed Investment Shares pursuant to § 2 para. (2) or (3) irrevocably agrees to enter into a joint election in respect of such Self-financed Investment Shares under section 431(1) or section 431(2) of the Income Tax (Earnings and Pensions) Act 2003, if required to do so by Linde plc, the Committee or his/her employer or former employer, before or within 14 days of acquiring such Self-financed Investment Shares.
USA   

This section of the Annex to the Linde plc Group Plan Conditions for the LTIP 2018 (“ USA Annex ”) applies to Option Rights and Restricted Share Units held by Option Beneficiaries who are subject to U.S. taxation on all or any part of their Option Rights and/or Restricted Share Units. Option Rights and Restricted Share Units subject to this USA Annex are intended to comply with Section 409A of the U.S. Internal Revenue Code of 1986, as amended, and the U.S. Treasury Regulations thereunder (“ Section 409A ”). In the event of any conflict, this USA Annex takes precedence over any other section of the LTIP 2018 Plan Conditions, any Award Letters and any other applicable terms.

 

Option Rights and Restricted Share Units are intended to become payable upon the earlier of (i) a fixed time in accordance with U.S. Treasury Regulation § 1.409A-3(a)(4) or (ii) a “change in ownership”, “change in effective control”, or “change in the ownership of a substantial portion of the Company’s assets” as defined under Section 409A (a “ Section  409A Change in Control ”) in accordance with U.S. Treasury Regulation § 1.409A-3(a)(5). Accordingly, to the extent outstanding upon the expiration of the Waiting Period, Option Rights shall be deemed exercised, and Restricted Share Units shall be settled, immediately upon the expiration of the Waiting Period. Any shares received shall be credited to the Option Beneficiary’s LTIP 2018 Securities Account, and any cash compensation with respect thereto shall be paid, within 10 Banking Days of the expiration of the Waiting Period.

 

Where § 8 para. 2, 3 or 4 apply, to the extent that Option Rights or Restricted Share Units remain outstanding, they will not be deemed exercised or payable until the expiration of the Waiting Period. Any shares received shall be credited to the LTIP 2018 Securities Account, and any cash compensation with respect thereto shall be paid, within 10 Banking Days of the expiration of the Waiting Period. Notwithstanding the foregoing, where § 8 para. 3 a) applies, any Heirs’ Compensation which becomes payable shall be paid no later than the later of (i) December 31 of the year in which the Waiting Period expires or (ii) the 60th day following the day on which the Waiting Period expires.

 

Notwithstanding any provision of the LTIP 2018 Plan Conditions or any provision of this USA Annex to the contrary, if a transaction or event described in § 6 para. 6 constitutes a Section 409A Change in Control, all then outstanding Option Rights and Restricted Share Units that are subject to this USA Annex will automatically terminate upon the effective

 

19


 

time of such Section 409A Change in Control, and the cash compensation with respect thereto described in § 6 para. 6 shall be paid to the Beneficiary within 10 Banking Days of such Section 409A Change in Control.

 

If a transaction or event described in § 6 para. 6 does not constitute a Section 409A Change in Control, then to the extent that Linde plc terminates outstanding Option Rights or Restricted Share Units or otherwise accelerates the vesting or exercisability of Option Rights or Restricted Share Units, in each case, in accordance with § 6 para. 6 in connection with such transaction or event, any consideration in respect of Option Rights or Restricted Share Units pursuant to § 6 para. 6 shall become non-forfeitable at the time of the Change in Control, but it will not be paid to the Option Beneficiary prior to the expiration of the Waiting Period or such earlier time (if any) as may be paid in compliance with Section 409A. Any such consideration shall be provided to the Option Beneficiary not later than 10 Banking Days after the expiration of the Waiting Period.

 

20


GLOSSARY

The following provides a short, but not comprehensive, overview of the defined terms used in these Plan Conditions. Such description needs to be read in connection with the respective provision of the Plan Conditions referenced below; only the definition given in the respective section of the Plan Conditions shall be decisive.

 

Term    Meaning
Account Bank    The Bank nominated and engaged by Linde plc for the purpose of administration of the LTIP 2018, § 2 para. 1.
Active Linde AG LTIP Rights    The Linde AG LTIP Rights granted in 2015, 2016 and 2017, Preamble para. 3.
Award Letter    Individual award letter issued by Linde plc, Preamble para. 5.
Banking Day    Any day, other than Saturday and Sunday, on which banks are open for general business in Frankfurt am Main, Germany, § 7 para. 2.
BCA    The underlying business combination agreement (as amended from time to time) of the all-stock merger of equals transaction between, inter alia , Linde AG and Praxair to come together under Linde plc, Preamble para. 1.
Board    The Linde plc Board of Directors, Preamble para. 7.

Cash Compensation

 

 

Change in

Control

  

Cash payment per Linde plc Share by Linde plc in the amount equal to the excess of (i) the closing price of a Linde plc Share in the Xetra trading (or a comparable successor system) on the Frankfurt Stock Exchange on the Exercise Date (as defined in § 9 para. 4) over (ii) the Exercise Price, § 4 para. 2 b).

 

Any of the following transactions or events:

 

(1)    Acquisition of 20% of Linde plc Voting Power

 

Any person (either alone or together with any person acting in concert (within the meaning of the Irish Takeover Rules) with such person) acquires, directly or indirectly, securities of Linde plc that confer, in the aggregate, twenty percent (20%) or more of the voting rights in Linde plc;

 

(2)    A General Offer

 

Any person (either alone or together with any person acting in concert (within the meaning of the Irish Takeover Rules) with such person):

 

a)  obtains Control of Linde plc as a result of making a general offer to acquire the whole of Linde plc’s issued share capital (other than Linde plc Shares held or contracted to be acquired by such person or persons acting in concert (within the meaning of the Irish Takeover Rules) with such person); or

 

b)  already having Control of Linde plc, makes an offer to acquire all of the Linde plc Shares (other than Linde plc Shares held or contracted to be acquired by such person or persons acting in concert (within the meaning of the Irish Takeover Rules) with such person);

 

and such offer becomes or is declared wholly unconditional.

 

(3)    A Scheme of Arrangement or Merger

 

A compromise or arrangement in accordance with section 450 of Chapter 1, Part 9 of the Irish Companies Act 2014, as amended or replaced from time to time for the purposes of a change of Control of Linde plc or any merger, takeover or amalgamation with any other company or companies, resulting in a change of Control of Linde plc, is sanctioned by the High Court of Ireland or a merger is consummated in accordance with the provisions of any laws governing Linde plc, resulting in a change of Control of Linde plc.

 

21


  

(4)    Winding-up

 

The passing of a resolution for the voluntary winding-up or the making of an order for the compulsory winding up of Linde plc;

 

(5)    Asset Sale

 

The sale or disposition of all or substantially all of Linde plc’s assets;

 

but excluding, in the case of (2), (3) and (5) above, any such transaction or event pursuant to which the holders of Linde plc Shares immediately prior to such transaction or event hold, directly or indirectly, after such transaction or event, securities that confer, in the aggregate, more than fifty percent (50%) of the voting rights in the entity that acquires, in the case of a general offer described in (2) above or a scheme or arrangement or merger described in (3) above, Control of Linde plc or in the case of an asset sale described in (5) above, all or substantially all of Linde plc’s assets.

Committee    The compensation committee established by the Linde plc Board Of Directors, which shall be composed of two or more directors, as determined by the Board; provided that, to the extent necessary to comply with the rules of any competent exchange on which Linde plc Shares are listed or quoted and Rule 16b-3 under the Exchange Act, as amended, and any other applicable laws or rules, the compensation committee shall be composed of two or more directors, all of whom shall be independent directors and all of whom shall meet the independence requirements of any competent exchange on which Linde plc Shares are listed or quoted, Preamble para. 7.
Closing Time    October 31, 2018, provided that solely in the case of Option Beneficiaries who were members of Linde AG’s Executive Board as of October 31, 2018, Closing Time as used in the LTIP 2018 means the time of the effectiveness of the Post-Closing Reorganization, as defined in the BCA, Preamble para. 2.
Control    The meaning given by section 432 of the Irish Taxes Consolidation Act 1997, as amended or replaced from time to time.
Dealing Restrictions    Insider trading restrictions imposed by mandatory law or the rules of any stock exchange or by Linde plc, from time to time, § 2 para. 9.
Elapsed Months    The elapsed months consist of the number of months commencing with the first full calendar month after the date on which Tranches 2015, 2016 and 2017 were granted, respectively, up to and including the full calendar month of the Issue Date, § 7 para. 1.
Exchange Act    The U.S. Securities Exchange Act of 1934, as amended, Preamble para. 7.
Exchange Offer    The voluntary public takeover offer by Linde plc as of August 15, 2017 in the form of an exchange offer to acquire all ordinary bearer shares without par value ( auf den Inhaber lautende Stückaktien ohne Nennbetrag ) of Linde AG with the ISIN DE 0006483001 to the shareholders of Linde AG, which was accepted by more than 92 % of the outstanding shares, Preamble para. 2.
Exercise and Hold    Exercising the Option Rights in order to acquire and transfer the Linde plc Shares into the LTIP 2018 Securities Account, § 9 para. 3 a.
Exercise and Sell    Exercising the Option Rights with the instruction to the Option Office to sell all Linde plc Shares on behalf of the Option Beneficiary on the stock exchange without limit at the best possible price, § 9 para. 3 b.
Exercise and Sell to Cover    Exercising the Option Rights with the instruction to the Option Office to sell as many Linde plc Shares on behalf of the Option Beneficiary on the stock exchange without limit at the best possible price as necessary to cover (i) the

 

22


   Exercise Price for all Linde plc Shares, (ii) all charges and costs arising from, or becoming payable due to, the exercising of the Option Rights or this instruction, and (iii) the advance payment on taxes and other charges (as described in § 9 para. 4) and to transfer the remaining Linde plc Shares into the LTIP 2018 Securities Account, § 9 para. 3 c.
Exercise Date    The Banking Day on which the following conditions have been fulfilled by 11:00 am (Frankfurt am Main, Germany, local time): the Exercise Notice has been received by the Option Office and only with respect to the alternative “Exercise and Hold” (as described in § 9 para. 3), an amount designated on the website for the LTIP 2018 comprising (i) the Exercise Price for all Linde plc Shares to be acquired by the Option Beneficiary, unless Linde plc decided to choose the exercise alternative pursuant to § 4 para. 2 a), (ii) all costs and charges which become payable upon exercise of the Option Rights, and (iii) the advance payment on taxes and other charges (as described in § 13 para. 5), if applicable in the respective country, has been paid to Linde plc, § 9 para. 4.
Exercise Notice    An electronic exercise notice by the Option Beneficiary using the pre-printed forms available on the website for the LTIP 2018 or otherwise made available to the Option Beneficiaries, § 9 para. 2.
Exercise Period    The period of twelve months after the end of the respective Waiting Period, § 7 para. 2.
Exercise Price    EUR 1.67, § 4 para. 1.
Exercise Times    The periods between the Lock-up Periods during which the Option Beneficiary may exercise the Option Rights, § 7 para. 2.
Heirs’ Compensation    Cash Compensation for the Option Rights which have lapsed in accordance with § 8 para. 3 granted by Linde plc in the event of the Option Beneficiary’s death to the person(s) entitled to exercise the deceased Option Beneficiary’s property rights, § 8 para. 3.
Investment Period    The period of four months following the Issue Date, § 2 para. 2.
Irish Takeover Rules    The Irish Takeover Panel Act, 1997, Takeover Rules, 2013, as amended or replaced from time to time.
Issue Date    The date specified in the Option Beneficiary’s Award Letter, § 3 para. 3.
Linde AG    Linde Aktiengesellschaft, with its registered office in Munich, registered with the commercial register (Handelsregister) of the local court of Munich under registration number HRB 169850, and its legal successor, if any, Preamble para. 1.
Linde AG Group    Linde AG together with its subsidiaries and affiliated companies, Preamble para. 1.
Linde AG LTIP    The Linde Long Term Incentive Plan (2012) authorized at the annual general meeting of Linde AG on May 4, 2012 as implemented from time to time, Preamble para. 3.
Linde AG LTIP Rights    Linde AG Option Rights and Linde AG Matching Share Rights granted by Linde AG under the Linde AG LTIP to the members of the Executive Board ( Vorstand ) of Linde AG as well as to members of management bodies of its affiliated companies in Germany and abroad and to selected executives of Linde AG and its affiliated companies in Germany and abroad, Preamble para. 3.
Linde AG LTIP Tranches    Tranche 2015, Tranche 2016 and Tranche 2017, Preamble para. 3.
Linde AG Matching Share Rights    Matching share rights granted by Linde AG under the Linde AG LTIP to the members of the Executive Board ( Vorstand ) of Linde AG as well as to members of management bodies of its affiliated companies in Germany and abroad and to selected executives of Linde AG and its affiliated companies in Germany and abroad, Preamble para. 3.
Linde AG Option Rights    Option rights granted by Linde AG under the Linde AG LTIP to the members of the Executive Board ( Vorstand ) of Linde AG as well as to members of management bodies of its affiliated companies in Germany and abroad and to selected executives of Linde AG and its affiliated companies in Germany and abroad, Preamble para. 3.

 

23


Linde plc    Linde Public Limited Company, registered under the laws of Ireland and with its registered office at Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland and principal executive offices at The Priestley Centre, 10 Priestley Road, The Surrey Research Park, Guildford, Surrey GU2 7XY, United Kingdom, Preamble para. 1.
Linde plc Group    Linde plc together with its subsidiaries and affiliated companies from time to time, Preamble para. 1.
Linde plc Shares    Ordinary shares in Linde plc, nominal value of €0.001 per share, Preamble para. 5.
Lock-up Periods    Three weeks before and until one day after the publication of quarterly results or results for the first six months, the last two weeks before the end of a financial year until one day after the publication of the results of the respective financial year, the period starting 14 weeks before until the third Banking Day after the annual general meeting of Linde plc and such other lock-up period(s) determined by Linde plc from time to time, § 7 para. 2.
LTIP 2018    Long Term Incentive Plan 2018 of Linde plc.
LTIP 2018 Clearing Account    Clearing account relating to the LTIP 2018 Securities Account opened and maintained during the term of the LTIP 2018 by the Account Bank for the Option Beneficiaries, § 2 para. 1.
LTIP 2018 Securities Account    Separate securities account of the Option Beneficiary with an account bank or other entity nominated and engaged by Linde plc for the purpose of administration of the LTIP 2018, § 2 para. 1.
Option Beneficiary    Those persons who, immediately prior to the Closing Time, held any Active Linde AG LTIP Rights and who, as of the relevant Issue Date a) are in service or employment with a member of Linde AG Group, b) have not given or received notice of termination of such service or employment, and c) have received an Award Letter, § 1 para. 1.
Option Office    An employee of Linde plc or a member of the Linde plc Group, a credit institute, a specialist share/option plan administrator or an accounting firm appointed by Linde plc. For the purposes of these Plan Conditions the Option Office acts exclusively for the Option Beneficiary in exercising such Option Beneficiary’s Option Rights, § 10.
Option Ratio    Each Option Right entitles the Option Beneficiary to subscribe for one share of Linde plc, § 4 para. 1.
Option Rights    Replacement option rights granted by Linde plc to an Option Beneficiary which confer the right to subscribe for Linde plc Shares as set forth in these Plan Conditions, § 3 para. 1.
Praxair    Praxair, Inc., a Delaware corporation, Preamble para.1.
Restricted Share Units    Replacement restricted share units granted by Linde plc, that represent an unfunded and unsecured promise to deliver Linde plc Shares to certain Option Beneficiaries, § 5 para. 1.
Self-financed Investment Share    The respective number of Linde plc Shares the Option Beneficiaries acquired as self-financed investment, § 2 para. 2.
Tranche 2015    Linde AG LTIP Rights granted in 2015, Preamble para. 3.
Tranche 2016    Linde AG LTIP Rights granted in 2016, Preamble para. 3.
Tranche 2017    Linde AG LTIP Rights granted in 2017, Preamble para. 3.
Waiting Period    The period of forty-eight months after the Issue Date less the respective Elapsed Months, § 7 para. 1.
Withholding of Income Tax    In case Option Beneficiaries are obliged to pay taxes in Germany, the income tax and any other taxes and compulsory social security contributions on the non-cash benefit obtained by the Option Beneficiary from the granting or exercising of Option Rights and the delivery of Linde plc Shares will be retained from the payments to the Option Beneficiary in accordance with legal provisions applicable from time to time, § 13 para. 2.

 

24

Exhibit 5.1

[Arthur Cox Letterhead]

31 October 2018

 

To:

Board of Directors

    

Linde plc

    

The Priestley Centre

    

10 Priestley Road

    

The Surrey Research Park

    

Guildford

    

Surrey GU2 7XY

    

United Kingdom

 

Re:

Linde plc Registration Statement on Form S-8 in relation to the Plans

Ladies and Gentlemen,

 

1.

Basis of Opinion

 

  1.1

We are acting as Irish counsel to Linde plc, a public company limited by shares, incorporated under the laws of Ireland, with its registered office at Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland (the “ Company ”), in connection with the filing by the Company of a registration statement on Form S-8 (the “ Registration Statement ”) with the United States Securities and Exchange Commission (the “ SEC ”) on or around the date hereof under the Securities Act of 1933, as amended (the “ Securities Act ”), relating to the registration of ordinary shares with nominal value €0.001 of the Company (the “ Shares ”) that may be delivered pursuant to the 2002 Praxair, Inc. Long Term Incentive Plan, the 2005 Equity Compensation Plan for Non-Employee Directors of Praxair, Inc., the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan (each of which will be assumed by the Company) and the Linde plc Long Term Incentive Plan 2018 (together, the “ Plans ”).

 

  1.2

This Opinion is confined to, given in all respects on the basis of, governed by and is to be construed in accordance with, the laws of Ireland (meaning Ireland exclusive of Northern Ireland) in force as at the date hereof as currently applied and interpreted by the courts of Ireland. We have made no investigation of and we express no opinion as to the laws of any other jurisdiction or the effect thereof.

 

  1.3

This Opinion is also strictly confined to:

 

  (a)

the matters expressly stated herein at paragraph 2 below and is not to be read as extending by implication or otherwise to any other matter;

 

  (b)

the Documents (as defined in the Schedule); and

 

  (c)

the searches listed at paragraph 1.5 below.


We express no opinion, and make no representation or warranty, as to any matter of fact or in respect of any documents which may exist in relation to the Plans other than the Documents.

 

  1.4

For the purpose of giving this Opinion, we have examined copies sent to us by email in pdf or other electronic format of the Documents.

 

  1.5

For the purpose of giving this Opinion, we have caused to be made the following legal searches against the Company on or about the date hereof (the “ Searches ”):

 

  (a)

on the file of the Company maintained by the Irish Registrar of Companies in Dublin for returns of allotments, special resolutions amending the Memorandum and Articles of Association of the Company and notice of the appointment of directors and secretary of the Company and for the appointment of any receiver, examiner or liquidator;

 

  (b)

in the Judgments Office of the High Court of Ireland; and

 

  (c)

in the Central Office of the High Court of Dublin for any proceedings or petitions filed.

 

2.

Opinion

Subject to the assumptions and qualifications set out in this Opinion and to any matters not disclosed to us, we are of the opinion that:

 

  2.1

the Company is a public company limited by shares, is duly incorporated and validly existing under the laws of Ireland and has the requisite corporate authority to issue the Shares; and

 

  2.2

when the Shares have been issued and, if required, paid for pursuant to and in accordance with the terms and conditions referred to or summarized in the applicable resolutions and the Plans, the Shares will be validly issued, fully paid up and non-assessable (which term means when used herein that no further sums are required to be paid by the holders thereof in connection with the issue of such shares).

 

3.

Assumptions

For the purpose of giving this Opinion, we assume the following without any responsibility on our part if any assumption proves to have been untrue as we have not verified independently any assumption:

 

  3.1

that the Company will receive consideration equal to the aggregate of the nominal value and any premium required to be paid up on the Shares issued pursuant to awards under the Plans and that such consideration will be in cash and/or otherwise provided in accordance with Irish law;

 

  3.2

that the filing of the Registration Statement with the SEC has been authorized by all necessary actions under all applicable laws other than Irish law;

 

  3.3

that the vesting of any awards granted under the Plans and the issue of the Shares upon vesting of such awards (and the issue of the Shares in connection with any other awards granted under the Plans) will be conducted in accordance with the terms and the procedures described in the Plans and the applicable award agreement;

 

2


  3.4

that the exercise of any options granted under the Plans and the issue of the Shares upon exercise of such options (and the issue of the Shares in connection with any other awards granted under the Plans) will be conducted in accordance with the terms and the procedures described in the Plans and the applicable award or enrolment agreement, as the case may be;

 

  3.5

with respect to Shares issued on or after 17 October 2023 (the date of expiry of the Company’s existing authority to issue Shares), that the Company will have renewed its authority to issue the Shares in accordance with the terms and conditions set out in the Articles of Association of the Company and the Companies Act 2014 of Ireland for the remainder of the period that the Registration Statement will continue in effect;

 

  3.6

with respect to Shares issued on or after 17 April 2020 (the date of expiry of the Company’s existing determination of the re-allotment price of any shares which constitute treasury shares), that the Company has determined at a general meeting in accordance with Sections 109 and/or 1078 of the Companies Act 2014 of Ireland the re-allotment price of any Shares which constitute treasury shares;

 

  3.7

that, at the time of grant or issue by the compensation committee of the board of directors of the Company (the “ Committee ”) of any award or Share under the Plans, the Committee has been duly constituted and remains a duly constituted committee of the board of directors of the Company having the necessary powers and authorities to issue awards and the Shares;

Authenticity and bona fides

 

  3.8

the completeness and authenticity of all documents submitted to us as originals or copies of originals and (in the case of copies) conformity to the originals of copy documents and the genuineness of all signatories, stamps and seals thereon;

 

  3.9

where incomplete Documents have been submitted to us or signature pages only have been supplied to us for the purposes of issuing this Opinion, that the originals of such Documents correspond in all respects with the last draft of the complete Documents submitted to us;

 

  3.10

that the terms of the Documents will be observed and performed by the parties thereto;

 

  3.11

that the copies produced to us of minutes of meetings and/or of resolutions correctly record the proceedings at such meetings and/or the subject matter which they purport to record and that any meetings referred to in such copies were duly convened, duly quorate and held, that those present at any such meetings were entitled to attend and vote at the meeting, and acted bona fide throughout and that no further resolutions have been passed or other action taken which would or might alter the effectiveness thereof;

 

  3.12

that the Memorandum and Articles of Association of the Company amended and restated on 17 October 2018 are the current Memorandum and Articles of Association of the Company, are up to date and have not been amended or superseded and that there are no other terms governing the Shares other than those set out in the Memorandum and Articles of Association of the Company;

 

3


Accuracy of searches and warranties

 

  3.13

the accuracy and completeness of the information disclosed in the searches referred to in paragraph 1.5 above and that such information has not since the time of such search or enquiry been altered. It should be noted that searches at the Companies Registration Office, Dublin, do not necessarily reveal whether or not a prior charge has been created or a resolution has been passed or a petition presented or any other action taken for the winding-up of or the appointment of a receiver or an examiner to the Company;

 

  3.14

the truth, completeness and accuracy of all representations and statements as to factual matters contained in the Documents; and

Commercial Benefit

 

  3.15

that the Documents have been entered into for bona fide commercial purposes, on arm’s length terms and for the benefit of each party thereto and are in those parties’ respective commercial interest and for their respective corporate benefit.

 

4.

Disclosure

This Opinion is addressed to you in connection with the registration of the Shares with the SEC. We hereby consent to the inclusion of this Opinion as an exhibit to the Registration Statement to be filed with the SEC. In giving this consent, we do not thereby admit that we are in a category of person whose consent is required under Section 7 of the Securities Act.

 

Yours faithfully,
/s/ Arthur Cox
ARTHUR COX

 

4


SCHEDULE

Documents

 

1.

A copy of the form of the Registration Statement to be filed by the Company with the SEC;

 

2.

A copy of the Plans;

 

3.

The results of the Searches;

 

4.

A copy of the resolutions of the board of directors of the Company dated 22 October 2018 and 23 October 2018;

 

5.

A copy of the Memorandum and Articles of Association of the Company as amended and restated by resolutions of the sole shareholder of the Company on 17 October 2018;

 

6.

A copy of the Certificate of Incorporation of the Company dated and executed 18 April 2017;

 

7.

A copy of the certificate from Guillermo Bichara, an Authorised Officer of the Company, dated 22 October 2018 in relation to the share capital of the Company; and

 

8.

Letter of Status from the Irish Companies Registration Office dated 30 October 2018.

 

5

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of Linde plc of our report dated March 23, 2018 relating to the financial statements, which appears in Linde plc’s 2017 Annual Report on Form 10-K for the year ended December 31, 2017.

/s/ PricewaterhouseCoopers LLP

Stamford, Connecticut

October 31, 2018

Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of Linde plc of our report dated February 28, 2018 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in Praxair Inc.’s 2017 Annual Report on Form 10-K for the year ended December 31, 2017.

/s/ PricewaterhouseCoopers LLP

Stamford, Connecticut

October 31, 2018

Exhibit 23.3

Consent of Independent Auditor

The Board of Directors

Linde Aktiengesellschaft:

We consent to the use of our report dated February 19, 2018, with respect to the consolidated group statements of financial position of Linde Aktiengesellschaft as of December 31, 2017 and 2016, and the related consolidated group statements of profit or loss, comprehensive income, cash flows and changes in group equity for each of the years in the three-year period ended December 31, 2017, and the related notes (collectively, the “consolidated financial statements”), incorporated herein by reference.

/s/ KPMG AG Wirtschaftsprüfungsgesellschaft

Munich, Germany

October 31, 2018